リバビリン (Synonyms: Ribavirin; Ribasphere)

Name: Ribavirin
Brand: MedChemExpress
SKU: HY-B0434
Rating: 5.0 (56 reviews)

製品番号: HY-B0434 純度: 99.96%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

Ribavirin (ICN-1229) is an antiviral agent against a broad spectrum of viruses including HCV, HIVl, and RSV. Ribavirin also has anti-orthopoxvirus and anti-variola activities.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 36791-04-5

容量	価格（税別）	在庫状況	数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 72	在庫あり	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 72	在庫あり	Estimated Time of Arrival: December 31
Solid
100 mg	$66	在庫あり	Estimated Time of Arrival: December 31
200 mg	$95	在庫あり	Estimated Time of Arrival: December 31
500 mg	$198	在庫あり	Estimated Time of Arrival: December 31
1 g		お問い合わせ
5 g		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 56 publication(s) in Google Scholar

Other Forms of Ribavirin:

Ribavirin (Standard) 在庫あり
Ribavirin-¹³C₅ お問い合わせ
Ribavirin-₁₅N, d₂ お問い合わせ
Ribavirin-13C₂ お問い合わせ
Ribavirin (GMP) お問い合わせ

顧客検証

Cell Proliferation/Viability Assay

IHC

RT-PCR

: Ribavirin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Apr 12.; Viability of A549 cells following treatment with 10 μM Ribavirin or the control for 1–5 days.

: Ribavirin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Apr 12.; Ribavirin (10 μg/mL; 0-24 h). Immunoblotting of phosphorylated AMPK (p-AMPK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the lysates of mouse Lewis lung carcinoma (LLC) cells in the presence of Ribavirin.

: Ribavirin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Apr 12.; Ribavirin (10 μM; 0-24 h). Quantitative real-time polymerase chain reaction (qRT-PCR) measurement of 4ebp1 transcripts in LLC cells in the presence of phosphate buffered saline (PBS) or the indicated concentrations of Ribavirin.

: Ribavirin purchased from MedChemExpress. Usage Cited in: mBio. 2023 Oct 31;14(5):e0211023. [Abstract]; Ribavirin (40 mg/kg; po). The RSV F protein level in the lung tissues of each group were determined using immunofluorescence assay.

: Ribavirin purchased from MedChemExpress. Usage Cited in: mBio. 2023 Oct 31;14(5):e0211023. [Abstract]; Ribavirin (40 mg/kg; po). Histopathological analysis of lung tissues in each group was performed using hematoxylin-eosin staining. Black arrow indicates the pulmonary infiltration of inflammatory cells.

Antibiotic アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam

生物活性
プロトコル
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

Ribavirin (ICN-1229) is an antiviral agent against a broad spectrum of viruses including HCV, HIVl, and RSV. Ribavirin also has anti-orthopoxvirus and anti-variola activities.

Cellular Effect

Cell Line	Type	Value	Description	References
A-431	IC₅₀	3.18 3 Compound: RBV	Antiproliferative activity against human A-431 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human A-431 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
A-431	IC₅₀	3.18 3 Compound: RBV	Antiproliferative activity against human A-431 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human A-431 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
A549	CC₅₀	>50 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
A549	CC₅₀	307 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 30612844]
A549	CC₅₀	129.65 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay	[PMID: 32882419]
A549	CC₅₀	129.65 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay	[PMID: 32882419]
A549	CC₅₀	307 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 30612844]
A549	CC₅₀	7611.1 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 34425312]
A549	CC₅₀	>50 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 34273661]
A549	CC₅₀	7611.1 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 34425312]
ACHN	IC₅₀	>100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of ACHN human kidney adenocarcinoma Compound was tested for its effect on the proliferation of ACHN human kidney adenocarcinoma	10.1016/0960-894X(96)00216-8
A549	CC₅₀	> 50 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 34273661]
B16-F10	IC₅₀	3.5 3 Compound: RBV	Antiproliferative activity against mouse B16-F10 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against mouse B16-F10 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
A549	CC₅₀	> 50 3 Compound: Ribavirin	Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
BHK-21	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against hamster BHK21 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT assay Cytotoxicity against hamster BHK21 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT assay	[PMID: 19482481]
ACHN	IC₅₀	> 100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of ACHN human kidney adenocarcinoma Compound was tested for its effect on the proliferation of ACHN human kidney adenocarcinoma	10.1016/0960-894X(96)00216-8
BHK-21	CC₅₀	5.46 3 Compound: RBV	Cytotoxicity against hamster BHK-21 cells incubated for 4 days by MTS assay Cytotoxicity against hamster BHK-21 cells incubated for 4 days by MTS assay	[PMID: 36764470]
B16-F10	IC₅₀	3.5 3 Compound: RBV	Antiproliferative activity against mouse B16-F10 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against mouse B16-F10 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
BHK-21	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against mock-infected BHK21 cells after 48 to 96 hrs by MTT assay Cytotoxicity against mock-infected BHK21 cells after 48 to 96 hrs by MTT assay	[PMID: 25082514]
BHK-21	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against Reo-1 virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against Reo-1 virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 26443549]
BHK-21	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against Reovirus type-1 infected in BHK21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against Reovirus type-1 infected in BHK21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 25082514]
BHK-21	CC₅₀	5.46 3 Compound: RBV	Cytotoxicity against hamster BHK-21 cells incubated for 4 days by MTS assay Cytotoxicity against hamster BHK-21 cells incubated for 4 days by MTS assay	[PMID: 36764470]
BHK-21	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in BHK-21 cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by MTT assay Antiviral activity against Reovirus-1 infected in BHK-21 cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by MTT assay	[PMID: 19482481]
BHK-21	EC₅₀	18 3 Compound: Ribavirin	Inhibition of West Nile viral Rluc-Neo-Rep in BHK21 cell line Inhibition of West Nile viral Rluc-Neo-Rep in BHK21 cell line	[PMID: 16539402]
BHK-21	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against hamster BHK21 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT assay Cytotoxicity against hamster BHK21 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT assay	[PMID: 19482481]
BHK-21	EC₅₀	1.1 3 Compound: Ribavirin	Inhibition of West Nile virus VLP replicon in BHK21 cell line Inhibition of West Nile virus VLP replicon in BHK21 cell line	[PMID: 16539402]
BHK-21	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against mock-infected BHK21 cells after 48 to 96 hrs by MTT assay Cytotoxicity against mock-infected BHK21 cells after 48 to 96 hrs by MTT assay	[PMID: 25082514]
BJ	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human BJ cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay Cytotoxicity against human BJ cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay	[PMID: 28350454]
BHK-21	EC₅₀	1.1 3 Compound: Ribavirin	Inhibition of West Nile virus VLP replicon in BHK21 cell line Inhibition of West Nile virus VLP replicon in BHK21 cell line	[PMID: 16539402]
C6	IC₅₀	13.51 3 Compound: RBV	Antiproliferative activity against rat C6 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against rat C6 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
BHK-21	EC₅₀	18 3 Compound: Ribavirin	Inhibition of West Nile viral Rluc-Neo-Rep in BHK21 cell line Inhibition of West Nile viral Rluc-Neo-Rep in BHK21 cell line	[PMID: 16539402]
C8166	IC₅₀	>100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of C8166 cells expressing the TAT gene of HTLV-1. Compound was tested for its effect on the proliferation of C8166 cells expressing the TAT gene of HTLV-1.	10.1016/0960-894X(96)00216-8
BHK-21	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in BHK-21 cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by MTT assay Antiviral activity against Reovirus-1 infected in BHK-21 cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by MTT assay	[PMID: 19482481]
Caco-2	IC₅₀	34.5 3 Compound: RBV	Antiproliferative activity against human CaCo-2 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human CaCo-2 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
BHK-21	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Yellow fever virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by MTT assay Antiviral activity against Yellow fever virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by MTT assay	[PMID: 19482481]
BHK-21	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Reovirus type-1 infected in BHK21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against Reovirus type-1 infected in BHK21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 25082514]
Calu-3	CC₅₀	160 3 Compound: Ribavirin	Cytotoxicity against human Calu-3 cells assessed as cell growth inhibition incubated for 4 hrs by XTT assay Cytotoxicity against human Calu-3 cells assessed as cell growth inhibition incubated for 4 hrs by XTT assay	[PMID: 36965227]
CCRF-CEM	EC₅₀	>50 3 Compound: Ribavirin	Antiviral activity against HIV-1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis Antiviral activity against HIV-1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis	[PMID: 24312722]
BHK-21	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Yellow fever virus infected in BHK21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against Yellow fever virus infected in BHK21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 25082514]
CCRF-CEM	EC₅₀	>50 3 Compound: Ribavirin	Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis	[PMID: 22464686]
BHK-21	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Reo-1 virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against Reo-1 virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 26443549]
CCRF-CEM	IC₅₀	19 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of CCRF-CEM human lymphoblastic T-leukemia cell line Compound was tested for its effect on the proliferation of CCRF-CEM human lymphoblastic T-leukemia cell line	10.1016/0960-894X(96)00216-8
BHK-21	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against YFV infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against YFV infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 26443549]
CCRF-CEM	IC₅₀	63 3 Compound: Ribavirin	Cytostatic activity against human CEM/0 after 72 hrs by cell counting Cytostatic activity against human CEM/0 after 72 hrs by cell counting	[PMID: 22555152]
BJ	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human BJ cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay Cytotoxicity against human BJ cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay	[PMID: 28350454]
C6	IC₅₀	13.51 3 Compound: RBV	Antiproliferative activity against rat C6 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against rat C6 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
CCRF-CEM	IC₅₀	1 3 Compound: Ribavirin	Inhibition of IMPDH in human CEM cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins Inhibition of IMPDH in human CEM cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins	[PMID: 22555152]
CCRF-CEM	IC₅₀	19 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in CEM cell line Tested for inhibitory effect on RNA virus cell growth in CEM cell line	[PMID: 8246242]
CCRF-SB	IC₅₀	>100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of CCRF-SB human lymphoblastic B-leukemia cell line. Compound was tested for its effect on the proliferation of CCRF-SB human lymphoblastic B-leukemia cell line.	10.1016/0960-894X(96)00216-8
C8166	IC₅₀	> 100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of C8166 cells expressing the TAT gene of HTLV-1. Compound was tested for its effect on the proliferation of C8166 cells expressing the TAT gene of HTLV-1.	10.1016/0960-894X(96)00216-8
CHO	IC₅₀	622.5 3 Compound: ribavirin	Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits	[PMID: 23812503]
CCRF-CEM	EC₅₀	> 50 3 Compound: Ribavirin	Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis	[PMID: 22464686]
CHO-K1	IC₅₀	50 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of CHO-K1 hamster ovarian cancer cell line. Compound was tested for its effect on the proliferation of CHO-K1 hamster ovarian cancer cell line.	10.1016/0960-894X(96)00216-8
CCRF-CEM	EC₅₀	> 50 3 Compound: Ribavirin	Antiviral activity against Human immunodeficiency virus 2 ROD infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis Antiviral activity against Human immunodeficiency virus 2 ROD infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis	[PMID: 22464686]
DU-145	IC₅₀	>100 3 Compound: RBV	Antiproliferative activity against human DU-145 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human DU-145 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
CCRF-CEM	EC₅₀	> 50 3 Compound: Ribavirin	Antiviral activity against HIV-1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis Antiviral activity against HIV-1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis	[PMID: 24312722]
E6SM	CC₅₀	>400 6 Compound: ribavirin	Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of E6SM cells Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of E6SM cells	[PMID: 8709116]
CCRF-CEM	EC₅₀	> 50 3 Compound: Ribavirin	Antiviral activity against HIV-2 ROD infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis Antiviral activity against HIV-2 ROD infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic analysis	[PMID: 24312722]
CCRF-CEM	IC₅₀	1 3 Compound: Ribavirin	Inhibition of IMPDH in human CEM cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins Inhibition of IMPDH in human CEM cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins	[PMID: 22555152]
E6SM	EC₅₀	70 6 Compound: ribavirin	Antiviral activity against HSV1 KOS in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against HSV1 KOS in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
CCRF-CEM	IC₅₀	19 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of CCRF-CEM human lymphoblastic T-leukemia cell line Compound was tested for its effect on the proliferation of CCRF-CEM human lymphoblastic T-leukemia cell line	10.1016/0960-894X(96)00216-8
E6SM	EC₅₀	>400 6 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against HSV1 KOS infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
CCRF-CEM	IC₅₀	19 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in CEM cell line Tested for inhibitory effect on RNA virus cell growth in CEM cell line	[PMID: 8246242]
E6SM	EC₅₀	150 6 Compound: ribavirin	Antiviral activity against HSV2 G in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against HSV2 G in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
CCRF-CEM	IC₅₀	63 3 Compound: Ribavirin	Cytostatic activity against human CEM/0 after 72 hrs by cell counting Cytostatic activity against human CEM/0 after 72 hrs by cell counting	[PMID: 22555152]
E6SM	EC₅₀	48 6 Compound: Ribavirin	Antiviral activity against Vaccina virus infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vaccina virus infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
E6SM	EC₅₀	20 6 Compound: ribavirin	Antiviral activity against Vaccinia virus in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Vaccinia virus in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
CCRF-SB	IC₅₀	> 100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of CCRF-SB human lymphoblastic B-leukemia cell line. Compound was tested for its effect on the proliferation of CCRF-SB human lymphoblastic B-leukemia cell line.	10.1016/0960-894X(96)00216-8
E6SM	EC₅₀	240 6 Compound: ribavirin	Antiviral activity against VSV in E6SM cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against VSV in E6SM cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
CHO	IC₅₀	622.5 3 Compound: ribavirin	Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits	[PMID: 23812503]
E6SM	EC₅₀	960 3 Compound: d	concentration required to inhibit HSV-1(KOS)-induced cytopathicity by 50% in E6SM cells concentration required to inhibit HSV-1(KOS)-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
E6SM	EC₅₀	128 3 Compound: d	concentration required to inhibit HSV-1/TK (B2006) or VMW1837-induced cytopathicity by 50% in E6SM cells concentration required to inhibit HSV-1/TK (B2006) or VMW1837-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
E6SM	EC₅₀	192 3 Compound: d	concentration required to inhibit VSV-induced cytopathicity by 50% in E6SM cells concentration required to inhibit VSV-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
E6SM	EC₅₀	320 3 Compound: Ribavirin	Effective concentration required to inhibit Herpes simplex virus-1 (HSV-1) induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit Herpes simplex virus-1 (HSV-1) induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
E6SM	EC₅₀	0.005 3 Compound: Ribavirin	Effective concentration required to inhibit Herpes simplex virus-1(HSV-1) / thymine kinase deficient (TK-)B2006 / VMW1837 induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit Herpes simplex virus-1(HSV-1) / thymine kinase deficient (TK-)B2006 / VMW1837 induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
E6SM	EC₅₀	65 3 Compound: Ribavirin	Effective concentration required to inhibit Vaccinia virus-induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit Vaccinia virus-induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
CHO-K1	IC₅₀	50 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of CHO-K1 hamster ovarian cancer cell line. Compound was tested for its effect on the proliferation of CHO-K1 hamster ovarian cancer cell line.	10.1016/0960-894X(96)00216-8
E6SM	EC₅₀	40 3 Compound: Ribavirin	Effective concentration required to inhibit vesicular stomatitis virus(VSV) -induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit vesicular stomatitis virus(VSV) -induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
Caco-2	IC₅₀	34.5 3 Compound: RBV	Antiproliferative activity against human CaCo-2 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human CaCo-2 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
E6SM	EC₅₀	48 6 Compound: Ribavirin	Inhibitory activity against HSV-1 (F) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-1 (F) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
E6SM	EC₅₀	240 6 Compound: Ribavirin	Inhibitory activity against HSV-1 (McIntyre) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-1 (McIntyre) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
E6SM	EC₅₀	80 6 Compound: Ribavirin	Inhibitory activity against HSV-2 (G) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-2 (G) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
Calu-3	CC₅₀	160 3 Compound: Ribavirin	Cytotoxicity against human Calu-3 cells assessed as cell growth inhibition incubated for 4 hrs by XTT assay Cytotoxicity against human Calu-3 cells assessed as cell growth inhibition incubated for 4 hrs by XTT assay	[PMID: 36965227]
E6SM	EC₅₀	>400 6 Compound: Ribavirin	Inhibitory activity against vesicular stomatitis virus (VSV) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against vesicular stomatitis virus (VSV) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
DU-145	IC₅₀	> 100 3 Compound: RBV	Antiproliferative activity against human DU-145 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human DU-145 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
Epithelial cell	EC₅₀	>1024.6 3 Compound: Ribavirin	Antiviral activity against influenza B (Hong kong/5/72) in human epithelial cells Antiviral activity against influenza B (Hong kong/5/72) in human epithelial cells	[PMID: 12729645]
ESM	IC₅₀	>= 350 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus HSV-1(KOS) in ESM cell line Tested for inhibitory effect on DNA virus HSV-1(KOS) in ESM cell line	[PMID: 8246242]
E6SM	CC₅₀	> 400 6 Compound: ribavirin	Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of E6SM cells Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of E6SM cells	[PMID: 8709116]
ESM	IC₅₀	>300 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus HSV-2 (G) in ESM cell line Tested for inhibitory effect on DNA virus HSV-2 (G) in ESM cell line	[PMID: 8246242]
E6SM	EC₅₀	0.005 3 Compound: Ribavirin	Effective concentration required to inhibit Herpes simplex virus-1(HSV-1) / thymine kinase deficient (TK-)B2006 / VMW1837 induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit Herpes simplex virus-1(HSV-1) / thymine kinase deficient (TK-)B2006 / VMW1837 induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
E6SM	EC₅₀	128 3 Compound: d	concentration required to inhibit HSV-1/TK (B2006) or VMW1837-induced cytopathicity by 50% in E6SM cells concentration required to inhibit HSV-1/TK (B2006) or VMW1837-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
ESM	IC₅₀	>135 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus TK-HSV-1 (B2006) in ESM cell line Tested for inhibitory effect on DNA virus TK-HSV-1 (B2006) in ESM cell line	[PMID: 8246242]
E6SM	EC₅₀	150 6 Compound: ribavirin	Antiviral activity against HSV2 G in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against HSV2 G in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
ESM	IC₅₀	110 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus TK-HSV-1(VMW 1837) in ESM cell line Tested for inhibitory effect on DNA virus TK-HSV-1(VMW 1837) in ESM cell line	[PMID: 8246242]
E6SM	EC₅₀	192 3 Compound: d	concentration required to inhibit VSV-induced cytopathicity by 50% in E6SM cells concentration required to inhibit VSV-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
ESM	IC₅₀	45 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus VV in ESM cell line Tested for inhibitory effect on DNA virus VV in ESM cell line	[PMID: 8246242]
E6SM	EC₅₀	192 3 Compound: d	concentration required to inhibit vaccinia virus-induced cytopathicity by 50% in E6SM cells concentration required to inhibit vaccinia virus-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
ESM	IC₅₀	>= 400 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in ESM cell line Tested for inhibitory effect on RNA virus cell morphology in ESM cell line	[PMID: 8246242]
Fibroblast	CC₅₀	>200 3 Compound: Rib	Cytotoxicity against chicken embryo fibroblast assessed as reduction in cell viability after 48 hrs by CCK8 assay Cytotoxicity against chicken embryo fibroblast assessed as reduction in cell viability after 48 hrs by CCK8 assay	[PMID: 32092589]
E6SM	EC₅₀	20 6 Compound: ribavirin	Antiviral activity against Vaccinia virus in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Vaccinia virus in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
E6SM	EC₅₀	20 6 Compound: ribavirin	Antiviral activity against thymidine kinase-deficient HSV1 B2006 in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against thymidine kinase-deficient HSV1 B2006 in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
Fibroblast	CC₅₀	>200 3 Compound: Rib	Cytotoxicity against chicken embryo fibroblasts assessed as reduction in cell viability after 48 hrs by CCK-8 assay Cytotoxicity against chicken embryo fibroblasts assessed as reduction in cell viability after 48 hrs by CCK-8 assay	[PMID: 30365885]
FM3A	IC₅₀	3.9 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in FM3A cell line Tested for inhibitory effect on RNA virus cell growth in FM3A cell line	[PMID: 8246242]
E6SM	EC₅₀	240 6 Compound: Ribavirin	Inhibitory activity against HSV-1 (McIntyre) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-1 (McIntyre) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
HCT-116	EC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human HCT-116 cells incubated for 48 hrs by MTT assay Cytotoxicity against human HCT-116 cells incubated for 48 hrs by MTT assay	[PMID: 36518704]
E6SM	EC₅₀	240 6 Compound: Ribavirin	Inhibitory activity against HSV-2 (196) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-2 (196) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
HEK293	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by MTT assay Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by MTT assay	[PMID: 24313730]
E6SM	EC₅₀	240 6 Compound: Ribavirin	Inhibitory activity against HSV-2 (Lyons) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-2 (Lyons) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
E6SM	EC₅₀	240 6 Compound: Ribavirin	Inhibitory activity against TK-deficient HSV-1 (KOS) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against TK-deficient HSV-1 (KOS) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
HEK293	EC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human HEK293 cells incubated for 48 hrs by MTT assay Cytotoxicity against human HEK293 cells incubated for 48 hrs by MTT assay	[PMID: 36518704]
HEK293	EC₅₀	15 3 Compound: RBV	Inhibition of influenza A virus RNA-dependent RNA polymerase expressed in HEK293 cells after 24 hrs by dual luciferase reporter gene assay Inhibition of influenza A virus RNA-dependent RNA polymerase expressed in HEK293 cells after 24 hrs by dual luciferase reporter gene assay	[PMID: 24313730]
E6SM	EC₅₀	240 6 Compound: Ribavirin	Inhibitory activity against vaccinia virus (VV) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against vaccinia virus (VV) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
HEK-293T	CC₅₀	>200 3 Compound: ribavirin	Cytotoxicity against HEK293T cells assessed as cell viability measured at 24 hrs by MTS assay Cytotoxicity against HEK293T cells assessed as cell viability measured at 24 hrs by MTS assay	[PMID: 26288686]
E6SM	EC₅₀	240 6 Compound: ribavirin	Antiviral activity against VSV in E6SM cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against VSV in E6SM cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
HEK-293T	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay	[PMID: 30142611]
E6SM	EC₅₀	320 3 Compound: Ribavirin	Effective concentration required to inhibit Herpes simplex virus-1 (HSV-1) induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit Herpes simplex virus-1 (HSV-1) induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
HEK-293T	CC₅₀	>250 3 Compound: RBV; Ribavirin	Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay	[PMID: 26924568]
E6SM	EC₅₀	320 3 Compound: Ribavirin	Effective concentration required to inhibit Herpes simplex virus-2 (HSV-2) induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit Herpes simplex virus-2 (HSV-2) induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
E6SM	EC₅₀	40 3 Compound: Ribavirin	Effective concentration required to inhibit vesicular stomatitis virus(VSV) -induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit vesicular stomatitis virus(VSV) -induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
HEK-293T	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against HEK293T cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay Cytotoxicity against HEK293T cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay	[PMID: 28350454]
E6SM	EC₅₀	48 6 Compound: Ribavirin	Inhibitory activity against HSV-1 (F) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-1 (F) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
HEK-293T	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against HEK293T cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay Cytotoxicity against HEK293T cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay	[PMID: 31734025]
HEK-293T	CC₅₀	>205 3 Compound: Ribavirin	Cytotoxicity against human 293T cells expressing Gluc assessed as inhibition of cell proliferation after 24 hrs by CCK8 assay Cytotoxicity against human 293T cells expressing Gluc assessed as inhibition of cell proliferation after 24 hrs by CCK8 assay	[PMID: 28314599]
E6SM	EC₅₀	48 6 Compound: Ribavirin	Inhibitory activity against HSV-1 (KOS) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-1 (KOS) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
E6SM	EC₅₀	48 6 Compound: Ribavirin	Antiviral activity against Vaccina virus infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vaccina virus infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
HEK-293T	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against human HEK293T cells after 24 hrs by MTT assay Cytotoxicity against human HEK293T cells after 24 hrs by MTT assay	[PMID: 24785979]
HEK-293T	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human HEK293T cells assessed as cell viability after 48 hrs by CCK-8 assay Cytotoxicity against human HEK293T cells assessed as cell viability after 48 hrs by CCK-8 assay	[PMID: 35304224]
E6SM	EC₅₀	65 3 Compound: Ribavirin	Effective concentration required to inhibit Vaccinia virus-induced cytopathicity by 50% in E6SM cell lines Effective concentration required to inhibit Vaccinia virus-induced cytopathicity by 50% in E6SM cell lines	[PMID: 11495586]
E6SM	EC₅₀	70 6 Compound: ribavirin	Antiviral activity against HSV1 KOS in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against HSV1 KOS in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
HEK-293T	CC₅₀	>250 3 Compound: RBV, Ribavirin	Cytotoxicity against human HEK293T cells assessed as decrease in cell viability by MTT assay Cytotoxicity against human HEK293T cells assessed as decrease in cell viability by MTT assay	[PMID: 25856229]
HEK-293T	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human HEK293T cells assessed as reduction in cell viability after 48 hrs by CCK8 assay Cytotoxicity against human HEK293T cells assessed as reduction in cell viability after 48 hrs by CCK8 assay	[PMID: 32805550]
E6SM	EC₅₀	70 6 Compound: ribavirin	Antiviral activity against thymidine kinase deficient HSV1 VMW1837 in E6SM cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against thymidine kinase deficient HSV1 VMW1837 in E6SM cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17518459]
E6SM	EC₅₀	80 6 Compound: Ribavirin	Inhibitory activity against HSV-2 (G) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against HSV-2 (G) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
HEK-293T	EC₅₀	13.1 3 Compound: ribavirin	Antiviral activity against Chikungunya virus infected in HEK293T cells assessed as reduction of infectivity measured at 24 hrs postinfection by gaussia luciferase reporter gene assay Antiviral activity against Chikungunya virus infected in HEK293T cells assessed as reduction of infectivity measured at 24 hrs postinfection by gaussia luciferase reporter gene assay	[PMID: 26540338]
E6SM	EC₅₀	960 3 Compound: d	concentration required to inhibit HSV-1(KOS)-induced cytopathicity by 50% in E6SM cells concentration required to inhibit HSV-1(KOS)-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
HEK-293T	EC₅₀	8.4 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in HEK293T cells assessed as reduction in viral RNP reconstitution measured at 24 hrs by luciferase reporter gene assay Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in HEK293T cells assessed as reduction in viral RNP reconstitution measured at 24 hrs by luciferase reporter gene assay	[PMID: 26288686]
HEK-293T	EC₅₀	18.4 3 Compound: ribavirin	Antiviral activity against O'nyong-nyong virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis Antiviral activity against O'nyong-nyong virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis	[PMID: 26540338]
E6SM	EC₅₀	960 3 Compound: d	concentration required to inhibit HSV-2(G)-induced cytopathicity by 50% in E6SM cells concentration required to inhibit HSV-2(G)-induced cytopathicity by 50% in E6SM cells	[PMID: 9748360]
E6SM	EC₅₀	> 400 6 Compound: Ribavirin	Inhibitory activity against vesicular stomatitis virus (VSV) replication in E6SM cell cultures of human embryonic skin-muscle Inhibitory activity against vesicular stomatitis virus (VSV) replication in E6SM cell cultures of human embryonic skin-muscle	[PMID: 12459010]
HEK-293T	EC₅₀	20 3 Compound: ribavirin	Antiviral activity against wild type Chikungunya virus IMT infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis Antiviral activity against wild type Chikungunya virus IMT infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis	[PMID: 26540338]
HEK-293T	EC₅₀	5.12 3 Compound: ribavirin	Antiviral activity against wild type Sindbis virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis Antiviral activity against wild type Sindbis virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis	[PMID: 26540338]
E6SM	EC₅₀	> 400 6 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against HSV1 KOS infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
HEK-293T	EC₅₀	18 3 Compound: RBV, Ribavirin	Inhibition of Influenza A virus (A/PR/8/34) RNA-dependent-RNA polymerase transfected in HEK293T cells after 24 hrs by renilla luciferase activity/minireplicon assay Inhibition of Influenza A virus (A/PR/8/34) RNA-dependent-RNA polymerase transfected in HEK293T cells after 24 hrs by renilla luciferase activity/minireplicon assay	[PMID: 25856229]
E6SM	EC₅₀	> 400 6 Compound: Ribavirin	Antiviral activity against HSV2 G infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against HSV2 G infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
HEK-293T	EC₅₀	24.9 3 Compound: RBV	Inhibition of Influenza A virus RdRP infected in human HEK293T cells after 24 hrs by dual luciferase reporter gene assay Inhibition of Influenza A virus RdRP infected in human HEK293T cells after 24 hrs by dual luciferase reporter gene assay	[PMID: 24785979]
E6SM	EC₅₀	> 400 6 Compound: Ribavirin	Antiviral activity against TK-deficient acyclovir-resistant HSV1 KOS infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against TK-deficient acyclovir-resistant HSV1 KOS infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
HEK-293T	EC₅₀	23.8 3 Compound: RBV; Ribavirin	Inhibition of Influenza A virus RdRp transfected in HEK293T cells at 24 hrs by dual luciferase reporter gene-based minireplicon assay Inhibition of Influenza A virus RdRp transfected in HEK293T cells at 24 hrs by dual luciferase reporter gene-based minireplicon assay	[PMID: 26924568]
E6SM	EC₅₀	> 400 6 Compound: Ribavirin	Antiviral activity against VSV infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against VSV infected in human E6SM cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
HEK-293T	IC₅₀	15.36 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in human 293T cells pretreated for 2 hrs followed by viral infection and measured after 24 hrs by Gaussia luciferase reporter gene assay Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in human 293T cells pretreated for 2 hrs followed by viral infection and measured after 24 hrs by Gaussia luciferase reporter gene assay	[PMID: 32273213]
HEK-293T	IC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human HEK-293T cells assessed as reduction in cell viability after 48 hrs by CCK-8 assay Cytotoxicity against human HEK-293T cells assessed as reduction in cell viability after 48 hrs by CCK-8 assay	[PMID: 33571829]
HEL	CC₅₀	>500 3 Compound: Ribavirin	Cytotoxicity against HEL cells Cytotoxicity against HEL cells	[PMID: 17181162]
HEL	CC₅₀	>250 3 Compound: Ribavirin	Cytotoxicity against HEL cells after 3 days by coulter counter analysis Cytotoxicity against HEL cells after 3 days by coulter counter analysis	[PMID: 21232828]
HEL	CC₅₀	>250 3 Compound: Ribavirin	Cytotoxicity against Herpes simplex virus 1 KOS infected HEL cells by trypan blue exclusion method Cytotoxicity against Herpes simplex virus 1 KOS infected HEL cells by trypan blue exclusion method	[PMID: 20034711]
HEL	EC₅₀	125 3 Compound: Ribavirin	Antiviral activity against acyclovir-sensitive Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against acyclovir-sensitive Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HEL	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against HCMV AD169 infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against HCMV AD169 infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEL	EC₅₀	1 6 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEL	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HEL	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HEL	EC₅₀	2 6 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEL	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HEL	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus type 1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Herpes simplex virus type 1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HEL	EC₅₀	>250 6 Compound: Ribavirin	Antiviral activity against Herpes simplex virus-1 KOS infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Herpes simplex virus-1 KOS infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
HEL	EC₅₀	300 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS in HEL cells Antiviral activity against HSV1 KOS in HEL cells	[PMID: 17181162]
HEL	EC₅₀	>500 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS in HEL cells Antiviral activity against HSV1 KOS in HEL cells	[PMID: 17181162]
HEL	EC₅₀	>250 3 Compound: ribavirin	Antiviral activity against HSV1 KOS in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against HSV1 KOS in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEL	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against HSV1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEL	EC₅₀	>250 6 Compound: ribavirin	Antiviral activity against HSV1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against HSV1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
HEL	EC₅₀	>250 6 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against HSV1 KOS infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HEL	EC₅₀	250 3 Compound: ribavirin	Antiviral activity against HSV2 G in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against HSV2 G in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEL	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Human herpesvirus 1 strain KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human herpesvirus 1 strain KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEL	EC₅₀	100 3 Compound: Ribavirin	Antiviral activity against vaccinia virus in HEL cells Antiviral activity against vaccinia virus in HEL cells	[PMID: 17181162]
HEL	EC₅₀	10 6 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEL	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEL	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Vaccinia virus infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HEL	EC₅₀	146 6 Compound: ribavirin	Antiviral activity against Vaccinia virus infected in in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Vaccinia virus infected in in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
HEL	EC₅₀	112 3 Compound: ribavirin	Antiviral activity against Vaccinia virus Lederle in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against Vaccinia virus Lederle in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEL	EC₅₀	112 3 Compound: 1	Antiviral activity against Vaccinia virus lederle infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vaccinia virus lederle infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
HEL	EC₅₀	>250 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEL	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HEL	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HEL	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
HEL	EC₅₀	120 6 Compound: ribavirin	Antiviral activity against VSV in HEL cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against VSV in HEL cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
HEL	EC₅₀	125 3 Compound: ribavirin	Antiviral activity against VSV in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against VSV in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEL	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against VSV infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay Antiviral activity against VSV infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay	[PMID: 20034711]
HEL	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against VSV infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against VSV infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HEL 299	CC₅₀	>250 3 Compound: Ribavirin	Cytotoxicity against human HEL 299 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay Cytotoxicity against human HEL 299 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay	[PMID: 37252100]
HEL 299	IC₅₀	45 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of HELL-299 human diploid embryonal lung cell line. Compound was tested for its effect on the proliferation of HELL-299 human diploid embryonal lung cell line.	10.1016/0960-894X(96)00216-8
HeLa	CC₅₀	>200 6 Compound: ribavirin	Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of HeLa cells Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of HeLa cells	[PMID: 8709116]
HeLa	CC₅₀	300 6 Compound: Rib (Ribavirin)	Cytotoxicity against HeLa cells Cytotoxicity against HeLa cells	[PMID: 14505657]
HeLa	CC₅₀	>500 3 Compound: Ribavirin	Cytotoxicity against HeLa cells Cytotoxicity against HeLa cells	[PMID: 17181162]
HeLa	CC₅₀	>250 3 Compound: Ribavirin	Cytotoxicity against Homo sapiens (human) HeLa cells assessed as change in cellular morphology Cytotoxicity against Homo sapiens (human) HeLa cells assessed as change in cellular morphology	[PMID: 32214762]
HeLa	CC₅₀	>250 3 Compound: Ribavirin	Cytotoxicity against Human coxsackievirus B4 infected human HeLa cells by trypan blue exclusion method Cytotoxicity against Human coxsackievirus B4 infected human HeLa cells by trypan blue exclusion method	[PMID: 20034711]
HeLa	CC₅₀	>300 6 Compound: ribavirin	Cytotoxicity against human HeLa cells Cytotoxicity against human HeLa cells	[PMID: 17046264]
HeLa	CC₅₀	300 6 Compound: Rib	Cytotoxicity against human HeLa cells after 2 days by MTT assay Cytotoxicity against human HeLa cells after 2 days by MTT assay	[PMID: 12444692]
HeLa	CC₅₀	>250 6 Compound: ribavirin	Cytotoxicity against human HeLa cells after 3 days by MTS assay Cytotoxicity against human HeLa cells after 3 days by MTS assay	[PMID: 20347509]
HeLa	CC₅₀	426 6 Compound: Ribovirin	Cytotoxicity against human HeLa cells after 48 hrs by MTT assay Cytotoxicity against human HeLa cells after 48 hrs by MTT assay	[PMID: 19374435]
HeLa	CC₅₀	>500 6 Compound: Ribavirin	Cytotoxicity against human HeLa cells after 72 hrs by MTT assay Cytotoxicity against human HeLa cells after 72 hrs by MTT assay	[PMID: 23920438]
HeLa	CC₅₀	>250 6 Compound: Ribavirin	Cytotoxicity against human HeLa cells assessed as cell viability by MTS assay Cytotoxicity against human HeLa cells assessed as cell viability by MTS assay	[PMID: 20971531]
HeLa	CC₅₀	>250 3 Compound: Ribavirin	Cytotoxicity against human HeLa cells assessed as growth inhibition after 3 days by coulter counting analysis Cytotoxicity against human HeLa cells assessed as growth inhibition after 3 days by coulter counting analysis	[PMID: 21565516]
HeLa	EC₅₀	27.8 6 Compound: Ribavirin	Antiviral activity against Adenovirus type 7 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method Antiviral activity against Adenovirus type 7 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method	[PMID: 23920438]
HeLa	EC₅₀	>500 3 Compound: Ribavirin	Antiviral activity against Coxsackie B4 virus in HeLa cells Antiviral activity against Coxsackie B4 virus in HeLa cells	[PMID: 17181162]
HeLa	EC₅₀	48 6 Compound: ribavirin	Antiviral activity against coxsackie B4 virus in HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against coxsackie B4 virus in HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
HeLa	EC₅₀	150 3 Compound: ribavirin	Antiviral activity against coxsackie B4 virus in HeLa cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against coxsackie B4 virus in HeLa cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
HeLa	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against coxsackie B4 virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against coxsackie B4 virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
HeLa	EC₅₀	90 6 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 in HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackie virus B4 in HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
HeLa	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in HeLa cells Antiviral activity against Coxsackie virus B4 infected in HeLa cells	[PMID: 22464686]
HeLa	EC₅₀	73.1 3 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 20347509]
HeLa	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
HeLa	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
HeLa	EC₅₀	50 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 in human HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 in human HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HeLa	EC₅₀	69 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
ESM	IC₅₀	110 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus TK-HSV-1(VMW 1837) in ESM cell line Tested for inhibitory effect on DNA virus TK-HSV-1(VMW 1837) in ESM cell line	[PMID: 8246242]
ESM	IC₅₀	45 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus VV in ESM cell line Tested for inhibitory effect on DNA virus VV in ESM cell line	[PMID: 8246242]
HeLa	EC₅₀	14 6 Compound: Ribavirin	Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HeLa	EC₅₀	50 6 Compound: Ribavirin	Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
ESM	IC₅₀	> 135 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus TK-HSV-1 (B2006) in ESM cell line Tested for inhibitory effect on DNA virus TK-HSV-1 (B2006) in ESM cell line	[PMID: 8246242]
ESM	IC₅₀	> 300 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus HSV-2 (G) in ESM cell line Tested for inhibitory effect on DNA virus HSV-2 (G) in ESM cell line	[PMID: 8246242]
HeLa	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
HeLa	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
ESM	IC₅₀	>= 350 6 Compound: ribavirin	Tested for inhibitory effect on DNA virus HSV-1(KOS) in ESM cell line Tested for inhibitory effect on DNA virus HSV-1(KOS) in ESM cell line	[PMID: 8246242]
HeLa	EC₅₀	146 6 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
ESM	IC₅₀	>= 400 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in ESM cell line Tested for inhibitory effect on RNA virus cell morphology in ESM cell line	[PMID: 8246242]
HeLa	EC₅₀	22 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
HeLa	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HeLa	EC₅₀	112 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
HeLa	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HeLa	EC₅₀	28.5 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Human coxsackievirus B4 infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Epithelial cell	EC₅₀	> 1024.6 3 Compound: Ribavirin	Antiviral activity against influenza B (Hong kong/5/72) in human epithelial cells Antiviral activity against influenza B (Hong kong/5/72) in human epithelial cells	[PMID: 12729645]
HeLa	EC₅₀	30 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay	[PMID: 20034711]
FM3A	IC₅₀	3.9 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in FM3A cell line Tested for inhibitory effect on RNA virus cell growth in FM3A cell line	[PMID: 8246242]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Respiratory syncytial virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Fibroblast	CC₅₀	> 200 3 Compound: Rib	Cytotoxicity against chicken embryo fibroblasts assessed as reduction in cell viability after 48 hrs by CCK-8 assay Cytotoxicity against chicken embryo fibroblasts assessed as reduction in cell viability after 48 hrs by CCK-8 assay	[PMID: 30365885]
Fibroblast	CC₅₀	> 200 3 Compound: Rib	Cytotoxicity against chicken embryo fibroblast assessed as reduction in cell viability after 48 hrs by CCK8 assay Cytotoxicity against chicken embryo fibroblast assessed as reduction in cell viability after 48 hrs by CCK8 assay	[PMID: 32092589]
HeLa	EC₅₀	4.6 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in HeLa cells Antiviral activity against Respiratory syncytial virus infected in HeLa cells	[PMID: 22464686]
HCT-116	EC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HCT-116 cells incubated for 48 hrs by MTT assay Cytotoxicity against human HCT-116 cells incubated for 48 hrs by MTT assay	[PMID: 36518704]
HeLa	EC₅₀	5.8 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
HCT-116	EC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HCT-116 cells overexpressing human BCRP incubated for 48 hrs by MTT assay Cytotoxicity against human HCT-116 cells overexpressing human BCRP incubated for 48 hrs by MTT assay	[PMID: 36518704]
HCT-116	EC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HCT-116 cells overexpressing human MDR1 incubated for 48 hrs by MTT assay Cytotoxicity against human HCT-116 cells overexpressing human MDR1 incubated for 48 hrs by MTT assay	[PMID: 36518704]
HeLa	EC₅₀	2.8 6 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HeLa	EC₅₀	6 6 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HeLa	EC₅₀	22 6 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
HeLa	EC₅₀	5 3 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
HeLa	EC₅₀	19 3 Compound: 1	Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
HeLa	EC₅₀	5 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
HeLa	EC₅₀	12 3 Compound: Ribavirin	Antiviral activity against RSV in HeLa cells Antiviral activity against RSV in HeLa cells	[PMID: 17181162]
HeLa	EC₅₀	24 6 Compound: ribavirin	Antiviral activity against RSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against RSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
HeLa	EC₅₀	3 3 Compound: Ribavirin	Antiviral activity against RSV infected in HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against RSV infected in HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
HeLa	EC₅₀	16 6 Compound: Ribavirin	Antiviral activity against RSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against RSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
HeLa	EC₅₀	6.6 3 Compound: ribavirin	Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 20347509]
HeLa	EC₅₀	10 6 Compound: ribavirin	Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
HEK-293T	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against HEK293T cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay Cytotoxicity against HEK293T cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay	[PMID: 28350454]
HeLa	EC₅₀	10 6 Compound: Ribavirin	Antiviral activity against RSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against RSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HeLa	EC₅₀	16 6 Compound: ribavirin	Antiviral activity against RSV Long in HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against RSV Long in HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
HEK-293T	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against HEK293T cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay Cytotoxicity against HEK293T cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay	[PMID: 31734025]
HeLa	EC₅₀	10 3 Compound: ribavirin	Antiviral activity against RSV Long in human HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against RSV Long in human HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEK-293T	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HEK293T cells assessed as reduction in cell viability after 48 hrs by CCK8 assay Cytotoxicity against human HEK293T cells assessed as reduction in cell viability after 48 hrs by CCK8 assay	[PMID: 32805550]
HeLa	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Vesicular stomatitis virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEK-293T	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HEK293T cells assessed as cell viability after 48 hrs by CCK-8 assay Cytotoxicity against human HEK293T cells assessed as cell viability after 48 hrs by CCK-8 assay	[PMID: 35304224]
HeLa	EC₅₀	12.1 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Vesicular stomatitis virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
HEK-293T	CC₅₀	> 200 3 Compound: ribavirin	Cytotoxicity against HEK293T cells assessed as cell viability measured at 24 hrs by MTS assay Cytotoxicity against HEK293T cells assessed as cell viability measured at 24 hrs by MTS assay	[PMID: 26288686]
HeLa	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HeLa cells Antiviral activity against Vesicular stomatitis virus infected in HeLa cells	[PMID: 22464686]
HEK-293T	CC₅₀	> 205 3 Compound: Ribavirin	Cytotoxicity against human 293T cells expressing Gluc assessed as inhibition of cell proliferation after 24 hrs by CCK8 assay Cytotoxicity against human 293T cells expressing Gluc assessed as inhibition of cell proliferation after 24 hrs by CCK8 assay	[PMID: 28314599]
HeLa	EC₅₀	17 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HeLa cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Vesicular stomatitis virus infected in HeLa cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 24906510]
HEK-293T	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against human HEK293T cells after 24 hrs by MTT assay Cytotoxicity against human HEK293T cells after 24 hrs by MTT assay	[PMID: 24785979]
HEK-293T	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay	[PMID: 30142611]
HeLa	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
HeLa	EC₅₀	3.6 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEK-293T	CC₅₀	> 250 3 Compound: RBV, Ribavirin	Cytotoxicity against human HEK293T cells assessed as decrease in cell viability by MTT assay Cytotoxicity against human HEK293T cells assessed as decrease in cell viability by MTT assay	[PMID: 25856229]
HeLa	EC₅₀	10 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
HEK-293T	CC₅₀	> 250 3 Compound: RBV; Ribavirin	Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay Cytotoxicity against HEK293T cells assessed as decrease in cell viability after 24 hrs by MTT assay	[PMID: 26924568]
HEK-293T	CC₅₀	> 50 3 Compound: RBV	Cytotoxicity against HEK293T cells incubated for 48 hrs by MTT assay Cytotoxicity against HEK293T cells incubated for 48 hrs by MTT assay	[PMID: 39153334]
HeLa	EC₅₀	22 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
HEK-293T	EC₅₀	13.1 3 Compound: ribavirin	Antiviral activity against Chikungunya virus infected in HEK293T cells assessed as reduction of infectivity measured at 24 hrs postinfection by gaussia luciferase reporter gene assay Antiviral activity against Chikungunya virus infected in HEK293T cells assessed as reduction of infectivity measured at 24 hrs postinfection by gaussia luciferase reporter gene assay	[PMID: 26540338]
HeLa	EC₅₀	22 3 Compound: 1	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
HEK-293T	EC₅₀	18 3 Compound: RBV, Ribavirin	Inhibition of Influenza A virus (A/PR/8/34) RNA-dependent-RNA polymerase transfected in HEK293T cells after 24 hrs by renilla luciferase activity/minireplicon assay Inhibition of Influenza A virus (A/PR/8/34) RNA-dependent-RNA polymerase transfected in HEK293T cells after 24 hrs by renilla luciferase activity/minireplicon assay	[PMID: 25856229]
HeLa	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HeLa	EC₅₀	29 6 Compound: ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
HEK-293T	EC₅₀	18.4 3 Compound: ribavirin	Antiviral activity against O'nyong-nyong virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis Antiviral activity against O'nyong-nyong virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis	[PMID: 26540338]
HeLa	EC₅₀	29 3 Compound: ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
HEK-293T	EC₅₀	20 3 Compound: ribavirin	Antiviral activity against wild type Chikungunya virus IMT infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis Antiviral activity against wild type Chikungunya virus IMT infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis	[PMID: 26540338]
HeLa	EC₅₀	80 6 Compound: ribavirin	Antiviral activity against VSV in HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against VSV in HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
HEK-293T	EC₅₀	23.8 3 Compound: RBV; Ribavirin	Inhibition of Influenza A virus RdRp transfected in HEK293T cells at 24 hrs by dual luciferase reporter gene-based minireplicon assay Inhibition of Influenza A virus RdRp transfected in HEK293T cells at 24 hrs by dual luciferase reporter gene-based minireplicon assay	[PMID: 26924568]
HEK-293T	EC₅₀	24.9 3 Compound: RBV	Inhibition of Influenza A virus RdRP infected in human HEK293T cells after 24 hrs by dual luciferase reporter gene assay Inhibition of Influenza A virus RdRP infected in human HEK293T cells after 24 hrs by dual luciferase reporter gene assay	[PMID: 24785979]
HeLa	EC₅₀	22 3 Compound: ribavirin	Antiviral activity against VSV in human HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against VSV in human HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HeLa	EC₅₀	14.8 3 Compound: Ribavirin	Antiviral activity against VSV infected in HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against VSV infected in HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
HEK-293T	EC₅₀	5.12 3 Compound: ribavirin	Antiviral activity against wild type Sindbis virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis Antiviral activity against wild type Sindbis virus infected in HEK293T cells assessed as inhibition of infectivity measured at 24 hrs postinfection by FITC/DAPI staining based array scan VTI HCS reader analysis	[PMID: 26540338]
HEK-293T	EC₅₀	8.4 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in HEK293T cells assessed as reduction in viral RNP reconstitution measured at 24 hrs by luciferase reporter gene assay Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in HEK293T cells assessed as reduction in viral RNP reconstitution measured at 24 hrs by luciferase reporter gene assay	[PMID: 26288686]
HeLa	EC₅₀	48 6 Compound: Ribavirin	Antiviral activity against VSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against VSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
HeLa	EC₅₀	17.2 3 Compound: ribavirin	Antiviral activity against VSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against VSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 20347509]
HEK-293T	IC₅₀	15.36 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in human 293T cells pretreated for 2 hrs followed by viral infection and measured after 24 hrs by Gaussia luciferase reporter gene assay Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in human 293T cells pretreated for 2 hrs followed by viral infection and measured after 24 hrs by Gaussia luciferase reporter gene assay	[PMID: 32273213]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against VSV infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay Antiviral activity against VSV infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay	[PMID: 20034711]
HEK-293T	IC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HEK-293T cells assessed as reduction in cell viability after 48 hrs by CCK-8 assay Cytotoxicity against human HEK-293T cells assessed as reduction in cell viability after 48 hrs by CCK-8 assay	[PMID: 33571829]
HeLa	EC₅₀	29 6 Compound: Ribavirin	Antiviral activity against VSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against VSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HeLa	EC₅₀	181.36 6 Compound: Rib (Ribavirin)	Compound was evaluated for its inhibitory effect on the replication of Coxsackie virus B3 (Cox. B3) in HeLa cells Compound was evaluated for its inhibitory effect on the replication of Coxsackie virus B3 (Cox. B3) in HeLa cells	[PMID: 14505657]
HEK293	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by MTT assay Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by MTT assay	[PMID: 24313730]
HEK293	EC₅₀	15 3 Compound: RBV	Inhibition of influenza A virus RNA-dependent RNA polymerase expressed in HEK293 cells after 24 hrs by dual luciferase reporter gene assay Inhibition of influenza A virus RNA-dependent RNA polymerase expressed in HEK293 cells after 24 hrs by dual luciferase reporter gene assay	[PMID: 24313730]
HeLa	EC₅₀	20.94 6 Compound: Rib (Ribavirin)	Compound was evaluated for its inhibitory effect on the replication of encephalomyocarditis virus (EMCV) in HeLa cells Compound was evaluated for its inhibitory effect on the replication of encephalomyocarditis virus (EMCV) in HeLa cells	[PMID: 14505657]
HeLa	EC₅₀	14.41 6 Compound: Rib (Ribavirin)	Compound was evaluated for its inhibitory effect on the replication of vesicular stomatitis virus (VSV) in HeLa cells Compound was evaluated for its inhibitory effect on the replication of vesicular stomatitis virus (VSV) in HeLa cells	[PMID: 14505657]
HEK293	EC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HEK293 cells incubated for 48 hrs by MTT assay Cytotoxicity against human HEK293 cells incubated for 48 hrs by MTT assay	[PMID: 36518704]
HeLa	EC₅₀	320 3 Compound: d	concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cells concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cells	[PMID: 9748360]
HeLa	EC₅₀	192 3 Compound: d	concentration required to inhibit VSV-induced cytopathicity by 50% in HeLa cells concentration required to inhibit VSV-induced cytopathicity by 50% in HeLa cells	[PMID: 9748360]
HeLa	EC₅₀	>320 3 Compound: Ribavirin	Effective concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cell lines Effective concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cell lines	[PMID: 11495586]
HEL	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Herpes simplex virus 1 KOS infected HEL cells by trypan blue exclusion method Cytotoxicity against Herpes simplex virus 1 KOS infected HEL cells by trypan blue exclusion method	[PMID: 20034711]
HeLa	EC₅₀	1.5 3 Compound: Ribavirin	Effective concentration required to inhibit respiratory synaptial(RSV) virus-induced cytopathicity by 50% in HeLa cell lines Effective concentration required to inhibit respiratory synaptial(RSV) virus-induced cytopathicity by 50% in HeLa cell lines	[PMID: 11495586]
HEL	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Herpes simplex virus 2 G infected HEL cells by trypan blue exclusion method Cytotoxicity against Herpes simplex virus 2 G infected HEL cells by trypan blue exclusion method	[PMID: 20034711]
HeLa	EC₅₀	1 2 Compound: Ribavirin	Effective concentration required to inhibit vesicular stomatitis virus (VSV)-induced cytopathicity by 50% in HeLa cell lines Effective concentration required to inhibit vesicular stomatitis virus (VSV)-induced cytopathicity by 50% in HeLa cell lines	[PMID: 11495586]
HEL	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against VSV infected HEL cells by trypan blue exclusion method Cytotoxicity against VSV infected HEL cells by trypan blue exclusion method	[PMID: 20034711]
HeLa	IC₅₀	20.3 6 Compound: Ribovirin	Antiviral activity against Coxsackie virus B3 Nacy infected in human HeLa cells assessed as reduction of virus-induced cytopathic effect by MTT assay Antiviral activity against Coxsackie virus B3 Nacy infected in human HeLa cells assessed as reduction of virus-induced cytopathic effect by MTT assay	[PMID: 19374435]
HEL	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Vaccinia virus infected HEL cells by trypan blue exclusion method Cytotoxicity against Vaccinia virus infected HEL cells by trypan blue exclusion method	[PMID: 20034711]
HeLa	IC₅₀	20 6 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 in HeLa cells Antiviral activity against Coxsackie virus B4 in HeLa cells	[PMID: 17518459]
HEL	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against acyclovir-sensitive Herpes simplex virus 1 KOS infected HEL cells by trypan blue exclusion method Cytotoxicity against acyclovir-sensitive Herpes simplex virus 1 KOS infected HEL cells by trypan blue exclusion method	[PMID: 20034711]
HEL	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against HEL cells after 3 days by coulter counter analysis Cytotoxicity against HEL cells after 3 days by coulter counter analysis	[PMID: 21232828]
HeLa	IC₅₀	2 6 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus in HeLa cells Antiviral activity against Respiratory syncytial virus in HeLa cells	[PMID: 17518459]
HeLa	IC₅₀	11.4 3 Compound: Ribavirin	Inhibitory concentration against respiratory syncytial virus in HeLa cells Inhibitory concentration against respiratory syncytial virus in HeLa cells	[PMID: 7658442]
HEL	CC₅₀	> 500 3 Compound: Ribavirin	Cytotoxicity against HEL cells Cytotoxicity against HEL cells	[PMID: 17181162]
HEL	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HeLa	IC₅₀	>= 400 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in HeLa cell line Tested for inhibitory effect on RNA virus cell morphology in HeLa cell line	[PMID: 8246242]
HEL	EC₅₀	100 3 Compound: Ribavirin	Antiviral activity against vaccinia virus in HEL cells Antiviral activity against vaccinia virus in HEL cells	[PMID: 17181162]
HeLa	IC₅₀	70 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Polio-1 in HeLa cell line Tested for inhibitory effect on RNA virus Polio-1 in HeLa cell line	[PMID: 8246242]
HeLa	IC₅₀	4 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus RSV in HeLa cell line Tested for inhibitory effect on RNA virus RSV in HeLa cell line	[PMID: 8246242]
HEL	EC₅₀	10 6 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HeLa	IC₅₀	14 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus VSV in HeLa cell line Tested for inhibitory effect on RNA virus VSV in HeLa cell line	[PMID: 8246242]
HEL	EC₅₀	112 3 Compound: 1	Antiviral activity against Vaccinia virus lederle infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vaccinia virus lederle infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
HEL	EC₅₀	112 3 Compound: ribavirin	Antiviral activity against Vaccinia virus Lederle in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against Vaccinia virus Lederle in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEp-2	CC₅₀	62.5 6 Compound: ribavirin	Cytotoxicity against human Hep2 cells after 3 days by MTT reduction assay Cytotoxicity against human Hep2 cells after 3 days by MTT reduction assay	[PMID: 16724853]
HEp-2	CC₅₀	>1 2 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability	[PMID: 35729787]
HEL	EC₅₀	120 6 Compound: ribavirin	Antiviral activity against VSV in HEL cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against VSV in HEL cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
HEL	EC₅₀	125 3 Compound: Ribavirin	Antiviral activity against acyclovir-sensitive Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against acyclovir-sensitive Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HEp-2	CC₅₀	571.6 6 Compound: Ribavirin	Cytotoxicity against human Hep2 cells assessed as reduction in cell viability after 3 days by MTT assay Cytotoxicity against human Hep2 cells assessed as reduction in cell viability after 3 days by MTT assay	[PMID: 28858766]
HEp-2	CC₅₀	3039.67 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33571829]
HEL	EC₅₀	125 3 Compound: ribavirin	Antiviral activity against VSV in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against VSV in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEp-2	CC₅₀	653.33 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 37859725]
HEL	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEp-2	CC₅₀	95 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 6 days by CellTiter-Glo assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 6 days by CellTiter-Glo assay	[PMID: 36596229]
HEL	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HEL	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HEp-2	CC₅₀	273.8 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 48 hrs by MTS assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 48 hrs by MTS assay	[PMID: 31734025]
HEp-2	CC₅₀	418.21 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 60 hrs by MTT assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 60 hrs by MTT assay	[PMID: 34256126]
HEL	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against VSV infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against VSV infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HEL	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
HEp-2	CC₅₀	113.9 3 Compound: 1	Cytotoxicity against human Hep2 cells by Cell Titer-Glo assay Cytotoxicity against human Hep2 cells by Cell Titer-Glo assay	[PMID: 23043370]
HEp-2	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells measured after 3 days by CellTiter 96 aqueous one solution assay (Rvb >100 microM) Cytotoxicity against human HEp-2 cells measured after 3 days by CellTiter 96 aqueous one solution assay (Rvb >100 microM)	[PMID: 38579352]
HEL	EC₅₀	146 6 Compound: ribavirin	Antiviral activity against Vaccinia virus infected in in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Vaccinia virus infected in in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
HEL	EC₅₀	1 6 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEp-2	CC₅₀	250 3 Compound: Ribavirin	Cytotoxicity in human Hep2 cells assessed as reduction in cell viability measured after 3 days by beckman coulter counting method Cytotoxicity in human Hep2 cells assessed as reduction in cell viability measured after 3 days by beckman coulter counting method	[PMID: 33894564]
HEp-2	EC₅₀	20.7 3 Compound: Ribavirin	Antiviral activity against DMSO-passaged wild type RSV RSS infected human Hep2 cells by plaque reduction assay Antiviral activity against DMSO-passaged wild type RSV RSS infected human Hep2 cells by plaque reduction assay	[PMID: 17576833]
HEL	EC₅₀	250 3 Compound: ribavirin	Antiviral activity against HSV2 G in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against HSV2 G in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEL	EC₅₀	2 6 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEp-2	EC₅₀	15.83 3 Compound: Ribavirin	Antiviral activity against GFP-fused wild-type RSV subgroup A Long infected in human HEp-2 cells measured 24 to 72 hrs post infection by fluorescence assay Antiviral activity against GFP-fused wild-type RSV subgroup A Long infected in human HEp-2 cells measured 24 to 72 hrs post infection by fluorescence assay	[PMID: 31734025]
HEp-2	EC₅₀	17.6 3 Compound: Ribavirin	Antiviral activity against plaque picked RSV604-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay Antiviral activity against plaque picked RSV604-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay	[PMID: 17576833]
HEL	EC₅₀	2 6 Compound: Ribavirin	Antiviral activity against thymidine kinase deficient acyclovir-resistant Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against thymidine kinase deficient acyclovir-resistant Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HEp-2	EC₅₀	1.8 6 Compound: ribavirin	Antiviral activity against respiratory syncytial virus A2 in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against respiratory syncytial virus A2 in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 9784173]
HEL	EC₅₀	300 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS in HEL cells Antiviral activity against HSV1 KOS in HEL cells	[PMID: 17181162]
HEp-2	EC₅₀	20.12 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay	[PMID: 37859725]
HEL	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HEp-2	EC₅₀	5.4 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay	[PMID: 36596229]
HEL	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Vaccinia virus infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
HEp-2	EC₅₀	18.53 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells incubated for 60 hrs by MTT assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells incubated for 60 hrs by MTT assay	[PMID: 34256126]
HEL	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against HCMV AD169 infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against HCMV AD169 infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEp-2	EC₅₀	28.4 3 Compound: 1	Antiviral activity against Respiratory syncytial virus Long infected in human Hep2 cells assessed as reduction in virus-induced cytopathogenicity by Cell Titer-Glo assay Antiviral activity against Respiratory syncytial virus Long infected in human Hep2 cells assessed as reduction in virus-induced cytopathogenicity by Cell Titer-Glo assay	[PMID: 23043370]
HEL	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against HCMV Davis infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against HCMV Davis infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEp-2	EC₅₀	19 3 Compound: Ribavirin	Antiviral activity against RSV A2 infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV A2 infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Human herpesvirus 1 strain KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human herpesvirus 1 strain KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Human herpesvirus 2 strain G infected HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human herpesvirus 2 strain G infected HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEp-2	EC₅₀	2.2 6 Compound: Ribavirin	Antiviral activity against RSV A-2 infected in human Hep2 cells after 3 days by plaque neutralization assay Antiviral activity against RSV A-2 infected in human Hep2 cells after 3 days by plaque neutralization assay	[PMID: 9599250]
HEp-2	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against RSV B infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV B infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Vesicular stomatitis virus infected HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against acyclovir-resistant TK-deficient Hepres simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against acyclovir-resistant TK-deficient Hepres simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
HEp-2	EC₅₀	2.3 6 Compound: Ribavirin	Antiviral activity against RSV infected in human Hep2 cells assessed as virus-induced cytopathic effect administered 3 hrs postinfection Antiviral activity against RSV infected in human Hep2 cells assessed as virus-induced cytopathic effect administered 3 hrs postinfection	[PMID: 9599250]
HEp-2	EC₅₀	16.8 3 Compound: Ribavirin	Antiviral activity against RSV Long infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV Long infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against VSV infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay Antiviral activity against VSV infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay	[PMID: 20034711]
HEp-2	EC₅₀	1.8 6 Compound: Ribavirin	Antiviral activity against RSV long infected in human Hep2 cells assessed as virus-induced cytopathic effect after 3 days Antiviral activity against RSV long infected in human Hep2 cells assessed as virus-induced cytopathic effect after 3 days	[PMID: 9599250]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against HSV1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEp-2	EC₅₀	13.3 3 Compound: Ribavirin	Antiviral activity against RSV RSS infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV RSS infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against HSV2 G infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against HSV2 G infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEp-2	EC₅₀	11.5 3 Compound: Ribavirin	Antiviral activity against RSV RSS infected human Hep2 cells assessed as inhibition of virus-induced cell death after 6 days by XTT assay Antiviral activity against RSV RSS infected human Hep2 cells assessed as inhibition of virus-induced cell death after 6 days by XTT assay	[PMID: 17576833]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against thymidine kinase deficient acyclovir-resistant HSV1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against thymidine kinase deficient acyclovir-resistant HSV1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 21232828]
HEp-2	EC₅₀	25.3 3 Compound: Ribavirin	Antiviral activity against RSV RSS infected human Hep2 cells assessed as reduction of viral antigen synthesis after 3 days by ELISA Antiviral activity against RSV RSS infected human Hep2 cells assessed as reduction of viral antigen synthesis after 3 days by ELISA	[PMID: 17576833]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HEp-2	IC₅₀	10.6 3 Compound: Ribavirin	Antiviral activity against Human respiratory syncytial virus infected in human HEp-2 cells assessed as plaque reduction preincubated with cells 15 mins followed by viral infection for 2.5 hrs and measured after 3 days by crystal violet staining based micr Antiviral activity against Human respiratory syncytial virus infected in human HEp-2 cells assessed as plaque reduction preincubated with cells 15 mins followed by viral infection for 2.5 hrs and measured after 3 days by crystal violet staining based micr	[PMID: 38579352]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HEp-2	IC₅₀	2.6 6 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect	[PMID: 11678648]
HEp-2	IC₅₀	10.7 3 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay	[PMID: 19267453]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HEp-2	IC₅₀	20 3 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by XTT assay Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by XTT assay	[PMID: 25420212]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against thymidine kinase-deficient Herpes simplex virus 1 infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against thymidine kinase-deficient Herpes simplex virus 1 infected in HEL cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HEp-2	IC₅₀	19 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect by CPE inhibition assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect by CPE inhibition assay	[PMID: 35729787]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus type 1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Herpes simplex virus type 1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HEp-2	IC₅₀	20.4 3 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as virus-induced cytopathicity by XTT assay Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as virus-induced cytopathicity by XTT assay	[PMID: 24882250]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus type 2 G infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Herpes simplex virus type 2 G infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HEp-2	IC₅₀	0.08 3 Compound: Ribavirin	Antiviral activity against RSV infected in human HEp-2 cells assessed as inhibition of viral induced cytopathic effect by CPE assay Antiviral activity against RSV infected in human HEp-2 cells assessed as inhibition of viral induced cytopathic effect by CPE assay	[PMID: 32937282]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vaccinia virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HEp-2	IC₅₀	17.33 3 Compound: Ribavirin	Antiviral activity against RSV Long expressing mGFP infected in HEp-2 cells assessed as reduction in viral replication after 48 hrs by MTS assay Antiviral activity against RSV Long expressing mGFP infected in HEp-2 cells assessed as reduction in viral replication after 48 hrs by MTS assay	[PMID: 33571829]
HEL	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against thymidine kinase-deficient Herpes simplex virus type 1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against thymidine kinase-deficient Herpes simplex virus type 1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HEp-2	IC₅₀	3 6 Compound: ribavirin	Antiviral activity against RSV Long in human Hep2 cells assessed as reduction of virus induced cytopathic effect Antiviral activity against RSV Long in human Hep2 cells assessed as reduction of virus induced cytopathic effect	[PMID: 16724853]
HEL	EC₅₀	> 250 3 Compound: ribavirin	Antiviral activity against HSV1 KOS in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against HSV1 KOS in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEp-2	IC₅₀	25 6 Compound: Ribavirin	Cytotoxicity against RSV A-2 infected human Hep2 cells after 3 days Cytotoxicity against RSV A-2 infected human Hep2 cells after 3 days	[PMID: 9599250]
HEL	EC₅₀	> 250 3 Compound: ribavirin	Antiviral activity against thymidine kinase deficient and acyclovir resistant HSV1 KOS in human HEL cells assessed as protection against virus-induced cytopathicity Antiviral activity against thymidine kinase deficient and acyclovir resistant HSV1 KOS in human HEL cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HEp-2	IC₅₀	35 6 Compound: Ribavirin	Cytotoxicity against RSV long infected human Hep2 cells after 3 days Cytotoxicity against RSV long infected human Hep2 cells after 3 days	[PMID: 9599250]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against HSV1 KOS infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HepG2	CC₅₀	>500 6 Compound: Ribavirin	Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay	[PMID: 23920438]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against HSV2 G infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against HSV2 G infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HepG2	EC₅₀	22.3 6 Compound: Ribavirin	Antiviral activity against Coxsackievirus B5 infected in human HepG2 cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method Antiviral activity against Coxsackievirus B5 infected in human HepG2 cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method	[PMID: 23920438]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Vaccinia virus infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against thymidine kinase-deficient acyclovir-resistant HSV1 KOS infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against thymidine kinase-deficient acyclovir-resistant HSV1 KOS infected in human HEL cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Huh-5-2	CC₅₀	86 3 Compound: ribavirin	Cytotoxicity against human HuH5.2 cells Cytotoxicity against human HuH5.2 cells	[PMID: 19170598]
Huh-5-2	CC₅₀	21 6 Compound: Ribavirin	Cytotoxicity against human Huh-5-2 cells Cytotoxicity against human Huh-5-2 cells	[PMID: 18445526]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Herpes simplex virus-1 KOS infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Herpes simplex virus-1 KOS infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Herpes simplex virus-2 G infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Herpes simplex virus-2 G infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Huh-5-2	EC₅₀	7 6 Compound: Ribavirin	Antiviral activity against Hepatitis C virus infected human Huh-5-2 cells assessed as inhibition of luciferase activity after 4 days by RNA replicon assay Antiviral activity against Hepatitis C virus infected human Huh-5-2 cells assessed as inhibition of luciferase activity after 4 days by RNA replicon assay	[PMID: 18445526]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Vaccinia virus infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Vaccinia virus infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Huh-7	CC₅₀	>200 3 Compound: Ribavirin	Cytotoxicity against Huh7 cells by XTT assay Cytotoxicity against Huh7 cells by XTT assay	[PMID: 17766124]
Huh-7	CC₅₀	177.94 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells Cytotoxicity against human HuH7 cells	[PMID: 20579888]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against acyclovir-resistant TK deficient Herpes simplex virus-1 KOS infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against acyclovir-resistant TK deficient Herpes simplex virus-1 KOS infected in human HEL cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
HEL	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Huh-7	CC₅₀	56 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells after 72 hrs by MTS assay Cytotoxicity against human HuH7 cells after 72 hrs by MTS assay	[PMID: 25330401]
Huh-7	CC₅₀	1060 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells after3 days by MTT assay Cytotoxicity against human HuH7 cells after3 days by MTT assay	[PMID: 20337460]
HEL	EC₅₀	> 250 6 Compound: ribavirin	Antiviral activity against HSV1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against HSV1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Huh-7	CC₅₀	512.8 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
HEL	EC₅₀	> 250 6 Compound: ribavirin	Antiviral activity against HSV2 G infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against HSV2 G infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
HEL	EC₅₀	> 250 6 Compound: ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Vesicular stomatitis virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Huh-7	CC₅₀	56.31 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells assessed as cell viability after 3 days by XTT assay Cytotoxicity against human HuH7 cells assessed as cell viability after 3 days by XTT assay	[PMID: 24727241]
Huh-7	CC₅₀	56.31 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells assessed as growth inhibition after 3 days by XTT method Cytotoxicity against human HuH7 cells assessed as growth inhibition after 3 days by XTT method	[PMID: 29031073]
HEL	EC₅₀	> 250 6 Compound: ribavirin	Antiviral activity against thymidine kinase-deficient ACV-resistant HSV1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against thymidine kinase-deficient ACV-resistant HSV1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
HEL	EC₅₀	> 500 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS in HEL cells Antiviral activity against HSV1 KOS in HEL cells	[PMID: 17181162]
Huh-7	CC₅₀	8.9 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay Cytotoxicity against human Huh-7 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay	[PMID: 37252100]
Huh-7	CC₅₀	200 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability by Celltiter-Glo luminescent cell viability assay Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability by Celltiter-Glo luminescent cell viability assay	[PMID: 34273661]
HEL	EC₅₀	> 500 3 Compound: Ribavirin	Antiviral activity against HSV2 in HEL cells Antiviral activity against HSV2 in HEL cells	[PMID: 17181162]
Huh-7	CC₅₀	100 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells assessed as reduction in cell viability by measuring ATP level measured after 72 hrs by CellTiter-Glo luminescent assay Cytotoxicity against human HuH7 cells assessed as reduction in cell viability by measuring ATP level measured after 72 hrs by CellTiter-Glo luminescent assay	[PMID: 32435411]
HEL	EC₅₀	> 500 3 Compound: Ribavirin	Antiviral activity against vesicular somatitis virus in HEL cells Antiviral activity against vesicular somatitis virus in HEL cells	[PMID: 17181162]
Huh-7	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells incubated for 3 days by MTT assay Cytotoxicity against human Huh-7 cells incubated for 3 days by MTT assay	[PMID: 32787106]
Huh-7	CC₅₀	32 3 Compound: RBV	Cytotoxicity against human HuH7 cells infected with HCV1b after 3 days by MTS assay Cytotoxicity against human HuH7 cells infected with HCV1b after 3 days by MTS assay	[PMID: 22100256]
Huh-7	CC₅₀	>30 3 Compound: Ribavirin	Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability incubated for 1 hr by WST-1 assay Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability incubated for 1 hr by WST-1 assay	[PMID: 26428870]
Huh-7	CC₅₀	30.5 3 Compound: Ribavirin	Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability preincubated for 1 hr followed by fresh drug administration every 24 hrs at 1/10th of initial concentration for 48 hrs by WST-1 ass Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability preincubated for 1 hr followed by fresh drug administration every 24 hrs at 1/10th of initial concentration for 48 hrs by WST-1 ass	[PMID: 26428870]
Huh-7	CC₅₀	>100 3 Compound: ribavirin	Cytotoxicity against mock-infected human Huh7.5 cells assessed as reduction in cell viability incubated for 5 hrs by MTT assay Cytotoxicity against mock-infected human Huh7.5 cells assessed as reduction in cell viability incubated for 5 hrs by MTT assay	[PMID: 26613291]
Huh-7	EC₅₀	12.6 3 Compound: Ribavirin	Antiviral activity against dengue virus 2 infected in human HuH7 cells after 72 hrs by Western blot and ECL detection based assay Antiviral activity against dengue virus 2 infected in human HuH7 cells after 72 hrs by Western blot and ECL detection based assay	[PMID: 25330401]
Huh-7	EC₅₀	17.6 3 Compound: Ribavirin	Antiviral activity against HCV 1b infected in human HuH7 cells assessed as inhibition of viral RNA replication after 4 days by replicon assay Antiviral activity against HCV 1b infected in human HuH7 cells assessed as inhibition of viral RNA replication after 4 days by replicon assay	[PMID: 20337460]
Huh-7	EC₅₀	22 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease T54A double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease T54A double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	43 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	36 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	42 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155T double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155T double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	33 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	41 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	14 3 Compound: RBV	Antiviral activity against HCV genotype 1b infected in human HuH7 cells after 3 days by renilla luciferase reporter assay Antiviral activity against HCV genotype 1b infected in human HuH7 cells after 3 days by renilla luciferase reporter assay	[PMID: 22100256]
Huh-7	EC₅₀	33.5 3 Compound: Ribavirin	Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs and fresh drug admini Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs and fresh drug admini	[PMID: 26428870]
Huh-7	EC₅₀	30.4 3 Compound: Ribavirin	Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs measured at 72 hrs Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs measured at 72 hrs	[PMID: 26428870]
Huh-7	EC₅₀	81.9 3 Compound: Ribavirin	Antiviral activity against HCV subtype 1a infected in Huh-7 cells assessed as reduction in viral RNA level after 8 to 10 days by quantitative PCR analysis Antiviral activity against HCV subtype 1a infected in Huh-7 cells assessed as reduction in viral RNA level after 8 to 10 days by quantitative PCR analysis	[PMID: 24485784]
Huh-7	EC₅₀	20 6 Compound: Ribavirin	Antiviral activity against Hepatitis C virus subtype 1a infected in human HuH7 cells after 2 days by q-PCR analysis Antiviral activity against Hepatitis C virus subtype 1a infected in human HuH7 cells after 2 days by q-PCR analysis	[PMID: 22985854]
Huh-7	EC₅₀	16.3 3 Compound: ribavirin	Antiviral activity against recombinant HCV genotype 2a JFH1 infected in human Huh7 cells incubated for 5 hrs measured on day 3 post infection by luciferase reporter gene assay Antiviral activity against recombinant HCV genotype 2a JFH1 infected in human Huh7 cells incubated for 5 hrs measured on day 3 post infection by luciferase reporter gene assay	[PMID: 26613291]
Huh-7	EC₅₀	58 3 Compound: ribavirin	Antiviral activity against wild type Con1-mADE HCV replicon in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against wild type Con1-mADE HCV replicon in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	54.8 3 Compound: Ribavirin	Inhibition of HCV replication in Huh7 cells after 48 hrs by luciferase assay Inhibition of HCV replication in Huh7 cells after 48 hrs by luciferase assay	[PMID: 17766124]
Huh-7	IC₅₀	53.7 3 Compound: RBV	Antiproliferative activity against human HuH-7 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human HuH-7 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
Huh-7	IC₅₀	4 3 Compound: Ribavirin	Antiviral activity against Dengue virus serotype 2 New Guinea C infected at 50 TCID50 in human HuH7 cells assessed as inhibition of viral replication and 72 hrs later re-infected pre-seeded HuH7 cells with viral supernatant collected from previous infecte Antiviral activity against Dengue virus serotype 2 New Guinea C infected at 50 TCID50 in human HuH7 cells assessed as inhibition of viral replication and 72 hrs later re-infected pre-seeded HuH7 cells with viral supernatant collected from previous infecte	[PMID: 32435411]
Huh-7	IC₅₀	12.61 3 Compound: Ribavirin	Antiviral activity against DENV2 16681 infected in human Huh-7 cells after 3 days by luciferase reporter gene assay Antiviral activity against DENV2 16681 infected in human Huh-7 cells after 3 days by luciferase reporter gene assay	[PMID: 24727241]
Huh-7	IC₅₀	37 3 Compound: ribavirin	Antiviral activity against HCV 1b Con1 with NS3-4A R155K mutation in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against HCV 1b Con1 with NS3-4A R155K mutation in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Huh-7	IC₅₀	39 3 Compound: ribavirin	Antiviral activity against HCV 1b with NS3-4A R155M mutation in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against HCV 1b with NS3-4A R155M mutation in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Huh-7	IC₅₀	32 3 Compound: ribavirin	Antiviral activity against HCV 1b with NS3-4A R155T mutation in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against HCV 1b with NS3-4A R155T mutation in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Huh-7	IC₅₀	58 3 Compound: ribavirin	Antiviral activity against wild type HCV 1b Con1 in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against wild type HCV 1b Con1 in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Huh-7	IC₅₀	>200 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells after 3 days by MTT assay Cytotoxicity against human HuH7 cells after 3 days by MTT assay	[PMID: 30721061]
Huh-7.5	CC₅₀	1654 3 Compound: RBV	Cytotoxicity against human Huh7.5 cells assessed as reduction in cell viability by MTS assay Cytotoxicity against human Huh7.5 cells assessed as reduction in cell viability by MTS assay	[PMID: 35661850]
IGROV-1	IC₅₀	25 6 Compound: RBV	Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay	[PMID: 31883488]
IGROV-1	IC₅₀	21 6 Compound: RBV	Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay	[PMID: 31883488]
IGROV-1	IC₅₀	16 6 Compound: RBV	Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 7 days by trypan blue exclusion assay Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 7 days by trypan blue exclusion assay	[PMID: 31883488]
L1210	IC₅₀	16.6 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of L1210 murine leukemia cell line. Compound was tested for its effect on the proliferation of L1210 murine leukemia cell line.	10.1016/0960-894X(96)00216-8
L1210	IC₅₀	1 3 Compound: Ribavirin	Inhibition of IMPDH in mouse L1210 cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins Inhibition of IMPDH in mouse L1210 cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins	[PMID: 22555152]
L1210	IC₅₀	7.1 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in L1210 cell line Tested for inhibitory effect on RNA virus cell growth in L1210 cell line	[PMID: 8246242]
MDA-MB-231	IC₅₀	>100 3 Compound: RBV	Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
MDA-MB-435	IC₅₀	38.3 3 Compound: RBV	Antiproliferative activity against human MDA-MB-435 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human MDA-MB-435 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
MDCK	CC₅₀	>125 6 Compound: ribavirin	Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
MDCK	CC₅₀	62.5 6 Compound: ribavirin	Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
MDCK	CC₅₀	>500 11 Compound: Ribavirin	Cytotoxicity against dog MDCK cells Cytotoxicity against dog MDCK cells	[PMID: 18160286]
HEL 299	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against human HEL 299 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay Cytotoxicity against human HEL 299 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay	[PMID: 37252100]
MDCK	CC₅₀	>= 20 3 Compound: ribavirin	Cytotoxicity against dog MDCK cells assessed as cell viability after 72 hrs by MTS assay Cytotoxicity against dog MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 24900429]
HEL 299	IC₅₀	45 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of HELL-299 human diploid embryonal lung cell line. Compound was tested for its effect on the proliferation of HELL-299 human diploid embryonal lung cell line.	10.1016/0960-894X(96)00216-8
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as cell viability by MTS assay Cytotoxicity against dog MDCK cells assessed as cell viability by MTS assay	[PMID: 23117173]
MDCK	CC₅₀	67 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay Cytotoxicity against dog MDCK cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay	[PMID: 37252100]
MDCK	CC₅₀	>200 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability Cytotoxicity against dog MDCK cells assessed as reduction in cell viability	[PMID: 34126455]
MDCK	CC₅₀	>2130 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability by MTT assay Cytotoxicity against dog MDCK cells assessed as reduction in cell viability by MTT assay	[PMID: 33129992]
HEp-2	CC₅₀	113.9 3 Compound: 1	Cytotoxicity against human Hep2 cells by Cell Titer-Glo assay Cytotoxicity against human Hep2 cells by Cell Titer-Glo assay	[PMID: 23043370]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 3 days by coulter counter method Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 3 days by coulter counter method	[PMID: 31586832]
HEp-2	CC₅₀	250 3 Compound: Ribavirin	Cytotoxicity in human Hep2 cells assessed as reduction in cell viability measured after 3 days by beckman coulter counting method Cytotoxicity in human Hep2 cells assessed as reduction in cell viability measured after 3 days by beckman coulter counting method	[PMID: 33894564]
MDCK	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 33328103]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 5 to 6 days by MTS assay Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 5 to 6 days by MTS assay	[PMID: 28477572]
HEp-2	CC₅₀	273.8 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 48 hrs by MTS assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 48 hrs by MTS assay	[PMID: 31734025]
HEp-2	CC₅₀	3039.67 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33571829]
MDCK	CC₅₀	>1 2 Compound: Ribavirin	Cytotoxicity against dog MDCK cells infected with Influenza A virus H1N1 Cytotoxicity against dog MDCK cells infected with Influenza A virus H1N1	[PMID: 37077387]
HEp-2	CC₅₀	386.3 3 Compound: Ribavirin	Cytotoxicity against Coxsackievirus B3 infected human Hep-2 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay Cytotoxicity against Coxsackievirus B3 infected human Hep-2 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay	[PMID: 38976838]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay Cytotoxicity against HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay	[PMID: 29906392]
HEp-2	CC₅₀	418.21 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 60 hrs by MTT assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability measured after 60 hrs by MTT assay	[PMID: 34256126]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against Influenza A virus subtype H1N1 infected MDCK cells by trypan blue exclusion method Cytotoxicity against Influenza A virus subtype H1N1 infected MDCK cells by trypan blue exclusion method	[PMID: 20034711]
MDCK	CC₅₀	2336 3 Compound: ribavirin	Cytotoxicity against MDCK cells Cytotoxicity against MDCK cells	[PMID: 17194832]
HEp-2	CC₅₀	571.6 6 Compound: Ribavirin	Cytotoxicity against human Hep2 cells assessed as reduction in cell viability after 3 days by MTT assay Cytotoxicity against human Hep2 cells assessed as reduction in cell viability after 3 days by MTT assay	[PMID: 28858766]
MDCK	CC₅₀	>323.5 3 Compound: Ribavirin	Cytotoxicity against MDCK cells Cytotoxicity against MDCK cells	[PMID: 23811085]
HEp-2	CC₅₀	62.5 6 Compound: ribavirin	Cytotoxicity against human Hep2 cells after 3 days by MTT reduction assay Cytotoxicity against human Hep2 cells after 3 days by MTT reduction assay	[PMID: 16724853]
HEp-2	CC₅₀	653.33 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 37859725]
MDCK	CC₅₀	>200 3 Compound: RBV	Cytotoxicity against MDCK cells after 40 hrs by Celltiter-Glo assay Cytotoxicity against MDCK cells after 40 hrs by Celltiter-Glo assay	[PMID: 26686929]
HEp-2	CC₅₀	95 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 6 days by CellTiter-Glo assay Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability incubated for 6 days by CellTiter-Glo assay	[PMID: 36596229]
MDCK	CC₅₀	>2 2 Compound: Ribavirin	Cytotoxicity against MDCK cells after 48 hrs by MTT assay Cytotoxicity against MDCK cells after 48 hrs by MTT assay	[PMID: 30108810]
HEp-2	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against HEp-2 cells Cytotoxicity against HEp-2 cells	[PMID: 38447084]
MDCK	CC₅₀	>2130 3 Compound: Ribavirin	Cytotoxicity against MDCK cells after 48 hrs by MTT assay Cytotoxicity against MDCK cells after 48 hrs by MTT assay	[PMID: 29716780]
MDCK	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against MDCK cells after 48 hrs by MTT assay Cytotoxicity against MDCK cells after 48 hrs by MTT assay	[PMID: 24785979]
HEp-2	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells measured after 3 days by CellTiter 96 aqueous one solution assay (Rvb >100 microM) Cytotoxicity against human HEp-2 cells measured after 3 days by CellTiter 96 aqueous one solution assay (Rvb >100 microM)	[PMID: 38579352]
HEp-2	CC₅₀	> 1000 3 Compound: Ribavirin	Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability Cytotoxicity against human HEp-2 cells assessed as reduction in cell viability	[PMID: 35729787]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells after 72 hrs by MTS assay Cytotoxicity against MDCK cells after 72 hrs by MTS assay	[PMID: 25752526]
HEp-2	EC₅₀	1.8 6 Compound: Ribavirin	Antiviral activity against RSV long infected in human Hep2 cells assessed as virus-induced cytopathic effect after 3 days Antiviral activity against RSV long infected in human Hep2 cells assessed as virus-induced cytopathic effect after 3 days	[PMID: 9599250]
MDCK	CC₅₀	>2130 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell death incubated for 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as cell death incubated for 48 hrs by MTT assay	[PMID: 33171219]
MDCK	CC₅₀	>200 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as cell growth after 40 hrs by CellTiter-Glo assay Cytotoxicity against MDCK cells assessed as cell growth after 40 hrs by CellTiter-Glo assay	[PMID: 25681711]
HEp-2	EC₅₀	1.8 6 Compound: ribavirin	Antiviral activity against respiratory syncytial virus A2 in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against respiratory syncytial virus A2 in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 9784173]
MDCK	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as cell viability after 48 hrs by MTT assay	[PMID: 24313730]
HEp-2	EC₅₀	11.5 3 Compound: Ribavirin	Antiviral activity against RSV RSS infected human Hep2 cells assessed as inhibition of virus-induced cell death after 6 days by XTT assay Antiviral activity against RSV RSS infected human Hep2 cells assessed as inhibition of virus-induced cell death after 6 days by XTT assay	[PMID: 17576833]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability by colorimetric formazan-based MTS assay Cytotoxicity against MDCK cells assessed as cell viability by colorimetric formazan-based MTS assay	[PMID: 22459876]
HEp-2	EC₅₀	13.3 3 Compound: Ribavirin	Antiviral activity against RSV RSS infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV RSS infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
MDCK	CC₅₀	>100 6 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability by MTS assay Cytotoxicity against MDCK cells assessed as cell viability by MTS assay	[PMID: 20971531]
HEp-2	EC₅₀	15.83 3 Compound: Ribavirin	Antiviral activity against GFP-fused wild-type RSV subgroup A Long infected in human HEp-2 cells measured 24 to 72 hrs post infection by fluorescence assay Antiviral activity against GFP-fused wild-type RSV subgroup A Long infected in human HEp-2 cells measured 24 to 72 hrs post infection by fluorescence assay	[PMID: 31734025]
HEp-2	EC₅₀	16.8 3 Compound: Ribavirin	Antiviral activity against RSV Long infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV Long infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
MDCK	CC₅₀	>320 6 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability by neutral red assay Cytotoxicity against MDCK cells assessed as cell viability by neutral red assay	[PMID: 26291036]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability measured after 4 days by formazan-based MTS assay Cytotoxicity against MDCK cells assessed as cell viability measured after 4 days by formazan-based MTS assay	[PMID: 27112451]
HEp-2	EC₅₀	17.6 3 Compound: Ribavirin	Antiviral activity against plaque picked RSV604-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay Antiviral activity against plaque picked RSV604-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay	[PMID: 17576833]
HEp-2	EC₅₀	18.53 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells incubated for 60 hrs by MTT assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells incubated for 60 hrs by MTT assay	[PMID: 34256126]
MDCK	CC₅₀	>200 3 Compound: ribavirin	Cytotoxicity against MDCK cells assessed as cell viability measured at 24 hrs by MTS assay Cytotoxicity against MDCK cells assessed as cell viability measured at 24 hrs by MTS assay	[PMID: 26288686]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as change in cellular morphology Cytotoxicity against MDCK cells assessed as change in cellular morphology	[PMID: 32214762]
HEp-2	EC₅₀	19 3 Compound: Ribavirin	Antiviral activity against RSV A2 infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV A2 infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
HEp-2	EC₅₀	2.2 6 Compound: Ribavirin	Antiviral activity against RSV A-2 infected in human Hep2 cells after 3 days by plaque neutralization assay Antiviral activity against RSV A-2 infected in human Hep2 cells after 3 days by plaque neutralization assay	[PMID: 9599250]
MDCK	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay	[PMID: 30142611]
MDCK	CC₅₀	>250 3 Compound: RBV; Ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay	[PMID: 26924568]
HEp-2	EC₅₀	2.3 6 Compound: Ribavirin	Antiviral activity against RSV infected in human Hep2 cells assessed as virus-induced cytopathic effect administered 3 hrs postinfection Antiviral activity against RSV infected in human Hep2 cells assessed as virus-induced cytopathic effect administered 3 hrs postinfection	[PMID: 9599250]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs by MTS assay Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs by MTS assay	[PMID: 29220568]
HEp-2	EC₅₀	20.12 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay	[PMID: 37859725]
MDCK	CC₅₀	>100 3 Compound: ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTS assay Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTS assay	[PMID: 18778942]
HEp-2	EC₅₀	20.7 3 Compound: Ribavirin	Antiviral activity against DMSO-passaged wild type RSV RSS infected human Hep2 cells by plaque reduction assay Antiviral activity against DMSO-passaged wild type RSV RSS infected human Hep2 cells by plaque reduction assay	[PMID: 17576833]
MDCK	CC₅₀	>250 3 Compound: RBV, Ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTT assay Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTT assay	[PMID: 25856229]
HEp-2	EC₅₀	25.3 3 Compound: Ribavirin	Antiviral activity against RSV RSS infected human Hep2 cells assessed as reduction of viral antigen synthesis after 3 days by ELISA Antiviral activity against RSV RSS infected human Hep2 cells assessed as reduction of viral antigen synthesis after 3 days by ELISA	[PMID: 17576833]
MDCK	CC₅₀	100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as inhibition of cell viability by colorimetric formazan-based MTS assay Cytotoxicity against MDCK cells assessed as inhibition of cell viability by colorimetric formazan-based MTS assay	[PMID: 26114811]
HEp-2	EC₅₀	28.4 3 Compound: 1	Antiviral activity against Respiratory syncytial virus Long infected in human Hep2 cells assessed as reduction in virus-induced cytopathogenicity by Cell Titer-Glo assay Antiviral activity against Respiratory syncytial virus Long infected in human Hep2 cells assessed as reduction in virus-induced cytopathogenicity by Cell Titer-Glo assay	[PMID: 23043370]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 3 days by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 3 days by MTS assay	[PMID: 30170320]
HEp-2	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against RSV B infected human Hep2 cells after 5 days by plaque reduction assay Antiviral activity against RSV B infected human Hep2 cells after 5 days by plaque reduction assay	[PMID: 17576833]
HEp-2	EC₅₀	5.4 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect measured after 6 days by CellTiter-Glo assay	[PMID: 36596229]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 4 days by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 4 days by MTS assay	[PMID: 31753804]
HEp-2	IC₅₀	0.08 3 Compound: Ribavirin	Antiviral activity against RSV infected in human HEp-2 cells assessed as inhibition of viral induced cytopathic effect by CPE assay Antiviral activity against RSV infected in human HEp-2 cells assessed as inhibition of viral induced cytopathic effect by CPE assay	[PMID: 32937282]
MDCK	CC₅₀	1365.5 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by crystal violet staining based method Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by crystal violet staining based method	[PMID: 30033162]
MDCK	CC₅₀	>2130 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 30746065]
HEp-2	IC₅₀	10.6 3 Compound: Ribavirin	Antiviral activity against Human respiratory syncytial virus infected in human HEp-2 cells assessed as plaque reduction preincubated with cells 15 mins followed by viral infection for 2.5 hrs and measured after 3 days by crystal violet staining based micr Antiviral activity against Human respiratory syncytial virus infected in human HEp-2 cells assessed as plaque reduction preincubated with cells 15 mins followed by viral infection for 2.5 hrs and measured after 3 days by crystal violet staining based micr	[PMID: 38579352]
MDCK	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 28666191]
HEp-2	IC₅₀	10.7 3 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay	[PMID: 19267453]
HEp-2	IC₅₀	10.7 3 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay	[PMID: 19267453]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 72 hrs by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 72 hrs by MTS assay	[PMID: 24974341]
MDCK	CC₅₀	>300 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by CellTiter-Glo assay Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by CellTiter-Glo assay	[PMID: 36596229]
HEp-2	IC₅₀	17.33 3 Compound: Ribavirin	Antiviral activity against RSV Long expressing mGFP infected in HEp-2 cells assessed as reduction in viral replication after 48 hrs by MTS assay Antiviral activity against RSV Long expressing mGFP infected in HEp-2 cells assessed as reduction in viral replication after 48 hrs by MTS assay	[PMID: 33571829]
MDCK	CC₅₀	>250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 33962311]
HEp-2	IC₅₀	19 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect by CPE inhibition assay Antiviral activity against Respiratory syncytial virus infected in human HEp-2 cells assessed as inhibition of virus-induced cytopathic effect by CPE inhibition assay	[PMID: 35729787]
MDCK	CC₅₀	>50 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 34273661]
HEp-2	IC₅₀	2.6 6 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect	[PMID: 11678648]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 3 to 6 days by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 3 to 6 days by MTS assay	[PMID: 29886325]
HEp-2	IC₅₀	20 3 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by XTT assay Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by XTT assay	[PMID: 25420212]
HEp-2	IC₅₀	20.4 3 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as virus-induced cytopathicity by XTT assay Antiviral activity against Respiratory syncytial virus infected in human Hep2 cells assessed as virus-induced cytopathicity by XTT assay	[PMID: 24882250]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by alamar blue assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by alamar blue assay	[PMID: 31053507]
HEp-2	IC₅₀	25 6 Compound: Ribavirin	Cytotoxicity against RSV A-2 infected human Hep2 cells after 3 days Cytotoxicity against RSV A-2 infected human Hep2 cells after 3 days	[PMID: 9599250]
MDCK	CC₅₀	58 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by MTS assay	[PMID: 32220685]
HEp-2	IC₅₀	25 6 Compound: Ribavirin	Cytotoxicity against human Hep2 cells administered 3 hrs postinfection Cytotoxicity against human Hep2 cells administered 3 hrs postinfection	[PMID: 9599250]
MDCK	CC₅₀	>100 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured for 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured for 48 hrs by MTT assay	[PMID: 36764470]
MDCK	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured on day 5 by Celltiter-Glo luminescence assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured on day 5 by Celltiter-Glo luminescence assay	[PMID: 30852083]
HEp-2	IC₅₀	35 6 Compound: Ribavirin	Cytotoxicity against RSV long infected human Hep2 cells after 3 days Cytotoxicity against RSV long infected human Hep2 cells after 3 days	[PMID: 9599250]
HEp-2	IC₅₀	3 6 Compound: ribavirin	Antiviral activity against RSV Long in human Hep2 cells assessed as reduction of virus induced cytopathic effect Antiviral activity against RSV Long in human Hep2 cells assessed as reduction of virus induced cytopathic effect	[PMID: 16724853]
MDCK	CC₅₀	>100 3 Compound: ribavirin	Cytotoxicity against MDCK cells by MTS assay Cytotoxicity against MDCK cells by MTS assay	[PMID: 19281225]
MDCK	CC₅₀	>100 6 Compound: Ribavirin	Cytotoxicity against MDCK cells by MTS assay Cytotoxicity against MDCK cells by MTS assay	[PMID: 20724039]
MDCK	CC₅₀	20 3 Compound: Ribavirin	Cytotoxicity against MDCK cells by MTT assay Cytotoxicity against MDCK cells by MTT assay	[PMID: 33705902]
MDCK	CC₅₀	>512 3 Compound: ribavirin	Cytotoxicity against MDCK cells by MTT assay Cytotoxicity against MDCK cells by MTT assay	[PMID: 18640042]
MDCK	CC₅₀	>4095 3 Compound: Ribavirin	Cytotoxicity against MDCK cells infected with influenza A virus California/7/2009(H1N1) Cytotoxicity against MDCK cells infected with influenza A virus California/7/2009(H1N1)	[PMID: 36898483]
MDCK	CC₅₀	>100 3 Compound: ribavirin	Cytotoxicity against MDCK cells relative to control Cytotoxicity against MDCK cells relative to control	[PMID: 26260336]
MDCK	CC₅₀	>2000 6 Compound: ribavirin	Cytotoxicity in MDCK cells infected with influenza A H3N2 virus Cytotoxicity in MDCK cells infected with influenza A H3N2 virus	[PMID: 16183283]
MDCK	CC₅₀	>100 6 Compound: Ribavirin	The compound was evaluated for cytotoxicity by MTT assay in MDCK cells The compound was evaluated for cytotoxicity by MTT assay in MDCK cells	10.1016/S0960-894X(97)10154-8
HUVEC	CC₅₀	> 150 3 Compound: RBV	Cytotoxicity against HUVECs assessed as reduction in cell viability incubated for 48 hrs by CCK-8 method Cytotoxicity against HUVECs assessed as reduction in cell viability incubated for 48 hrs by CCK-8 method	[PMID: 38493729]
MDCK	EC₅₀	4.92 3 Compound: Ribavirin	Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Georgia/17/2006(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Georgia/17/2006(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain	[PMID: 20350949]
MDCK	EC₅₀	19.67 3 Compound: Ribavirin	Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/Georgia/20/2006(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microsc Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/Georgia/20/2006(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microsc	[PMID: 20350949]
MDCK	EC₅₀	20.92 3 Compound: Ribavirin	Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Florida/01/2009(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Florida/01/2009(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis	[PMID: 20350949]
MDCK	EC₅₀	35.6 3 Compound: Ribavirin	Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Washington/01/2007(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analy Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Washington/01/2007(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analy	[PMID: 20350949]
MDCK	EC₅₀	13.93 3 Compound: Ribavirin	Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus B/Memphis/20/1996 infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus B/Memphis/20/1996 infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain	[PMID: 20350949]
HeLa	CC₅₀	300 6 Compound: Rib	Cytotoxicity against human HeLa cells after 2 days by MTT assay Cytotoxicity against human HeLa cells after 2 days by MTT assay	[PMID: 12444692]
MDCK	EC₅₀	8.2 3 Compound: ribavirin	Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay	[PMID: 24900429]
HeLa	CC₅₀	300 6 Compound: Rib (Ribavirin)	Cytotoxicity against HeLa cells Cytotoxicity against HeLa cells	[PMID: 14505657]
MDCK	EC₅₀	8.7 3 Compound: ribavirin	Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
HeLa	CC₅₀	426 6 Compound: Ribovirin	Cytotoxicity against human HeLa cells after 48 hrs by MTT assay Cytotoxicity against human HeLa cells after 48 hrs by MTT assay	[PMID: 19374435]
HeLa	CC₅₀	> 200 6 Compound: ribavirin	Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of HeLa cells Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of HeLa cells	[PMID: 8709116]
MDCK	EC₅₀	3.56 3 Compound: RBV	Antiviral activity against amantadine-resistant influenza A virus HN/1222 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against amantadine-resistant influenza A virus HN/1222 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
MDCK	EC₅₀	1.43 3 Compound: RBV	Antiviral activity against amantadine-resistant influenza A virus JX/312 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against amantadine-resistant influenza A virus JX/312 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
HeLa	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Human coxsackievirus B4 infected human HeLa cells by trypan blue exclusion method Cytotoxicity against Human coxsackievirus B4 infected human HeLa cells by trypan blue exclusion method	[PMID: 20034711]
MDCK	EC₅₀	10 3 Compound: ribavirin	Antiviral activity against amantadine-sensitive Influenza A virus (A/FM/1/47 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantadine-sensitive Influenza A virus (A/FM/1/47 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
HeLa	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Respiratory syncytial virus infected human HeLa cells by trypan blue exclusion method Cytotoxicity against Respiratory syncytial virus infected human HeLa cells by trypan blue exclusion method	[PMID: 20034711]
MDCK	EC₅₀	7.6 3 Compound: ribavirin	Antiviral activity against amantadine-sensitive Influenza A virus (A/Ned/378/05 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantadine-sensitive Influenza A virus (A/Ned/378/05 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
HeLa	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against VSV infected human HeLa cells by trypan blue exclusion method Cytotoxicity against VSV infected human HeLa cells by trypan blue exclusion method	[PMID: 20034711]
HeLa	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against human HeLa cells assessed as growth inhibition after 3 days by coulter counting analysis Cytotoxicity against human HeLa cells assessed as growth inhibition after 3 days by coulter counting analysis	[PMID: 21565516]
MDCK	EC₅₀	8.1 3 Compound: ribavirin	Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay	[PMID: 24900429]
HeLa	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Homo sapiens (human) HeLa cells assessed as change in cellular morphology Cytotoxicity against Homo sapiens (human) HeLa cells assessed as change in cellular morphology	[PMID: 32214762]
MDCK	EC₅₀	8 3 Compound: ribavirin	Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
HeLa	CC₅₀	> 250 6 Compound: Ribavirin	Cytotoxicity against human HeLa cells assessed as cell viability by MTS assay Cytotoxicity against human HeLa cells assessed as cell viability by MTS assay	[PMID: 20971531]
MDCK	EC₅₀	4.6 3 Compound: Ribavirin	Antiviral activity against IInfluenza A virus H3N2 A/HK/7/87 infected in MDCK cells after 4 days by MTS assay Antiviral activity against IInfluenza A virus H3N2 A/HK/7/87 infected in MDCK cells after 4 days by MTS assay	[PMID: 31753804]
MDCK	EC₅₀	12 6 Compound: Ribavirin	Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HeLa	CC₅₀	> 250 6 Compound: ribavirin	Cytotoxicity against human HeLa cells after 3 days by MTS assay Cytotoxicity against human HeLa cells after 3 days by MTS assay	[PMID: 20347509]
MDCK	EC₅₀	9 6 Compound: Ribavirin	Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
HeLa	CC₅₀	> 300 6 Compound: ribavirin	Cytotoxicity against human HeLa cells Cytotoxicity against human HeLa cells	[PMID: 17046264]
HeLa	CC₅₀	> 500 3 Compound: Ribavirin	Cytotoxicity against HeLa cells Cytotoxicity against HeLa cells	[PMID: 17181162]
MDCK	EC₅₀	3.7 3 Compound: Ribavirin	Antiviral activity against influenza A H2N2(A2 japan/305/57) in MDCK cells Antiviral activity against influenza A H2N2(A2 japan/305/57) in MDCK cells	[PMID: 12729645]
MDCK	EC₅₀	12.5 3 Compound: Ribavirin	Antiviral activity against Influenza A H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathicity Antiviral activity against Influenza A H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
HeLa	CC₅₀	> 500 6 Compound: Ribavirin	Cytotoxicity against human HeLa cells after 72 hrs by MTT assay Cytotoxicity against human HeLa cells after 72 hrs by MTT assay	[PMID: 23920438]
MDCK	EC₅₀	8.4 6 Compound: Ribavirin	Antiviral activity against Influenza A H3N2 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Influenza A H3N2 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HeLa	EC₅₀	1.5 3 Compound: Ribavirin	Effective concentration required to inhibit respiratory synaptial(RSV) virus-induced cytopathicity by 50% in HeLa cell lines Effective concentration required to inhibit respiratory synaptial(RSV) virus-induced cytopathicity by 50% in HeLa cell lines	[PMID: 11495586]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Respiratory syncytial virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
MDCK	EC₅₀	24 6 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/California/07/2009(H1N1) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by visual assay Antiviral activity against Influenza A virus (A/California/07/2009(H1N1) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by visual assay	[PMID: 26291036]
MDCK	EC₅₀	16 6 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by neutral red assay Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by neutral red assay	[PMID: 26291036]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against VSV infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay Antiviral activity against VSV infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay	[PMID: 20034711]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in HeLa cells Antiviral activity against Respiratory syncytial virus infected in HeLa cells	[PMID: 22464686]
MDCK	EC₅₀	23.75 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay	[PMID: 23811085]
MDCK	EC₅₀	7.3 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
MDCK	EC₅₀	6.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy	[PMID: 24974341]
HeLa	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
MDCK	EC₅₀	7 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay	[PMID: 24900429]
HeLa	EC₅₀	10 3 Compound: ribavirin	Antiviral activity against RSV Long in human HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against RSV Long in human HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
HeLa	EC₅₀	1000 3 Compound: Ribavirin	Effective concentration required to inhibit vesicular stomatitis virus (VSV)-induced cytopathicity by 50% in HeLa cell lines Effective concentration required to inhibit vesicular stomatitis virus (VSV)-induced cytopathicity by 50% in HeLa cell lines	[PMID: 11495586]
MDCK	EC₅₀	7.7 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
MDCK	EC₅₀	6 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23099097]
HeLa	EC₅₀	10 6 Compound: Ribavirin	Antiviral activity against RSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against RSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
MDCK	EC₅₀	12 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 25752526]
HeLa	EC₅₀	10 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
MDCK	EC₅₀	8.7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity by MTS assay Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity by MTS assay	[PMID: 20805012]
HeLa	EC₅₀	10 6 Compound: ribavirin	Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
MDCK	EC₅₀	8.8 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/Ishikawa/7/82 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against Influenza A virus (A/Ishikawa/7/82 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
HeLa	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
HeLa	EC₅₀	112 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
MDCK	EC₅₀	18.43 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Perth/16/2009(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay Antiviral activity against Influenza A virus (A/Perth/16/2009(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay	[PMID: 23811085]
HeLa	EC₅₀	12 3 Compound: Ribavirin	Antiviral activity against RSV in HeLa cells Antiviral activity against RSV in HeLa cells	[PMID: 17181162]
MDCK	EC₅₀	6.8 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in MDCK cells assessed as 1-log10 reduction in viral RNA copy number after 24 hrs by quantitative RT-PCR analysis Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in MDCK cells assessed as 1-log10 reduction in viral RNA copy number after 24 hrs by quantitative RT-PCR analysis	[PMID: 26288686]
MDCK	EC₅₀	21 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
HeLa	EC₅₀	12.1 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Vesicular stomatitis virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis	[PMID: 23117173]
HeLa	EC₅₀	14.41 6 Compound: Rib (Ribavirin)	Compound was evaluated for its inhibitory effect on the replication of vesicular stomatitis virus (VSV) in HeLa cells Compound was evaluated for its inhibitory effect on the replication of vesicular stomatitis virus (VSV) in HeLa cells	[PMID: 14505657]
MDCK	EC₅₀	8.4 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 23117173]
HeLa	EC₅₀	14.8 3 Compound: Ribavirin	Antiviral activity against VSV infected in HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against VSV infected in HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	8 3 Compound: RBV, Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34) (H1N1) infected in MDCK cells assessed as reduction in plaque formation after 48 hrs by plaque reduction assay Antiviral activity against Influenza A virus (A/PR/8/34) (H1N1) infected in MDCK cells assessed as reduction in plaque formation after 48 hrs by plaque reduction assay	[PMID: 25856229]
HeLa	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
MDCK	EC₅₀	6.1 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23099097]
HeLa	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in HeLa cells Antiviral activity against Coxsackie virus B4 infected in HeLa cells	[PMID: 22464686]
MDCK	EC₅₀	2 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 12 hrs by toluidine blue staining assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 12 hrs by toluidine blue staining assay	[PMID: 24313730]
HeLa	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
MDCK	EC₅₀	8 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
HeLa	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 25752526]
HeLa	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis	[PMID: 25752526]
HeLa	EC₅₀	146 6 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
MDCK	EC₅₀	12 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Wisconsin/67/2005(H3N2)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against Influenza A virus (A/Wisconsin/67/2005(H3N2)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
HeLa	EC₅₀	14 6 Compound: Ribavirin	Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HeLa	EC₅₀	150 3 Compound: ribavirin	Antiviral activity against coxsackie B4 virus in HeLa cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against coxsackie B4 virus in HeLa cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
MDCK	EC₅₀	8.5 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 23117173]
HeLa	EC₅₀	16 6 Compound: Ribavirin	Antiviral activity against RSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against RSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
MDCK	EC₅₀	11 3 Compound: RBV	Antiviral activity against influenza A virus A/Padova/253/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against influenza A virus A/Padova/253/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
HeLa	EC₅₀	16 6 Compound: ribavirin	Antiviral activity against RSV Long in HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against RSV Long in HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
MDCK	EC₅₀	7 3 Compound: RBV	Antiviral activity against influenza A virus A/Padova/30/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against influenza A virus A/Padova/30/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
HeLa	EC₅₀	17 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HeLa cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Vesicular stomatitis virus infected in HeLa cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 24906510]
MDCK	EC₅₀	8.7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus induced cytopathic effect measured by visual scoring of cytopathic effect Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus induced cytopathic effect measured by visual scoring of cytopathic effect	[PMID: 27112451]
MDCK	EC₅₀	7.5 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus-induced cytopathic effect measured after 4 days by formazan-based MTS assay Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus-induced cytopathic effect measured after 4 days by formazan-based MTS assay	[PMID: 27112451]
HeLa	EC₅₀	17.2 3 Compound: ribavirin	Antiviral activity against VSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against VSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 20347509]
HeLa	EC₅₀	181.36 6 Compound: Rib (Ribavirin)	Compound was evaluated for its inhibitory effect on the replication of Coxsackie virus B3 (Cox. B3) in HeLa cells Compound was evaluated for its inhibitory effect on the replication of Coxsackie virus B3 (Cox. B3) in HeLa cells	[PMID: 14505657]
MDCK	EC₅₀	11 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
HeLa	EC₅₀	19 3 Compound: 1	Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
MDCK	EC₅₀	12 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy	[PMID: 24974341]
MDCK	EC₅₀	19.4 3 Compound: 3	Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
HeLa	EC₅₀	192 3 Compound: d	concentration required to inhibit VSV-induced cytopathicity by 50% in HeLa cells concentration required to inhibit VSV-induced cytopathicity by 50% in HeLa cells	[PMID: 9748360]
HeLa	EC₅₀	2.8 6 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
MDCK	EC₅₀	11.2 3 Compound: 3	Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
HeLa	EC₅₀	20.94 6 Compound: Rib (Ribavirin)	Compound was evaluated for its inhibitory effect on the replication of encephalomyocarditis virus (EMCV) in HeLa cells Compound was evaluated for its inhibitory effect on the replication of encephalomyocarditis virus (EMCV) in HeLa cells	[PMID: 14505657]
MDCK	EC₅₀	32.5 3 Compound: 3	Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	35.4 3 Compound: 3	Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
HeLa	EC₅₀	22 3 Compound: 1	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
HeLa	EC₅₀	22 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
MDCK	EC₅₀	27.4 3 Compound: 3	Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	23.6 3 Compound: 3	Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
HeLa	EC₅₀	22 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
HeLa	EC₅₀	22 3 Compound: ribavirin	Antiviral activity against VSV in human HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against VSV in human HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
MDCK	EC₅₀	12.9 6 Compound: Ribavirin	Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as cell viability after 2 days by MTS assay Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as cell viability after 2 days by MTS assay	[PMID: 20724039]
HeLa	EC₅₀	22 6 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
HeLa	EC₅₀	22 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
MDCK	EC₅₀	2.3 3 Compound: Ribavirin	Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HeLa	EC₅₀	24 6 Compound: ribavirin	Antiviral activity against RSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against RSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
MDCK	EC₅₀	6.7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay	[PMID: 22459876]
HeLa	EC₅₀	24 6 Compound: ribavirin	Antiviral activity against VSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against VSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
MDCK	EC₅₀	9.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection against virus-induced cytopathicity Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
HeLa	EC₅₀	27.8 6 Compound: Ribavirin	Antiviral activity against Adenovirus type 7 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method Antiviral activity against Adenovirus type 7 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method	[PMID: 23920438]
MDCK	EC₅₀	9.6 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
HeLa	EC₅₀	28.5 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Human coxsackievirus B4 infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
HeLa	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Vesicular stomatitis virus infected HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
MDCK	EC₅₀	2.5 3 Compound: ribavirin	Antiviral activity against influenza A virus H1N1 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay Antiviral activity against influenza A virus H1N1 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay	[PMID: 23811093]
HeLa	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HeLa cells Antiviral activity against Vesicular stomatitis virus infected in HeLa cells	[PMID: 22464686]
HeLa	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
MDCK	EC₅₀	8.4 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 A/HK/7/87 infected in MDCK cells assessed as reduction in virus induced cytopathic effect after 4 days by microscopy based method Antiviral activity against Influenza A virus H3N2 A/HK/7/87 infected in MDCK cells assessed as reduction in virus induced cytopathic effect after 4 days by microscopy based method	[PMID: 31753804]
MDCK	EC₅₀	7.8 6 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as cell viability after 2 days by MTS assay Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as cell viability after 2 days by MTS assay	[PMID: 20724039]
HeLa	EC₅₀	29 3 Compound: ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
MDCK	EC₅₀	9 3 Compound: 1	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
HeLa	EC₅₀	29 6 Compound: Ribavirin	Antiviral activity against VSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against VSV infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
HeLa	EC₅₀	29 6 Compound: ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
MDCK	EC₅₀	5.1 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
HeLa	EC₅₀	3 3 Compound: Ribavirin	Antiviral activity against RSV infected in HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against RSV infected in HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	5.6 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay	[PMID: 22459876]
HeLa	EC₅₀	3.6 6 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
MDCK	EC₅₀	9 6 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
HeLa	EC₅₀	30 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay	[PMID: 20034711]
MDCK	EC₅₀	6.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza A virus H3N2 infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
HeLa	EC₅₀	30 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 4 days by MTT assay Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 4 days by MTT assay	[PMID: 20034711]
MDCK	EC₅₀	7.2 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N3 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Influenza A virus H3N3 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
HeLa	EC₅₀	320 3 Compound: d	concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cells concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cells	[PMID: 9748360]
MDCK	EC₅₀	1.1 3 Compound: ribavirin	Antiviral activity against influenza A virus H3N3 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay Antiviral activity against influenza A virus H3N3 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay	[PMID: 23811093]
HeLa	EC₅₀	4.6 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	EC₅₀	9.4 3 Compound: 3	Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
HeLa	EC₅₀	48 6 Compound: Ribavirin	Antiviral activity against VSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity Antiviral activity against VSV infected in human HeLa cell assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
MDCK	EC₅₀	4.3 3 Compound: 3	Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
HeLa	EC₅₀	48 6 Compound: ribavirin	Antiviral activity against coxsackie B4 virus in HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against coxsackie B4 virus in HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
MDCK	EC₅₀	3.7 6 Compound: Ribavirin	Antiviral activity against influenza A virus NWS33 in MDCK cells assessed as inhibition of viral cytopathic effect by neutral red assay Antiviral activity against influenza A virus NWS33 in MDCK cells assessed as inhibition of viral cytopathic effect by neutral red assay	[PMID: 9214738]
HeLa	EC₅₀	5 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Respiratory syncytial virus Long infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
HeLa	EC₅₀	5 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Vesicular stomatitis virus infected in human HeLa cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
MDCK	EC₅₀	12.8 3 Compound: RBV; Ribavirin	Antiviral activity against Influenza A virus PR/8/34 infected in MDCK cells assessed as inhibition of plaque formation treated for 1 hr measured after 2 days by toluidine blue staining-based assay Antiviral activity against Influenza A virus PR/8/34 infected in MDCK cells assessed as inhibition of plaque formation treated for 1 hr measured after 2 days by toluidine blue staining-based assay	[PMID: 26924568]
MDCK	EC₅₀	25.1 3 Compound: 3	Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
HeLa	EC₅₀	5 3 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
MDCK	EC₅₀	23.3 3 Compound: 3	Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
HeLa	EC₅₀	5.8 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
MDCK	EC₅₀	13.9 3 Compound: 3	Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
HeLa	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
HeLa	EC₅₀	50 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 in human HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 in human HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
MDCK	EC₅₀	8.4 3 Compound: 3	Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
HeLa	EC₅₀	50 6 Compound: Ribavirin	Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against coxsackievirus B4 infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
MDCK	EC₅₀	20.2 3 Compound: 3	Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
HeLa	EC₅₀	6.6 3 Compound: ribavirin	Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against RSV infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 20347509]
MDCK	EC₅₀	16.4 3 Compound: 3	Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
HeLa	EC₅₀	69 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in HeLa cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in HeLa cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza A/HK/7/87 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay Antiviral activity against Influenza A/HK/7/87 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay	[PMID: 23149298]
MDCK	EC₅₀	8.68 3 Compound: ribavirin	Antiviral activity against influenza A/Hong Kong/7/87 (H3N2) in MDCK cells assessed as inhibition of virus-induced cytopathic effect by MTS assay Antiviral activity against influenza A/Hong Kong/7/87 (H3N2) in MDCK cells assessed as inhibition of virus-induced cytopathic effect by MTS assay	[PMID: 17588747]
HeLa	EC₅₀	6 6 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
MDCK	EC₅₀	6.8 3 Compound: Ribavirin	Antiviral activity against Influenza A/PR/8/34 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay Antiviral activity against Influenza A/PR/8/34 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay	[PMID: 23149298]
HeLa	EC₅₀	73.1 3 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 20347509]
MDCK	EC₅₀	5.73 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Florida/4/2006) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay Antiviral activity against Influenza B virus (B/Florida/4/2006) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay	[PMID: 23811085]
HeLa	EC₅₀	80 6 Compound: ribavirin	Antiviral activity against VSV in HeLa cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against VSV in HeLa cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
MDCK	EC₅₀	8.2 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
HeLa	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against coxsackie B4 virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against coxsackie B4 virus infected in human HeLa cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy	[PMID: 24974341]
HeLa	EC₅₀	90 6 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 in HeLa cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackie virus B4 in HeLa cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
MDCK	EC₅₀	0.094 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis	[PMID: 23117173]
HeLa	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Coxsackie virus B4 infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
MDCK	EC₅₀	0.14 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 23117173]
HeLa	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
MDCK	EC₅₀	4.6 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23099097]
HeLa	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Vesicular stomatitis virus infected in HeLa cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
HeLa	EC₅₀	> 320 3 Compound: Ribavirin	Effective concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cell lines Effective concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in HeLa cell lines	[PMID: 11495586]
MDCK	EC₅₀	3.4 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 25752526]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis	[PMID: 25752526]
HeLa	EC₅₀	> 500 3 Compound: Ribavirin	Antiviral activity against Coxsackie B4 virus in HeLa cells Antiviral activity against Coxsackie B4 virus in HeLa cells	[PMID: 17181162]
HeLa	IC₅₀	11.4 3 Compound: Ribavirin	Inhibitory concentration against respiratory syncytial virus in HeLa cells Inhibitory concentration against respiratory syncytial virus in HeLa cells	[PMID: 7658442]
MDCK	EC₅₀	6 3 Compound: RBV	Antiviral activity against Influenza B virus (B/Lee/1940) clinical isolate infected in MDCK cells assessed as inhibition of viral replication after 2 days by toluidine blue staining assay Antiviral activity against Influenza B virus (B/Lee/1940) clinical isolate infected in MDCK cells assessed as inhibition of viral replication after 2 days by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	4.28 3 Compound: RBV	Antiviral activity against influenza B virus B/SZ/155 infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against influenza B virus B/SZ/155 infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
HeLa	IC₅₀	14 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus VSV in HeLa cell line Tested for inhibitory effect on RNA virus VSV in HeLa cell line	[PMID: 8246242]
HeLa	IC₅₀	20.3 6 Compound: Ribovirin	Antiviral activity against Coxsackie virus B3 Nacy infected in human HeLa cells assessed as reduction of virus-induced cytopathic effect by MTT assay Antiviral activity against Coxsackie virus B3 Nacy infected in human HeLa cells assessed as reduction of virus-induced cytopathic effect by MTT assay	[PMID: 19374435]
MDCK	EC₅₀	4.8 3 Compound: ribavirin	Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method	[PMID: 19281225]
MDCK	EC₅₀	4 3 Compound: ribavirin	Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method	[PMID: 19281225]
HeLa	IC₅₀	20 6 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 in HeLa cells Antiviral activity against Coxsackie virus B4 in HeLa cells	[PMID: 17518459]
HeLa	IC₅₀	20 6 Compound: ribavirin	Antiviral activity against VSV in HeLa cells Antiviral activity against VSV in HeLa cells	[PMID: 17518459]
MDCK	EC₅₀	2.8 3 Compound: ribavirin	Antiviral activity against influenza B virus infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay Antiviral activity against influenza B virus infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay	[PMID: 23811093]
HeLa	IC₅₀	2 6 Compound: ribavirin	Antiviral activity against Respiratory syncytial virus in HeLa cells Antiviral activity against Respiratory syncytial virus in HeLa cells	[PMID: 17518459]
MDCK	EC₅₀	6 6 Compound: Ribavirin	Antiviral activity against influenza B virus infected in MDCK cells assessed as cell viability after 2 days by MTS assay Antiviral activity against influenza B virus infected in MDCK cells assessed as cell viability after 2 days by MTS assay	[PMID: 20724039]
MDCK	EC₅₀	4.3 6 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
HeLa	IC₅₀	4 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus RSV in HeLa cell line Tested for inhibitory effect on RNA virus RSV in HeLa cell line	[PMID: 8246242]
MDCK	EC₅₀	7 6 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
HeLa	IC₅₀	70 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Polio-1 in HeLa cell line Tested for inhibitory effect on RNA virus Polio-1 in HeLa cell line	[PMID: 8246242]
HeLa	IC₅₀	>= 400 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in HeLa cell line Tested for inhibitory effect on RNA virus cell morphology in HeLa cell line	[PMID: 8246242]
MDCK	EC₅₀	4.5 3 Compound: Ribavirin	Antiviral activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
MDCK	EC₅₀	4.8 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay	[PMID: 22459876]
MDCK	EC₅₀	7.3 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as protection against virus-induced cytopathicity Antiviral activity against Influenza B virus infected in MDCK cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	8.3 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
MDCK	EC₅₀	8.4 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	EC₅₀	19.5 3 Compound: 3	Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	10.2 3 Compound: 3	Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
MDCK	EC₅₀	8400 3 Compound: ribavirin	Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method	[PMID: 19281225]
MDCK	EC₅₀	900 3 Compound: ribavirin	Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method	[PMID: 19281225]
MDCK	EC₅₀	8.1 3 Compound: ribavirin	Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method	[PMID: 19281225]
MDCK	EC₅₀	9 3 Compound: ribavirin	Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method	[PMID: 19281225]
MDCK	EC₅₀	17 3 Compound: RBV	Antiviral activity against oseltamivir-resistant Influenza A virus (A/Parma/24/2009(H1N1)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against oseltamivir-resistant Influenza A virus (A/Parma/24/2009(H1N1)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	1.05 3 Compound: RBV	Antiviral activity against oseltamivir-resistant influenza A virus LN/1109 (H1N1) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against oseltamivir-resistant influenza A virus LN/1109 (H1N1) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
MDCK	EC₅₀	46.7 3 Compound: Ribavirin	Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Texas/12/2007 (clone)(H3N2)) harboring neuraminidase E119I mutant and harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Texas/12/2007 (clone)(H3N2)) harboring neuraminidase E119I mutant and harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral	[PMID: 20350949]
MDCK	EC₅₀	25 3 Compound: Ribavirin	Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza B virus B/Memphis/20/1996 harboring neuraminidase R152K mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic ana Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza B virus B/Memphis/20/1996 harboring neuraminidase R152K mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic ana	[PMID: 20350949]
MDCK	EC₅₀	11.5 3 Compound: Ribavirin	Antiviral activity against Unidentified Influenza A virus (H1N1) infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Unidentified Influenza A virus (H1N1) infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	EC₅₀	43 3 Compound: ribavirin	Inhibition of influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) replication in MDCK cells by neutral red uptake assay Inhibition of influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) replication in MDCK cells by neutral red uptake assay	[PMID: 17194832]
MDCK	EC₅₀	38.1 3 Compound: ribavirin	Inhibition of Influenza A virus (A/gull/Pennsylvania/4175/83 (H5N1)) replication in MDCK cells by neutral red uptake assay Inhibition of Influenza A virus (A/gull/Pennsylvania/4175/83 (H5N1)) replication in MDCK cells by neutral red uptake assay	[PMID: 17194832]
MDCK	EC₅₀	15.6 3 Compound: RBV	Inhibition of Influenza A virus A/PR/8/34 infected in MDCK cells after 48 hrs by plaque reduction assay Inhibition of Influenza A virus A/PR/8/34 infected in MDCK cells after 48 hrs by plaque reduction assay	[PMID: 24785979]
MDCK	EC₅₀	14.3 3 Compound: ribavirin	Inhibition of viral replication of influenza A virus (A/Hong Kong/213/03(H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay Inhibition of viral replication of influenza A virus (A/Hong Kong/213/03(H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay	[PMID: 17194832]
MDCK	EC₅₀	35.7 3 Compound: ribavirin	Inhibition of viral replication of influenza A virus (A/Vietnam/1203/2004 (H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay Inhibition of viral replication of influenza A virus (A/Vietnam/1203/2004 (H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay	[PMID: 17194832]
MDCK	EC₅₀	34.2 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 Bangkok/10/83 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 Bangkok/10/83 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	8.3 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 PR8/34 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 PR8/34 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	11.7 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 yamagata/120/86 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 yamagata/120/86 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	2.2 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 Adachi/2/57 in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 Adachi/2/57 in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	2.1 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 murakami/4/64 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 murakami/4/64 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	7.9 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 ishikawa/7/82 in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 ishikawa/7/82 in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	6.1 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 Philippine/2/82 in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 Philippine/2/82 in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	5.5 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza B norway/1/80 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza B norway/1/80 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	8.5 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza B Singapore/222/79 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza B Singapore/222/79 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	ED₅₀	24.6 3 Compound: Ribavirin	Antiviral activity against Influenza virus A/California/07/09 (H1N1) pdm09 infected in MDCK cells after 48 hrs followed by incubated in chicken erythrocytes for 1 hr by hemagglutinination based end-point dilution method Antiviral activity against Influenza virus A/California/07/09 (H1N1) pdm09 infected in MDCK cells after 48 hrs followed by incubated in chicken erythrocytes for 1 hr by hemagglutinination based end-point dilution method	[PMID: 23099095]
MDCK	IC₅₀	1.9 3 Compound: RBV	Antiinfluenza activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs Antiinfluenza activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs	[PMID: 22341943]
MDCK	IC₅₀	3.9 3 Compound: RBV	Antiinfluenza activity against influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs Antiinfluenza activity against influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs	[PMID: 22341943]
MDCK	IC₅₀	14.7 3 Compound: RBV	Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs	[PMID: 22341943]
MDCK	IC₅₀	3.73 6 Compound: ribavirin	Antiviral activity against influenza A H3N2 virus in MDCK cells Antiviral activity against influenza A H3N2 virus in MDCK cells	[PMID: 16183283]
MDCK	IC₅₀	1.92 6 Compound: RBV	Antiviral activity against Influenza A virus (A/FM/1/1947(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against Influenza A virus (A/FM/1/1947(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	8.8 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Guangdong-Luohu/219/2006(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Guangdong-Luohu/219/2006(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 22824205]
MDCK	IC₅₀	5.86 3 Compound: RBV	Antiviral activity against influenza A virus (A/Hanfang/359/95(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption Antiviral activity against influenza A virus (A/Hanfang/359/95(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption	[PMID: 26132528]
MDCK	IC₅₀	98.3 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay	[PMID: 32520560]
MDCK	IC₅₀	24.6 6 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as protection against virus-induced cytopathic effect after 48 hrs by crystal violet staining method Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as protection against virus-induced cytopathic effect after 48 hrs by crystal violet staining method	[PMID: 23411074]
MDCK	IC₅₀	114.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 48 hrs Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 48 hrs	[PMID: 22487178]
MDCK	IC₅₀	101 3 Compound: Ribavirin	Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay	[PMID: 24967847]
MDCK	IC₅₀	84 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining technique Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining technique	[PMID: 24495078]
MDCK	IC₅₀	185.9 3 Compound: ribavirin	Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay	[PMID: 26114936]
MDCK	IC₅₀	115 3 Compound: Ribavirin	Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells incubated for 48 hrs assessed as inhibition of virus-induced cytopathic effect by crystal violet staining assay Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells incubated for 48 hrs assessed as inhibition of virus-induced cytopathic effect by crystal violet staining assay	[PMID: 26046820]
MDCK	IC₅₀	113.1 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) PR/8 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 48 hrs by crystal-violet staining-based assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) PR/8 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 48 hrs by crystal-violet staining-based assay	[PMID: 23886345]
MDCK	IC₅₀	35.3 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Tianjin-Jinnan/15/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Tianjin-Jinnan/15/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 22824205]
MDCK	IC₅₀	20.2 3 Compound: RIBA	Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in dog MDCK cells after 3 days by CPE assay Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in dog MDCK cells after 3 days by CPE assay	[PMID: 23806112]
MDCK	IC₅₀	5.59 6 Compound: RBV	Antiviral activity against Influenza A virus A/hanfang/359/95(H3N2) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against Influenza A virus A/hanfang/359/95(H3N2) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	0.41 3 Compound: RIBA	Antiviral activity against Influenza A virus A/Hong Kong/8/68(H3N2) infected in dog MDCK cells after 3 days by CPE assay Antiviral activity against Influenza A virus A/Hong Kong/8/68(H3N2) infected in dog MDCK cells after 3 days by CPE assay	[PMID: 23806112]
MDCK	IC₅₀	87 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in dog MDCK cells after 48 hrs by CPE inhibition assay Antiviral activity against Influenza A virus H1N1 infected in dog MDCK cells after 48 hrs by CPE inhibition assay	[PMID: 23758051]
MDCK	IC₅₀	100.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as compound concentration required for inhibiting influenza virus yield at 48 h post-infection by crystal violet staining based CPE inhibition assay Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as compound concentration required for inhibiting influenza virus yield at 48 h post-infection by crystal violet staining based CPE inhibition assay	[PMID: 21879714]
MDCK	IC₅₀	131 3 Compound: ribavirin	Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay	[PMID: 24499327]
MDCK	IC₅₀	2.06 11 Compound: Ribavirin	Antiviral activity against influenza A virus H3N2 (A3 China/15/90) expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against influenza A virus H3N2 (A3 China/15/90) expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect	[PMID: 18160286]
MDCK	IC₅₀	87.7 6 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 A3/JINGKE/30/95 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs Antiviral activity against Influenza A virus H3N2 A3/JINGKE/30/95 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs	[PMID: 26791013]
MDCK	IC₅₀	42.6 3 Compound: ribavirin	Antiviral activity against Influenza A virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay Antiviral activity against Influenza A virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay	[PMID: 19267453]
MDCK	IC₅₀	7.01 3 Compound: ribavirin	Antiviral activity against influenza A/Hanfang/359/95 (H3N2) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Hanfang/359/95 (H3N2) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	5.04 3 Compound: ribavirin	Antiviral activity against influenza A/Jifang/15/90 (H3N2) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Jifang/15/90 (H3N2) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	176 3 Compound: ribavirin	Antiviral activity against influenza A/Jingfang/262/95(H1N1) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Jingfang/262/95(H1N1) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	14 3 Compound: Ribavirin	Antiviral activity against Influenza A/PR8/H1N1 virus infected in MDCK cells assessed as inhibition of virus yield after 24 hrs Antiviral activity against Influenza A/PR8/H1N1 virus infected in MDCK cells assessed as inhibition of virus yield after 24 hrs	[PMID: 24216089]
MDCK	IC₅₀	5.85 3 Compound: ribavirin	Antiviral activity against influenza A/Yuefang/243/72 (H3N2) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Yuefang/243/72 (H3N2) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	45.5 3 Compound: RBV	Antiviral activity against Influenza B virus (strain B/Jifang/13/97) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza B virus (strain B/Jifang/13/97) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 22824205]
MDCK	IC₅₀	4.27 11 Compound: Ribavirin	Antiviral activity against influenza B virus expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against influenza B virus expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect	[PMID: 18160286]
MDCK	IC₅₀	9 3 Compound: ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells after 3 days by neutral red dye-based plaque reduction assay Antiviral activity against Influenza B virus infected in MDCK cells after 3 days by neutral red dye-based plaque reduction assay	[PMID: 26260336]
MDCK	IC₅₀	3.27 6 Compound: RBV	Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of plaque formation after 3 to 4 days by crystal violet staining-based assay Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of plaque formation after 3 to 4 days by crystal violet staining-based assay	[PMID: 24583605]
MDCK	IC₅₀	7.84 6 Compound: RBV	Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	96.2 3 Compound: ribavirin	Antiviral activity against influenza B/Jifang/13/97 virus in MDCK cells by CPE assay Antiviral activity against influenza B/Jifang/13/97 virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	15.2 3 Compound: ribavirin	Antiviral activity against influenza B/Jingfang/76/98 in MDCK cells by CPE assay Antiviral activity against influenza B/Jingfang/76/98 in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	164 3 Compound: ribavirin	Antiviral activity against influenza B/Sichuan/83/2000 virus in MDCK cells by CPE assay Antiviral activity against influenza B/Sichuan/83/2000 virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	62.5 6 Compound: ribavirin	Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
MDCK	IC₅₀	6.5 6 Compound: RBV	Antiviral activity against oseltamivir-resistant Influenza A virus (A/Tianjinjinnan/15/2009/H1N1) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against oseltamivir-resistant Influenza A virus (A/Tianjinjinnan/15/2009/H1N1) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	2.6 6 Compound: ribavirin	Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
MDCK	IC₅₀	>1310 3 Compound: 3	Cytotoxicity against MDCK cells after 3 days by neutral red dye uptake assay Cytotoxicity against MDCK cells after 3 days by neutral red dye uptake assay	[PMID: 20231094]
MDCK	IC₅₀	>200 6 Compound: Ribavirin	Cytotoxicity against MDCK cells by neutral red assay Cytotoxicity against MDCK cells by neutral red assay	[PMID: 9214738]
MDCK	IC₅₀	4.9 3 Compound: Ribavirin	Inhibitory concentration against influenza virus A in MDCK cells Inhibitory concentration against influenza virus A in MDCK cells	[PMID: 7658442]
MDCK	IC₅₀	16.3 3 Compound: Ribavirin	Inhibitory concentration against influenza virus B in MDCK cells Inhibitory concentration against influenza virus B in MDCK cells	[PMID: 7658442]
MDCK	IC₅₀	>200 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in MDCK cell line Tested for inhibitory effect on RNA virus cell morphology in MDCK cell line	[PMID: 8246242]
MDCK	IC₅₀	4 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Influenza A in MDCK cell line Tested for inhibitory effect on RNA virus Influenza A in MDCK cell line	[PMID: 8246242]
MOLT-4	IC₅₀	5.7 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of MOLT-4 human lymphoblastic T-leukemia cell line. Compound was tested for its effect on the proliferation of MOLT-4 human lymphoblastic T-leukemia cell line.	10.1016/0960-894X(96)00216-8
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against human MT4 cells after 96 hrs by MTT assay Cytotoxicity against human MT4 cells after 96 hrs by MTT assay	[PMID: 19482481]
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against human MT4 cells after 96 hrs by MTT assay Cytotoxicity against human MT4 cells after 96 hrs by MTT assay	[PMID: 20359898]
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against human MT4 cells assessed as cell viability after 96 hrs by MTT assay Cytotoxicity against human MT4 cells assessed as cell viability after 96 hrs by MTT assay	[PMID: 26443549]
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against mock-infected human MT4 cells after 96 hrs by MTT assay Cytotoxicity against mock-infected human MT4 cells after 96 hrs by MTT assay	[PMID: 25082514]
MT4	IC₅₀	23 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of MT-4 cells expressing the TAT gene of HTLV-1. Compound was tested for its effect on the proliferation of MT-4 cells expressing the TAT gene of HTLV-1.	10.1016/0960-894X(96)00216-8
MT4	IC₅₀	6.5 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in MT-4 cell line Tested for inhibitory effect on RNA virus cell growth in MT-4 cell line	[PMID: 8246242]
MT4	IC₅₀	>5 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus HIV-1 in MT-4 cell line Tested for inhibitory effect on RNA virus HIV-1 in MT-4 cell line	[PMID: 8246242]
Raji	IC₅₀	56 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of RAJI burkitt lymphoma cell line. Compound was tested for its effect on the proliferation of RAJI burkitt lymphoma cell line.	10.1016/0960-894X(96)00216-8
RD	CC₅₀	1485 3 Compound: Ribavirin	Cytotoxicity against human RD cells assessed as reduction in cell viability after 12 hrs by CCK8 assay Cytotoxicity against human RD cells assessed as reduction in cell viability after 12 hrs by CCK8 assay	[PMID: 31063370]
RD	CC₅₀	485.9 6 Compound: Ribavirin	Cytotoxicity against human RD cells assessed as reduction in cell viability after 3 days by MTT assay Cytotoxicity against human RD cells assessed as reduction in cell viability after 3 days by MTT assay	[PMID: 28858766]
RD	IC₅₀	60 6 Compound: Ribavirin	Antiviral activity against C4 type Human enterovirus 71 FY0805 infected in human RD cells assessed as inhibition of viral replication by plaque reduction assay Antiviral activity against C4 type Human enterovirus 71 FY0805 infected in human RD cells assessed as inhibition of viral replication by plaque reduction assay	[PMID: 22342145]
Rhabdomyosarcoma cell	CC₅₀	>500 6 Compound: Ribavirin	Cytotoxicity against human rhabdomyosarcoma cells after 72 hrs by MTT assay Cytotoxicity against human rhabdomyosarcoma cells after 72 hrs by MTT assay	[PMID: 23920438]
SK-OV-3	IC₅₀	9 6 Compound: RBV	Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay	[PMID: 31883488]
SK-OV-3	IC₅₀	10 6 Compound: RBV	Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay	[PMID: 31883488]
SNB-19	CC₅₀	485.2 3 Compound: Ribavirin	Cytotoxicity against human SNB-19 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against human SNB-19 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
SNB-75	IC₅₀	18.53 3 Compound: RBV	Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
Vero	CC₅₀	>400 6 Compound: ribavirin	Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of Vero cells Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of Vero cells	[PMID: 8709116]
Vero	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero 76 cells by crystal violet staining Cytotoxicity against african green monkey Vero 76 cells by crystal violet staining	[PMID: 19482481]
Vero	CC₅₀	409 3 Compound: ribavirin	Cytotoxicity against african green monkey Vero B cells Cytotoxicity against african green monkey Vero B cells	[PMID: 26039671]
Vero	CC₅₀	>100 3 Compound: 9	Cytotoxicity against African green monkey Vero cells Cytotoxicity against African green monkey Vero cells	[PMID: 31549836]
Vero	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells Cytotoxicity against african green monkey Vero cells	[PMID: 20359898]
Vero	CC₅₀	>1 2 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells after 4 days by MTT assay Cytotoxicity against African green monkey Vero cells after 4 days by MTT assay	[PMID: 24679044]
Vero	CC₅₀	156 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells after 7 to 8 days by neutral-red dye uptake assay Cytotoxicity against african green monkey Vero cells after 7 to 8 days by neutral-red dye uptake assay	[PMID: 17606691]
Vero	CC₅₀	8189.67 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells after 96 hrs by MTT assay Cytotoxicity against african green monkey Vero cells after 96 hrs by MTT assay	[PMID: 23999140]
Vero	CC₅₀	470.5 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against African green monkey Vero cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
Vero	CC₅₀	1622 3 Compound: 95	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 4 days by MTT assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 4 days by MTT assay	[PMID: 28689975]
Vero	CC₅₀	>400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 30612844]
Vero	CC₅₀	1245 3 Compound: RBV	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTS assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTS assay	[PMID: 35661850]
Vero	CC₅₀	297 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTT assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTT assay	[PMID: 31843348]
Vero	CC₅₀	>400 3 Compound: 73	Cytotoxicity against African green monkey Vero cells by CCK8 assay method Cytotoxicity against African green monkey Vero cells by CCK8 assay method	[PMID: 33070079]
Vero	CC₅₀	>4100 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells by luciferase-based cell viability assay Cytotoxicity against African green monkey Vero cells by luciferase-based cell viability assay	[PMID: 18955536]
Vero	CC₅₀	300 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells by MTT assay Cytotoxicity against African green monkey Vero cells by MTT assay	[PMID: 33822611]
HepG2	CC₅₀	246.27 3 Compound: RBV	Cytotoxicity against human HepG2 cells measured after 24 hrs by MTT assay Cytotoxicity against human HepG2 cells measured after 24 hrs by MTT assay	[PMID: 37722289]
HepG2	CC₅₀	> 500 6 Compound: Ribavirin	Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay	[PMID: 23920438]
Vero	CC₅₀	>3562 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by neutral red dye based analysis Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by neutral red dye based analysis	[PMID: 36898483]
Vero	CC₅₀	>4094 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by visual analysis Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by visual analysis	[PMID: 36898483]
HepG2	EC₅₀	22.3 6 Compound: Ribavirin	Antiviral activity against Coxsackievirus B5 infected in human HepG2 cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method Antiviral activity against Coxsackievirus B5 infected in human HepG2 cells assessed as inhibition of virus-induced cytopathogenicity after 48 hrs by crystal violet staining method	[PMID: 23920438]
Vero	CC₅₀	3931 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells infected with Tacaribe virus TRVL11573 by neutral red dye based analysis Cytotoxicity against African green monkey Vero cells infected with Tacaribe virus TRVL11573 by neutral red dye based analysis	[PMID: 36898483]
Huh-5-2	CC₅₀	21 6 Compound: Ribavirin	Cytotoxicity against human Huh-5-2 cells Cytotoxicity against human Huh-5-2 cells	[PMID: 18445526]
Vero	CC₅₀	0.3 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells Cytotoxicity against African green monkey Vero E6 cells	[PMID: 27262598]
Huh-5-2	CC₅₀	86 3 Compound: ribavirin	Cytotoxicity against human HuH5.2 cells Cytotoxicity against human HuH5.2 cells	[PMID: 19170598]
Vero	CC₅₀	>410 3 Compound: Ribavirin	Cytotoxicity against DENV serotype 2 strain New Guinea C infected african green monkey Vero B cells by virus yield-reduction assay Cytotoxicity against DENV serotype 2 strain New Guinea C infected african green monkey Vero B cells by virus yield-reduction assay	[PMID: 25791449]
Huh-5-2	EC₅₀	7 6 Compound: Ribavirin	Antiviral activity against Hepatitis C virus infected human Huh-5-2 cells assessed as inhibition of luciferase activity after 4 days by RNA replicon assay Antiviral activity against Hepatitis C virus infected human Huh-5-2 cells assessed as inhibition of luciferase activity after 4 days by RNA replicon assay	[PMID: 18445526]
Vero	CC₅₀	>250 3 Compound: Ribavirin	Cytotoxicity against Human coxsackievirus B4 infected african green monkey Vero cells by trypan blue exclusion method Cytotoxicity against Human coxsackievirus B4 infected african green monkey Vero cells by trypan blue exclusion method	[PMID: 20034711]
Vero	CC₅₀	>500 3 Compound: Ribavirin	Cytotoxicity against Vero cells Cytotoxicity against Vero cells	[PMID: 17181162]
Vero	CC₅₀	>850 3 Compound: ribavirin	Cytotoxicity against Vero E6 cells Cytotoxicity against Vero E6 cells	[PMID: 17336519]
Vero	EC₅₀	2.42 3 Compound: Ribavirin	Antiviral activity against Chikungunya virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection Antiviral activity against Chikungunya virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection	[PMID: 31843348]
Vero	EC₅₀	240 6 Compound: ribavirin	Antiviral activity against coxsackie B4 virus in Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against coxsackie B4 virus in Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackie B4 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Coxsackie B4 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	>200 6 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 in Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackie virus B4 in Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
Vero	EC₅₀	250 6 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
Huh-7	CC₅₀	100 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells assessed as reduction in cell viability by measuring ATP level measured after 72 hrs by CellTiter-Glo luminescent assay Cytotoxicity against human HuH7 cells assessed as reduction in cell viability by measuring ATP level measured after 72 hrs by CellTiter-Glo luminescent assay	[PMID: 32435411]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Coxsackie virus B4 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Huh-7	CC₅₀	1060 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells after3 days by MTT assay Cytotoxicity against human HuH7 cells after3 days by MTT assay	[PMID: 20337460]
Vero	EC₅₀	>250 6 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Huh-7	CC₅₀	177.94 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells Cytotoxicity against human HuH7 cells	[PMID: 20579888]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Coxsackievirus B4 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Huh-7	CC₅₀	200 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability by Celltiter-Glo luminescent cell viability assay Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability by Celltiter-Glo luminescent cell viability assay	[PMID: 34273661]
Vero	EC₅₀	>= 250 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Huh-7	CC₅₀	30.5 3 Compound: Ribavirin	Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability preincubated for 1 hr followed by fresh drug administration every 24 hrs at 1/10th of initial concentration for 48 hrs by WST-1 ass Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability preincubated for 1 hr followed by fresh drug administration every 24 hrs at 1/10th of initial concentration for 48 hrs by WST-1 ass	[PMID: 26428870]
Huh-7	CC₅₀	32 3 Compound: RBV	Cytotoxicity against human HuH7 cells infected with HCV1b after 3 days by MTS assay Cytotoxicity against human HuH7 cells infected with HCV1b after 3 days by MTS assay	[PMID: 22100256]
Vero	EC₅₀	250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Huh-7	CC₅₀	512.8 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
Huh-7	CC₅₀	56 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells after 72 hrs by MTS assay Cytotoxicity against human HuH7 cells after 72 hrs by MTS assay	[PMID: 25330401]
Vero	EC₅₀	>250 6 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
Huh-7	CC₅₀	56.31 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells assessed as cell viability after 3 days by XTT assay Cytotoxicity against human HuH7 cells assessed as cell viability after 3 days by XTT assay	[PMID: 24727241]
Huh-7	CC₅₀	56.31 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells assessed as growth inhibition after 3 days by XTT method Cytotoxicity against human HuH7 cells assessed as growth inhibition after 3 days by XTT method	[PMID: 29031073]
Vero	EC₅₀	>250 6 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 26001344]
Huh-7	CC₅₀	8.9 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay Cytotoxicity against human Huh-7 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay	[PMID: 37252100]
Vero	EC₅₀	>250 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
Huh-7	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells incubated for 3 days by MTT assay Cytotoxicity against human Huh-7 cells incubated for 3 days by MTT assay	[PMID: 32787106]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Huh-7	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against human Huh-7 cells incubated for 72 hrs by Cell Titer-Glo luminescence assay Cytotoxicity against human Huh-7 cells incubated for 72 hrs by Cell Titer-Glo luminescence assay	[PMID: 32787106]
Vero	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay	[PMID: 25082514]
Huh-7	CC₅₀	> 100 3 Compound: ribavirin	Cytotoxicity against mock-infected human Huh7.5 cells assessed as reduction in cell viability incubated for 5 hrs by MTT assay Cytotoxicity against mock-infected human Huh7.5 cells assessed as reduction in cell viability incubated for 5 hrs by MTT assay	[PMID: 26613291]
Vero	EC₅₀	47.9 3 Compound: Ribavirin	Antiviral activity against DENV serotype 2 strain New Guinea C infected in african green monkey Vero cells assessed as reduction in production and release of infectious progeny virions after 2 hrs by virus yield-reduction assay Antiviral activity against DENV serotype 2 strain New Guinea C infected in african green monkey Vero cells assessed as reduction in production and release of infectious progeny virions after 2 hrs by virus yield-reduction assay	[PMID: 25791449]
Huh-7	CC₅₀	> 200 3 Compound: Ribavirin	Cytotoxicity against Huh7 cells by XTT assay Cytotoxicity against Huh7 cells by XTT assay	[PMID: 17766124]
Vero	EC₅₀	42 3 Compound: ribavirin	Antiviral activity against DENV serotype 2 strain New Guinea V infected in African green monkey Vero B cells assessed as inhibition of virus replication after 4 days by qRT-PCR analysis Antiviral activity against DENV serotype 2 strain New Guinea V infected in African green monkey Vero B cells assessed as inhibition of virus replication after 4 days by qRT-PCR analysis	[PMID: 26039671]
Huh-7	CC₅₀	> 30 3 Compound: Ribavirin	Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability incubated for 1 hr by WST-1 assay Cytotoxicity against human HuH7-J20 cells expressing secreted alkaline phosphatase reporter gene assessed as cell viability incubated for 1 hr by WST-1 assay	[PMID: 26428870]
Huh-7	EC₅₀	12.6 3 Compound: Ribavirin	Antiviral activity against dengue virus 2 infected in human HuH7 cells after 72 hrs by Western blot and ECL detection based assay Antiviral activity against dengue virus 2 infected in human HuH7 cells after 72 hrs by Western blot and ECL detection based assay	[PMID: 25330401]
Vero	EC₅₀	13.5 3 Compound: RIBA	Antiviral activity against DENV-2 New guinea infected in African green monkey Vero cells assessed as reduction in plaque formation administered post viral infection after 8 days by crystal violet staining technique Antiviral activity against DENV-2 New guinea infected in African green monkey Vero cells assessed as reduction in plaque formation administered post viral infection after 8 days by crystal violet staining technique	[PMID: 26638041]
Vero	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in african green monkey Vero cells after 3 days by plaque reduction assay Antiviral activity against HSV1 KOS infected in african green monkey Vero cells after 3 days by plaque reduction assay	[PMID: 20359898]
Huh-7	EC₅₀	14 3 Compound: RBV	Antiviral activity against HCV genotype 1b infected in human HuH7 cells after 3 days by renilla luciferase reporter assay Antiviral activity against HCV genotype 1b infected in human HuH7 cells after 3 days by renilla luciferase reporter assay	[PMID: 22100256]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Human coxsackievirus B4 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Huh-7	EC₅₀	16.3 3 Compound: ribavirin	Antiviral activity against recombinant HCV genotype 2a JFH1 infected in human Huh7 cells incubated for 5 hrs measured on day 3 post infection by luciferase reporter gene assay Antiviral activity against recombinant HCV genotype 2a JFH1 infected in human Huh7 cells incubated for 5 hrs measured on day 3 post infection by luciferase reporter gene assay	[PMID: 26613291]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay	[PMID: 20034711]
Huh-7	EC₅₀	17.6 3 Compound: Ribavirin	Antiviral activity against HCV 1b infected in human HuH7 cells assessed as inhibition of viral RNA replication after 4 days by replicon assay Antiviral activity against HCV 1b infected in human HuH7 cells assessed as inhibition of viral RNA replication after 4 days by replicon assay	[PMID: 20337460]
Huh-7	EC₅₀	20 6 Compound: Ribavirin	Antiviral activity against Hepatitis C virus subtype 1a infected in human HuH7 cells after 2 days by q-PCR analysis Antiviral activity against Hepatitis C virus subtype 1a infected in human HuH7 cells after 2 days by q-PCR analysis	[PMID: 22985854]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Human parainfluenza virus 3 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Human parainfluenza virus 3 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Huh-7	EC₅₀	22 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease T54A double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease T54A double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Huh-7	EC₅₀	30.4 3 Compound: Ribavirin	Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs measured at 72 hrs Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs measured at 72 hrs	[PMID: 26428870]
Vero	EC₅₀	45 3 Compound: Ribavirin	Antiviral activity against Human parainfluenza virus 3 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human parainfluenza virus 3 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Huh-7	EC₅₀	33 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Vero	EC₅₀	11 3 Compound: Ribavirin	Antiviral activity against Junin virus Candid-1 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days Antiviral activity against Junin virus Candid-1 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days	[PMID: 17606691]
Huh-7	EC₅₀	33.5 3 Compound: Ribavirin	Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs and fresh drug admini Antiviral activity against HCV JFH1 infected in human HuH7-J20 cells assessed as inhibition of viral life cycle by measuring secreted alkaline phosphatase level preincubated with cells for 1 hr followed by viral inoculation for 3 hrs and fresh drug admini	[PMID: 26428870]
Vero	EC₅₀	18.5 3 Compound: Ribavirin	Antiviral activity against Junin virus IV4454 infected in african green monkey Vero cells assessed as reduction in virus yield after 48 hrs by plaque assay Antiviral activity against Junin virus IV4454 infected in african green monkey Vero cells assessed as reduction in virus yield after 48 hrs by plaque assay	[PMID: 21115214]
Vero	EC₅₀	18.5 3 Compound: Ribavirin	Antiviral activity against Junin virus IV4454 infected in African green monkey Vero cells assessed as reduction in vrius yield after 48 hrs by plaque assay Antiviral activity against Junin virus IV4454 infected in African green monkey Vero cells assessed as reduction in vrius yield after 48 hrs by plaque assay	[PMID: 30612844]
Huh-7	EC₅₀	36 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Vero	EC₅₀	>= 174 3 Compound: Ribavirin	Antiviral activity against Mammalian orthoreovirus 1 infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Mammalian orthoreovirus 1 infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Huh-7	EC₅₀	36 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M/R155T double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M/R155T double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Vero	EC₅₀	300 3 Compound: Ribavirin	Antiviral activity against para influenza 3 virus in Vero cells Antiviral activity against para influenza 3 virus in Vero cells	[PMID: 17181162]
Huh-7	EC₅₀	41 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36M/R155K double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against para influenza 3 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against para influenza 3 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Huh-7	EC₅₀	42 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155T double mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A/R155T double mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Vero	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Para influenza-3 virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Para influenza-3 virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Huh-7	EC₅₀	43 3 Compound: ribavirin	Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A mutation in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against HCV Con1-mADE replicon with NS3 serine protease V36A mutation in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Vero	EC₅₀	120 6 Compound: ribavirin	Antiviral activity against Parainfluenza 3 in Vero cells reduction of virus-induced cytopathogenicity after 4 days Antiviral activity against Parainfluenza 3 in Vero cells reduction of virus-induced cytopathogenicity after 4 days	[PMID: 17948980]
Huh-7	EC₅₀	54.8 3 Compound: Ribavirin	Inhibition of HCV replication in Huh7 cells after 48 hrs by luciferase assay Inhibition of HCV replication in Huh7 cells after 48 hrs by luciferase assay	[PMID: 17766124]
Huh-7	EC₅₀	58 3 Compound: ribavirin	Antiviral activity against wild type Con1-mADE HCV replicon in human HuH7 cells after 48 hrs by RNA replicon assay Antiviral activity against wild type Con1-mADE HCV replicon in human HuH7 cells after 48 hrs by RNA replicon assay	[PMID: 17938182]
Vero	EC₅₀	73.5 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Parainfluenza virus 3 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Huh-7	EC₅₀	81.9 3 Compound: Ribavirin	Antiviral activity against HCV subtype 1a infected in Huh-7 cells assessed as reduction in viral RNA level after 8 to 10 days by quantitative PCR analysis Antiviral activity against HCV subtype 1a infected in Huh-7 cells assessed as reduction in viral RNA level after 8 to 10 days by quantitative PCR analysis	[PMID: 24485784]
Vero	EC₅₀	48 6 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
Huh-7	IC₅₀	12.61 3 Compound: Ribavirin	Antiviral activity against DENV2 16681 infected in human Huh-7 cells after 3 days by luciferase reporter gene assay Antiviral activity against DENV2 16681 infected in human Huh-7 cells after 3 days by luciferase reporter gene assay	[PMID: 24727241]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
Huh-7	IC₅₀	32 3 Compound: ribavirin	Antiviral activity against HCV 1b with NS3-4A R155T mutation in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against HCV 1b with NS3-4A R155T mutation in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
Huh-7	IC₅₀	37 3 Compound: ribavirin	Antiviral activity against HCV 1b Con1 with NS3-4A R155K mutation in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against HCV 1b Con1 with NS3-4A R155K mutation in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Vero	EC₅₀	121 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Parainfluenza virus 3 infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Huh-7	IC₅₀	39 3 Compound: ribavirin	Antiviral activity against HCV 1b with NS3-4A R155M mutation in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against HCV 1b with NS3-4A R155M mutation in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Vero	EC₅₀	>50 3 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Parainfluenza virus type 3 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Huh-7	IC₅₀	4 3 Compound: Ribavirin	Antiviral activity against Dengue virus serotype 2 New Guinea C infected at 50 TCID50 in human HuH7 cells assessed as inhibition of viral replication and 72 hrs later re-infected pre-seeded HuH7 cells with viral supernatant collected from previous infecte Antiviral activity against Dengue virus serotype 2 New Guinea C infected at 50 TCID50 in human HuH7 cells assessed as inhibition of viral replication and 72 hrs later re-infected pre-seeded HuH7 cells with viral supernatant collected from previous infecte	[PMID: 32435411]
Huh-7	IC₅₀	53.7 3 Compound: RBV	Antiproliferative activity against human HuH-7 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human HuH-7 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
Vero	EC₅₀	45 6 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Parainfluenza virus type 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Vero	EC₅₀	48 6 Compound: ribavirin	Antiviral activity against parainfluenza3 virus in Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against parainfluenza3 virus in Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
Huh-7	IC₅₀	58 3 Compound: ribavirin	Antiviral activity against wild type HCV 1b Con1 in human Huh7 cells after 48 hrs by replicon cell assay Antiviral activity against wild type HCV 1b Con1 in human Huh7 cells after 48 hrs by replicon cell assay	[PMID: 17556358]
Vero	EC₅₀	95 6 Compound: Ribavirin	Antiviral activity against parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Huh-7	IC₅₀	> 200 3 Compound: Ribavirin	Cytotoxicity against human HuH7 cells after 3 days by MTT assay Cytotoxicity against human HuH7 cells after 3 days by MTT assay	[PMID: 30721061]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Para-influenza-3 virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Para-influenza-3 virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	45 6 Compound: Ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Vero	EC₅₀	146 3 Compound: ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
Vero	EC₅₀	13 3 Compound: Ribavirin	Antiviral activity against Pichinde virus An 4763 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days Antiviral activity against Pichinde virus An 4763 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days	[PMID: 17606691]
Vero	EC₅₀	12 6 Compound: Ribavirin	Antiviral activity against Pichinde virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect Antiviral activity against Pichinde virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect	[PMID: 31431358]
Vero	EC₅₀	95 3 Compound: Ribavirin	Antiviral activity against PIV 3 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against PIV 3 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
Vero	EC₅₀	150 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Punta Toro virus expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Vero	EC₅₀	50 3 Compound: ribavirin	Antiviral activity against Punta Toro virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Punta Toro virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Huh-7.5	CC₅₀	1654 3 Compound: RBV	Cytotoxicity against human Huh7.5 cells assessed as reduction in cell viability by MTS assay Cytotoxicity against human Huh7.5 cells assessed as reduction in cell viability by MTS assay	[PMID: 35661850]
Vero	EC₅₀	100 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus in Vero cells Antiviral activity against Punta Toro virus in Vero cells	[PMID: 17181162]
IGROV-1	IC₅₀	16 6 Compound: RBV	Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 7 days by trypan blue exclusion assay Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 7 days by trypan blue exclusion assay	[PMID: 31883488]
IGROV-1	IC₅₀	21 6 Compound: RBV	Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay	[PMID: 31883488]
Vero	EC₅₀	150 3 Compound: ribavirin	Antiviral activity against Punta Toro virus in Vero cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against Punta Toro virus in Vero cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
Vero	EC₅₀	40 6 Compound: ribavirin	Antiviral activity against Punta Toro virus in Vero cells reduction of virus-induced cytopathogenicity after 4 days Antiviral activity against Punta Toro virus in Vero cells reduction of virus-induced cytopathogenicity after 4 days	[PMID: 17948980]
IGROV-1	IC₅₀	25 6 Compound: RBV	Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay Antiproliferative activity against human IGROV-1 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay	[PMID: 31883488]
Vero	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	112 6 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
L1210	IC₅₀	1 3 Compound: Ribavirin	Inhibition of IMPDH in mouse L1210 cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins Inhibition of IMPDH in mouse L1210 cells assessed as formation of [2,8-3H]hypoxanthine from [2,8-3H]IMP after 20 to 60 mins	[PMID: 22555152]
L1210	IC₅₀	16.6 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of L1210 murine leukemia cell line. Compound was tested for its effect on the proliferation of L1210 murine leukemia cell line.	10.1016/0960-894X(96)00216-8
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Vero	EC₅₀	126 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
L1210	IC₅₀	7.1 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in L1210 cell line Tested for inhibitory effect on RNA virus cell growth in L1210 cell line	[PMID: 8246242]
Vero	EC₅₀	183 3 Compound: 1	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
Vero	EC₅₀	146 6 Compound: ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
MDA-MB-231	IC₅₀	> 100 3 Compound: RBV	Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
Vero	EC₅₀	126 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
MDA-MB-435	IC₅₀	38.3 3 Compound: RBV	Antiproliferative activity against human MDA-MB-435 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human MDA-MB-435 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity by MTT assay Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity by MTT assay	[PMID: 20034711]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
MDCK	CC₅₀	100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as inhibition of cell viability by colorimetric formazan-based MTS assay Cytotoxicity against MDCK cells assessed as inhibition of cell viability by colorimetric formazan-based MTS assay	[PMID: 26114811]
Vero	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
MDCK	CC₅₀	1365.5 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by crystal violet staining based method Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by crystal violet staining based method	[PMID: 30033162]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	CC₅₀	20 3 Compound: Ribavirin	Cytotoxicity against MDCK cells by MTT assay Cytotoxicity against MDCK cells by MTT assay	[PMID: 33705902]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 26001344]
Vero	EC₅₀	125 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Punta Toro virus infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	CC₅₀	2336 3 Compound: ribavirin	Cytotoxicity against MDCK cells Cytotoxicity against MDCK cells	[PMID: 17194832]
Vero	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Punta Toro virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
MDCK	CC₅₀	58 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by MTS assay	[PMID: 32220685]
Vero	EC₅₀	126 3 Compound: ribavirin	Antiviral activity against Punts virus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Punts virus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
MDCK	CC₅₀	62.5 6 Compound: ribavirin	Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
Vero	EC₅₀	146 3 Compound: ribavirin	Antiviral activity against Reovirus 1 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Reovirus 1 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
MDCK	CC₅₀	67 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay Cytotoxicity against dog MDCK cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay	[PMID: 37252100]
MDCK	CC₅₀	707.3 3 Compound: RIB	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37517205]
Vero	EC₅₀	200 6 Compound: ribavirin	Antiviral activity against Reovirus 1 in Vero cells reduction of virus-induced cytopathogenicity after 4 days Antiviral activity against Reovirus 1 in Vero cells reduction of virus-induced cytopathogenicity after 4 days	[PMID: 17948980]
MDCK	CC₅₀	> 1 2 Compound: Ribavirin	Cytotoxicity against dog MDCK cells infected with Influenza A virus H1N1 Cytotoxicity against dog MDCK cells infected with Influenza A virus H1N1	[PMID: 37077387]
Vero	EC₅₀	250 3 Compound: Ribavirin	Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
Vero	EC₅₀	80 6 Compound: Ribavirin	Antiviral activity against Reovirus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Reovirus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
MDCK	CC₅₀	> 1 2 Compound: Ribavirin	Cytotoxicity against dog MDCK cells infected with Influenza A virus H3N2 Cytotoxicity against dog MDCK cells infected with Influenza A virus H3N2	[PMID: 37077387]
MDCK	CC₅₀	> 1 2 Compound: Ribavirin	Cytotoxicity against dog MDCK cells infected with Influenza B virus Cytotoxicity against dog MDCK cells infected with Influenza B virus	[PMID: 37077387]
Vero	EC₅₀	>250 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Reovirus-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Vero	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
MDCK	CC₅₀	> 100 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured for 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured for 48 hrs by MTT assay	[PMID: 36764470]
Vero	EC₅₀	250 3 Compound: ribavirin	Antiviral activity against reovirus1 virus in Vero cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against reovirus1 virus in Vero cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against Influenza A virus subtype H1N1 infected MDCK cells by trypan blue exclusion method Cytotoxicity against Influenza A virus subtype H1N1 infected MDCK cells by trypan blue exclusion method	[PMID: 20034711]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against Influenza A virus subtype H3N2 infected MDCK cells by trypan blue exclusion method Cytotoxicity against Influenza A virus subtype H3N2 infected MDCK cells by trypan blue exclusion method	[PMID: 20034711]
Vero	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 5 days by plaque reduction assay Antiviral activity against Respiratory syncytial virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 5 days by plaque reduction assay	[PMID: 25082514]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against Influenza B virus infected MDCK cells by trypan blue exclusion method Cytotoxicity against Influenza B virus infected MDCK cells by trypan blue exclusion method	[PMID: 20034711]
Vero	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against RSV A2 infected in african green monkey Vero cells after 5 days by plaque reduction assay Antiviral activity against RSV A2 infected in african green monkey Vero cells after 5 days by plaque reduction assay	[PMID: 20359898]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability by colorimetric formazan-based MTS assay Cytotoxicity against MDCK cells assessed as cell viability by colorimetric formazan-based MTS assay	[PMID: 22459876]
Vero	EC₅₀	35 3 Compound: Ribavirin	Antiviral activity against RSV infected in African green monkey Vero 76 cells after 5 days by plaque reduction assay Antiviral activity against RSV infected in African green monkey Vero 76 cells after 5 days by plaque reduction assay	[PMID: 25913116]
Vero	EC₅₀	250 3 Compound: ribavirin	Antiviral activity against Sindbis virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Sindbis virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as cell viability by MTS assay Cytotoxicity against dog MDCK cells assessed as cell viability by MTS assay	[PMID: 23117173]
Vero	EC₅₀	>500 3 Compound: Ribavirin	Antiviral activity against Sindbis virus in Vero cells Antiviral activity against Sindbis virus in Vero cells	[PMID: 17181162]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 72 hrs by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 72 hrs by MTS assay	[PMID: 24974341]
Vero	EC₅₀	50 3 Compound: ribavirin	Antiviral activity against sindbis virus in Vero cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against sindbis virus in Vero cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells after 72 hrs by MTS assay Cytotoxicity against MDCK cells after 72 hrs by MTS assay	[PMID: 25752526]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability measured after 4 days by formazan-based MTS assay Cytotoxicity against MDCK cells assessed as cell viability measured after 4 days by formazan-based MTS assay	[PMID: 27112451]
Vero	EC₅₀	>250 6 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero	EC₅₀	>400 6 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 5 to 6 days by MTS assay Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 5 to 6 days by MTS assay	[PMID: 28477572]
Vero	EC₅₀	111 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs by MTS assay Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs by MTS assay	[PMID: 29220568]
Vero	EC₅₀	9.3 6 Compound: Ribavirin	Antiviral activity against Tacaribe virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect Antiviral activity against Tacaribe virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect	[PMID: 31431358]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 3 to 6 days by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 3 to 6 days by MTS assay	[PMID: 29886325]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay Cytotoxicity against HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay	[PMID: 29906392]
Vero	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Tacaribe virus TRVL11573 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days Antiviral activity against Tacaribe virus TRVL11573 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days	[PMID: 17606691]
Vero	EC₅₀	95 3 Compound: Ribavirin	Antiviral activity against West Nile virus infected in African green monkey Vero cells incubated for 4 days by crystal violet staining based plaque reduction assay Antiviral activity against West Nile virus infected in African green monkey Vero cells incubated for 4 days by crystal violet staining based plaque reduction assay	[PMID: 30721061]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay	[PMID: 29906392]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 3 days by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 3 days by MTS assay	[PMID: 30170320]
Vero	EC₅₀	28 3 Compound: Ribavirin	Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as inhibition of virus induced cytopathic effect by microscopic analysis Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as inhibition of virus induced cytopathic effect by microscopic analysis	[PMID: 18955536]
Vero	EC₅₀	3.95 3 Compound: Ribavirin	Antiviral activity against Zika virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection Antiviral activity against Zika virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection	[PMID: 31843348]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured on day 5 by Celltiter-Glo luminescence assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured on day 5 by Celltiter-Glo luminescence assay	[PMID: 30852083]
Vero	EC₅₀	>1600 3 Compound: d	concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in Vero cells concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in Vero cells	[PMID: 9748360]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by alamar blue assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 72 hrs by alamar blue assay	[PMID: 31053507]
Vero	EC₅₀	64 3 Compound: d	concentration required to inhibit Punta Toro virus-induced cytopathicity by 50% in Vero cells concentration required to inhibit Punta Toro virus-induced cytopathicity by 50% in Vero cells	[PMID: 9748360]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 3 days by coulter counter method Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 3 days by coulter counter method	[PMID: 31586832]
Vero	EC₅₀	196 3 Compound: Ribavirin	Effective concentration required to inhibit parainfluenza-3 virus-induced cytopathicity by 50% in Vero cell lines Effective concentration required to inhibit parainfluenza-3 virus-induced cytopathicity by 50% in Vero cell lines	[PMID: 11495586]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 4 days by MTS assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 4 days by MTS assay	[PMID: 31753804]
Vero	EC₅₀	40 3 Compound: Ribavirin	Effective concentration required to inhibit PuntaToro virus-induced cytopathicity by 50% in Vero cell lines Effective concentration required to inhibit PuntaToro virus-induced cytopathicity by 50% in Vero cell lines	[PMID: 11495586]
MDCK	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as change in cellular morphology Cytotoxicity against MDCK cells assessed as change in cellular morphology	[PMID: 32214762]
Vero	EC₅₀	>1600 3 Compound: Ribavirin	Effective concentration required to inhibit respiratory synaptial (RSV) virus-induced cytopathicity by 50% in Vero cell lines Effective concentration required to inhibit respiratory synaptial (RSV) virus-induced cytopathicity by 50% in Vero cell lines	[PMID: 11495586]
MDCK	CC₅₀	> 100 3 Compound: ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTS assay Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTS assay	[PMID: 18778942]
MDCK	CC₅₀	> 100 3 Compound: ribavirin	Cytotoxicity against MDCK cells by MTS assay Cytotoxicity against MDCK cells by MTS assay	[PMID: 19281225]
Vero	EC₅₀	30 3 Compound: Ribavirin	Inhibition of Rluc-FL-WNV replicon in Vero cells Inhibition of Rluc-FL-WNV replicon in Vero cells	[PMID: 16539402]
MDCK	CC₅₀	> 100 3 Compound: ribavirin	Cytotoxicity against MDCK cells relative to control Cytotoxicity against MDCK cells relative to control	[PMID: 26260336]
Vero	EC₅₀	20.8 3 Compound: 9	Inhibition of RNA-dependent RNA polymerase in Zika virus MR766 infected in African green monkey Vero cells assessed as antiviral activity after 72 hrs by DAPI staining based assay Inhibition of RNA-dependent RNA polymerase in Zika virus MR766 infected in African green monkey Vero cells assessed as antiviral activity after 72 hrs by DAPI staining based assay	[PMID: 31549836]
Vero	EC₅₀	119 3 Compound: Ribavirin	Inhibition of West Nile viral Rluc-Neo-Rep in Vero cells Inhibition of West Nile viral Rluc-Neo-Rep in Vero cells	[PMID: 16539402]
MDCK	CC₅₀	> 100 6 Compound: Ribavirin	The compound was evaluated for cytotoxicity by MTT assay in MDCK cells The compound was evaluated for cytotoxicity by MTT assay in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	CC₅₀	> 100 6 Compound: Ribavirin	Cytotoxicity against MDCK cells by MTS assay Cytotoxicity against MDCK cells by MTS assay	[PMID: 20724039]
Vero	ED₅₀	0.19 2 Compound: 3	In vitro antiviral activity against herpes simplex virus type 2 (HSV-2) in Vero cells. In vitro antiviral activity against herpes simplex virus type 2 (HSV-2) in Vero cells.	[PMID: 3950908]
Vero	ED₅₀	0.19 2 Compound: Ribavirin	In vitro antiviral activity against herpes simplex virus type 2 virus was evaluated. In vitro antiviral activity against herpes simplex virus type 2 virus was evaluated.	[PMID: 4020823]
MDCK	CC₅₀	> 100 6 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability by MTS assay Cytotoxicity against MDCK cells assessed as cell viability by MTS assay	[PMID: 20971531]
MDCK	CC₅₀	> 125 6 Compound: ribavirin	Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
Vero	ED₅₀	0.16 2 Compound: 3	In vitro antiviral activity against parainfluenza type 3 virus in Vero cells. In vitro antiviral activity against parainfluenza type 3 virus in Vero cells.	[PMID: 3950908]
MDCK	CC₅₀	> 200 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as cell growth after 40 hrs by CellTiter-Glo assay Cytotoxicity against MDCK cells assessed as cell growth after 40 hrs by CellTiter-Glo assay	[PMID: 25681711]
Vero	ED₅₀	0.16 2 Compound: Ribavirin	In vitro antiviral activity against Parainfluenza type 3 was evaluated. In vitro antiviral activity against Parainfluenza type 3 was evaluated.	[PMID: 4020823]
Vero	IC₅₀	1576.11 3 Compound: Ribavirin	Antiviral activity against Coxsackie B3 virus Nancy in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs Antiviral activity against Coxsackie B3 virus Nancy in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs	[PMID: 23999140]
MDCK	CC₅₀	> 200 3 Compound: RBV	Cytotoxicity against MDCK cells after 40 hrs by Celltiter-Glo assay Cytotoxicity against MDCK cells after 40 hrs by Celltiter-Glo assay	[PMID: 26686929]
MDCK	CC₅₀	> 200 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability Cytotoxicity against dog MDCK cells assessed as reduction in cell viability	[PMID: 34126455]
Vero	IC₅₀	909.96 3 Compound: Ribavirin	Antiviral activity against Coxsackie B6 virus Schmitt in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs Antiviral activity against Coxsackie B6 virus Schmitt in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs	[PMID: 23999140]
Vero	IC₅₀	447.8 6 Compound: RVB	Antiviral activity against Coxsackie virus B3 growth by 50% in Vero cells Antiviral activity against Coxsackie virus B3 growth by 50% in Vero cells	[PMID: 15603937]
MDCK	CC₅₀	> 200 3 Compound: ribavirin	Cytotoxicity against MDCK cells assessed as cell viability measured at 24 hrs by MTS assay Cytotoxicity against MDCK cells assessed as cell viability measured at 24 hrs by MTS assay	[PMID: 26288686]
Vero	IC₅₀	4090 3 Compound: RBV	Antiviral activity against Coxsackievirus A16 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Coxsackievirus A16 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
MDCK	CC₅₀	> 2000 3 Compound: Ribavirin	Cytotoxicity against MDCK cells after 48 hrs by MTT assay Cytotoxicity against MDCK cells after 48 hrs by MTT assay	[PMID: 30108810]
Vero	IC₅₀	9622 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus A16 shzh05-1 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus A16 shzh05-1 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
MDCK	CC₅₀	> 2000 6 Compound: ribavirin	Cytotoxicity in MDCK cells infected with influenza A H3N2 virus Cytotoxicity in MDCK cells infected with influenza A H3N2 virus	[PMID: 16183283]
Vero	IC₅₀	2375 3 Compound: RBV	Antiviral activity against Coxsackievirus B1 Conn 5 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B1 Conn 5 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
MDCK	CC₅₀	> 2130 3 Compound: Ribavirin	Cytotoxicity against MDCK cells after 48 hrs by MTT assay Cytotoxicity against MDCK cells after 48 hrs by MTT assay	[PMID: 29716780]
MDCK	CC₅₀	> 2130 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 30746065]
Vero	IC₅₀	2375 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B1 Conn-5 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B1 Conn-5 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	1951 3 Compound: RBV	Antiviral activity against Coxsackievirus B1 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B1 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
MDCK	CC₅₀	> 2130 3 Compound: Ribavirin	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability by MTT assay Cytotoxicity against dog MDCK cells assessed as reduction in cell viability by MTT assay	[PMID: 33129992]
Vero	IC₅₀	>40948 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B2 (strain Ohio-1) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B2 (strain Ohio-1) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
MDCK	CC₅₀	> 2130 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell death incubated for 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as cell death incubated for 48 hrs by MTT assay	[PMID: 33171219]
Vero	IC₅₀	2101 3 Compound: RBV	Antiviral activity against Coxsackievirus B2 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B2 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
MDCK	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as cell viability after 48 hrs by MTT assay	[PMID: 24313730]
Vero	IC₅₀	>500 3 Compound: RBV	Antiviral activity against Coxsackievirus B2 Ohio-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B2 Ohio-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
MDCK	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against MDCK cells after 48 hrs by MTT assay Cytotoxicity against MDCK cells after 48 hrs by MTT assay	[PMID: 24785979]
Vero	IC₅₀	379.12 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B3 (strain Nancy) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B3 (strain Nancy) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
MDCK	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 28666191]
Vero	IC₅₀	1690 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
MDCK	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay	[PMID: 30142611]
Vero	IC₅₀	910 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis Antiviral activity against Coxsackievirus B3 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis	[PMID: 21880491]
MDCK	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 33328103]
MDCK	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 33962311]
Vero	IC₅₀	1200 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 26110443]
Vero	IC₅₀	222.2 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23734721]
MDCK	CC₅₀	> 250 3 Compound: RBV	Cytotoxicity against MDCK cells incubated for 48 hrs by MTT assay Cytotoxicity against MDCK cells incubated for 48 hrs by MTT assay	[PMID: 39153334]
Vero	IC₅₀	292 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27792321]
MDCK	CC₅₀	> 250 3 Compound: RBV, Ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTT assay Cytotoxicity against MDCK cells assessed as decrease in cell viability by MTT assay	[PMID: 25856229]
Vero	IC₅₀	1197.58 3 Compound: RBV	Antiviral activity against coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption Antiviral activity against coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption	[PMID: 26132528]
MDCK	CC₅₀	> 250 3 Compound: RBV; Ribavirin	Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay Cytotoxicity against MDCK cells assessed as decrease in cell viability after 48 hrs by MTT assay	[PMID: 26924568]
MDCK	CC₅₀	> 300 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by CellTiter-Glo assay Cytotoxicity against MDCK cells assessed as reduction in cell viability incubated for 48 hrs by CellTiter-Glo assay	[PMID: 36596229]
Vero	IC₅₀	0.9 92 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect after 48 hrs by Reed-Muench analysis Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect after 48 hrs by Reed-Muench analysis	[PMID: 24070022]
Vero	IC₅₀	694.6 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
MDCK	CC₅₀	> 320 6 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability by neutral red assay Cytotoxicity against MDCK cells assessed as cell viability by neutral red assay	[PMID: 26291036]
MDCK	CC₅₀	> 320 6 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as cell viability by visual assay Cytotoxicity against MDCK cells assessed as cell viability by visual assay	[PMID: 26291036]
Vero	IC₅₀	379.1 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 Nancy infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 Nancy infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	3316 3 Compound: RBV	Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
MDCK	CC₅₀	> 323.5 3 Compound: Ribavirin	Cytotoxicity against MDCK cells Cytotoxicity against MDCK cells	[PMID: 23811085]
MDCK	CC₅₀	> 4095 3 Compound: Ribavirin	Cytotoxicity against MDCK cells infected with influenza A virus California/7/2009(H1N1) Cytotoxicity against MDCK cells infected with influenza A virus California/7/2009(H1N1)	[PMID: 36898483]
Vero	IC₅₀	3316 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
MDCK	CC₅₀	> 50 3 Compound: Ribavirin	Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Cytotoxicity against MDCK cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 34273661]
Vero	IC₅₀	910.8 3 Compound: RBV	Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
MDCK	CC₅₀	> 500 11 Compound: Ribavirin	Cytotoxicity against dog MDCK cells Cytotoxicity against dog MDCK cells	[PMID: 18160286]
Vero	IC₅₀	2088 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B6 (strain Schmitt) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B6 (strain Schmitt) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	910 3 Compound: RBV	Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
MDCK	CC₅₀	> 512 3 Compound: ribavirin	Cytotoxicity against MDCK cells by MTT assay Cytotoxicity against MDCK cells by MTT assay	[PMID: 18640042]
Vero	IC₅₀	1708 3 Compound: RBV	Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
MDCK	CC₅₀	>= 20 3 Compound: ribavirin	Cytotoxicity against dog MDCK cells assessed as cell viability after 72 hrs by MTS assay Cytotoxicity against dog MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 24900429]
Vero	IC₅₀	2088 3 Compound: RBV	Antiviral activity against Coxsackievirus B6 Schmitt infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B6 Schmitt infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	884.9 3 Compound: Ribavirin	Antiviral activity against CVB3 infected in African green monkey Vero cells by MTT assay Antiviral activity against CVB3 infected in African green monkey Vero cells by MTT assay	[PMID: 31735601]
Vero	IC₅₀	253.1 3 Compound: Ribavirin	Antiviral activity against Enterovirus 71 BrCr infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay Antiviral activity against Enterovirus 71 BrCr infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay	[PMID: 24679044]
Vero	IC₅₀	2119 3 Compound: RBV	Antiviral activity against Enterovirus 71 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis Antiviral activity against Enterovirus 71 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis	[PMID: 21880491]
Vero	IC₅₀	0.04 3 Compound: Ribavirin	Antiviral activity against Hepatitis C virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against Hepatitis C virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect	[PMID: 27262598]
Vero	IC₅₀	38.49 6 Compound: RBV	Antiviral activity against Herpes simplex virus 1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect by microscopic analysis Antiviral activity against Herpes simplex virus 1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect by microscopic analysis	[PMID: 30578076]
Vero	IC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus type 1 L2 infected in African green monkey Vero E6 cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against Herpes simplex virus type 1 L2 infected in African green monkey Vero E6 cells assessed as reduction of virus-induced cytopathic effect	[PMID: 27262598]
Vero	IC₅₀	2340 3 Compound: RBV	Antiviral activity against Human enterovirus 71 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Human enterovirus 71 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
Vero	IC₅₀	13.3 3 Compound: Ribavirin	Antiviral activity against human EV71 infected in African green monkey Vero cells assessed as reduction in cytopathic effect by CCK-8 assay Antiviral activity against human EV71 infected in African green monkey Vero cells assessed as reduction in cytopathic effect by CCK-8 assay	[PMID: 32937282]
Vero	IC₅₀	20 6 Compound: ribavirin	Antiviral activity against Punta Toro virus in vero cells Antiviral activity against Punta Toro virus in vero cells	[PMID: 17518459]
Vero	IC₅₀	0.7 6 Compound: ribavirin	Antiviral activity against Reovirus1 in vero cells Antiviral activity against Reovirus1 in vero cells	[PMID: 17518459]
Vero	IC₅₀	37.3 3 Compound: ribavirin	Antiviral activity against Rift Valley fever virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay Antiviral activity against Rift Valley fever virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay	[PMID: 26260336]
Vero	IC₅₀	82 3 Compound: ribavirin	Antiviral activity against SARS-CoV Frankfurt1 in Vero E6 cells by plaque reduction assay Antiviral activity against SARS-CoV Frankfurt1 in Vero E6 cells by plaque reduction assay	[PMID: 17336519]
Vero	IC₅₀	26.7 3 Compound: ribavirin	Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay	[PMID: 26260336]
Vero	IC₅₀	>400 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay	[PMID: 21115214]
Vero	IC₅₀	286.8 3 Compound: Ribavirin	Inhibitory concentration against parainfluenza-3 virus in vero cells Inhibitory concentration against parainfluenza-3 virus in vero cells	[PMID: 7658442]
Vero	IC₅₀	>400 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in Vero cell line Tested for inhibitory effect on RNA virus cell morphology in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	20 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Coxsackie B4 in Vero cell line Tested for inhibitory effect on RNA virus Coxsackie B4 in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	5.2 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus JV in Vero cell line Tested for inhibitory effect on RNA virus JV in Vero cell line	[PMID: 8246242]
MDCK	EC₅₀	0.094 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis	[PMID: 23117173]
Vero	IC₅₀	160 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Reo-1 in Vero cell line Tested for inhibitory effect on RNA virus Reo-1 in Vero cell line	[PMID: 8246242]
MDCK	EC₅₀	0.14 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 23117173]
Vero	IC₅₀	>= 235 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus SFV in Vero cell line Tested for inhibitory effect on RNA virus SFV in Vero cell line	[PMID: 8246242]
MDCK	EC₅₀	1.05 3 Compound: RBV	Antiviral activity against oseltamivir-resistant influenza A virus LN/1109 (H1N1) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against oseltamivir-resistant influenza A virus LN/1109 (H1N1) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
Vero	IC₅₀	>= 250 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus SV in Vero cell line Tested for inhibitory effect on RNA virus SV in Vero cell line	[PMID: 8246242]
MDCK	EC₅₀	1.1 3 Compound: ribavirin	Antiviral activity against influenza A virus H3N3 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay Antiviral activity against influenza A virus H3N3 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay	[PMID: 23811093]
MDCK	EC₅₀	1.43 3 Compound: RBV	Antiviral activity against amantadine-resistant influenza A virus JX/312 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against amantadine-resistant influenza A virus JX/312 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
Vero	IC₅₀	6.4 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus TV in Vero cell line Tested for inhibitory effect on RNA virus TV in Vero cell line	[PMID: 8246242]
Vero 76	CC₅₀	>1 2 Compound: ribavirin	Cytotoxicity against African green monkey Vero 76 cells Cytotoxicity against African green monkey Vero 76 cells	[PMID: 26260336]
MDCK	EC₅₀	10 3 Compound: ribavirin	Antiviral activity against amantadine-sensitive Influenza A virus (A/FM/1/47 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantadine-sensitive Influenza A virus (A/FM/1/47 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
Vero 76	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by crystal violet staining method Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by crystal violet staining method	[PMID: 26443549]
MDCK	EC₅₀	10.2 3 Compound: 3	Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
Vero 76	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by MTT method Cytotoxicity against African green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by MTT method	[PMID: 25913116]
MDCK	EC₅₀	11 3 Compound: RBV	Antiviral activity against influenza A virus A/Padova/253/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against influenza A virus A/Padova/253/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
Vero 76	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero 76 cells assessed as decrease in cell viability after 48 to 96 hrs by MTT assay Cytotoxicity against African green monkey Vero 76 cells assessed as decrease in cell viability after 48 to 96 hrs by MTT assay	[PMID: 29028528]
MDCK	EC₅₀	11 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
MDCK	EC₅₀	11.2 3 Compound: 3	Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
Vero 76	CC₅₀	>4094 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero 76 cells infected with Rift Valley fever virus MP-12 by neutral red dye based analysis Cytotoxicity against African green monkey Vero 76 cells infected with Rift Valley fever virus MP-12 by neutral red dye based analysis	[PMID: 36898483]
Vero 76	CC₅₀	>100 3 Compound: Ribavirin	Cytotoxicity against mock-infected african green monkey Vero 76 cells after 48 to 96 hrs by MTT assay Cytotoxicity against mock-infected african green monkey Vero 76 cells after 48 to 96 hrs by MTT assay	[PMID: 25082514]
MDCK	EC₅₀	11.5 3 Compound: Ribavirin	Antiviral activity against Unidentified Influenza A virus (H1N1) infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Unidentified Influenza A virus (H1N1) infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Vero 76	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus type B2 virus infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay Antiviral activity against Coxsackie virus type B2 virus infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay	[PMID: 19482481]
MDCK	EC₅₀	11.7 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 yamagata/120/86 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 yamagata/120/86 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
Vero 76	EC₅₀	>100 3 Compound: Ribavirin	Antiviral activity against Human poliovirus 1 Sabin infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity by plaque reduction assay Antiviral activity against Human poliovirus 1 Sabin infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity by plaque reduction assay	[PMID: 26443549]
MDCK	EC₅₀	12 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Wisconsin/67/2005(H3N2)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against Influenza A virus (A/Wisconsin/67/2005(H3N2)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	12 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy Antiviral activity against Influenza A virus A/Virginia/ATCC3/2009 infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy	[PMID: 24974341]
Vero 76	EC₅₀	1.2 3 Compound: Ribavirin	Antiviral activity against Human respiratory syncytial virus A2 ATCC VR 1540 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 5 days by crystal violet staining-based plaque reduction assay Antiviral activity against Human respiratory syncytial virus A2 ATCC VR 1540 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 5 days by crystal violet staining-based plaque reduction assay	[PMID: 29028528]
Vero 76	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against human RSV infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by plaque reduction assay Antiviral activity against human RSV infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by plaque reduction assay	[PMID: 26443549]
MDCK	EC₅₀	12 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 25752526]
Vero 76	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus A2 infected in Vero-76 cells after 5 days by plaque reduction assay Antiviral activity against Respiratory syncytial virus A2 infected in Vero-76 cells after 5 days by plaque reduction assay	[PMID: 19482481]
MDCK	EC₅₀	12 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis	[PMID: 25752526]
Vero C1008	CC₅₀	>400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells assessed as cell growth inhibition measured after 48 hrs by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells assessed as cell growth inhibition measured after 48 hrs by CCK-8 assay	[PMID: 32992245]
MDCK	EC₅₀	12.5 3 Compound: Ribavirin	Antiviral activity against Influenza A H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathicity Antiviral activity against Influenza A H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	12.8 3 Compound: RBV; Ribavirin	Antiviral activity against Influenza A virus PR/8/34 infected in MDCK cells assessed as inhibition of plaque formation treated for 1 hr measured after 2 days by toluidine blue staining-based assay Antiviral activity against Influenza A virus PR/8/34 infected in MDCK cells assessed as inhibition of plaque formation treated for 1 hr measured after 2 days by toluidine blue staining-based assay	[PMID: 26924568]
Vero C1008	CC₅₀	>100 3 Compound: RBV	Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell viability Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell viability	[PMID: 31902708]
Vero C1008	CC₅₀	>400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells assessed as reduction of cell viability measured after 48 hrs by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells assessed as reduction of cell viability measured after 48 hrs by CCK-8 assay	[PMID: 32563814]
MDCK	EC₅₀	12.9 6 Compound: Ribavirin	Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as cell viability after 2 days by MTS assay Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as cell viability after 2 days by MTS assay	[PMID: 20724039]
Vero C1008	CC₅₀	>400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells by CCK8 assay Cytotoxicity against African green monkey Vero E6 cells by CCK8 assay	[PMID: 32511912]
MDCK	EC₅₀	12 6 Compound: Ribavirin	Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero C1008	CC₅₀	>400 3 Compound: 53	Cytotoxicity against African green monkey Vero E6 cells by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells by CCK-8 assay	[PMID: 33486200]
MDCK	EC₅₀	13.9 3 Compound: 3	Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	13.93 3 Compound: Ribavirin	Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus B/Memphis/20/1996 infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus B/Memphis/20/1996 infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain	[PMID: 20350949]
Vero C1008	CC₅₀	>400 3 Compound: 5	Cytotoxicity against African green monkey Vero E6 cells by the CCK8 assay Cytotoxicity against African green monkey Vero E6 cells by the CCK8 assay	[PMID: 32845145]
Vero C1008	CC₅₀	>400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells infected with SARS-COV-2 by celltiter-glo luminescent cell viability assay Cytotoxicity against African green monkey Vero E6 cells infected with SARS-COV-2 by celltiter-glo luminescent cell viability assay	[PMID: 34273661]
MDCK	EC₅₀	14.3 3 Compound: ribavirin	Inhibition of viral replication of influenza A virus (A/Hong Kong/213/03(H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay Inhibition of viral replication of influenza A virus (A/Hong Kong/213/03(H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay	[PMID: 17194832]
Vero C1008	CC₅₀	>160 3 Compound: R	Cytotoxicity against African green monkey Vero E6 cells infected with ZIKV COL345Si measured after 6 days by MTT assay Cytotoxicity against African green monkey Vero E6 cells infected with ZIKV COL345Si measured after 6 days by MTT assay	[PMID: 35969814]
MDCK	EC₅₀	15.6 3 Compound: RBV	Inhibition of Influenza A virus A/PR/8/34 infected in MDCK cells after 48 hrs by plaque reduction assay Inhibition of Influenza A virus A/PR/8/34 infected in MDCK cells after 48 hrs by plaque reduction assay	[PMID: 24785979]
MDCK	EC₅₀	16.4 3 Compound: 3	Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
Vero C1008	CC₅₀	>200 3 Compound: Ribavirin	Cytotoxicity in African green monkey Vero E6 cells assessed as reduction in cell viability Cytotoxicity in African green monkey Vero E6 cells assessed as reduction in cell viability	[PMID: 32378892]
Vero C1008	EC₅₀	109.5 3 Compound: 53	Antiviral activity against SARS-CoV infected in Vero E6 cells assessed as reduction in viral replication measured after 48 hrs by qRT-PCR assay Antiviral activity against SARS-CoV infected in Vero E6 cells assessed as reduction in viral replication measured after 48 hrs by qRT-PCR assay	[PMID: 33486200]
MDCK	EC₅₀	16 6 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by neutral red assay Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by neutral red assay	[PMID: 26291036]
Vero C1008	EC₅₀	33 3 Compound: RBV	Antiviral activity against Zika virus infected in African green monkey Vero E6 cells assessed as reduction in viral induced cytopathic effect Antiviral activity against Zika virus infected in African green monkey Vero E6 cells assessed as reduction in viral induced cytopathic effect	[PMID: 31902708]
MDCK	EC₅₀	17 3 Compound: RBV	Antiviral activity against oseltamivir-resistant Influenza A virus (A/Parma/24/2009(H1N1)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against oseltamivir-resistant Influenza A virus (A/Parma/24/2009(H1N1)) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
Vero C1008	EC₅₀	33 3 Compound: Ribavirin	Antiviral activity against Zika virus infected in Vero E6 cells assessed as reduction in virus-induced cytopathic effect incubated for 96 hrs by CCK8 assay Antiviral activity against Zika virus infected in Vero E6 cells assessed as reduction in virus-induced cytopathic effect incubated for 96 hrs by CCK8 assay	[PMID: 32378892]
MDCK	EC₅₀	18.43 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Perth/16/2009(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay Antiviral activity against Influenza A virus (A/Perth/16/2009(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay	[PMID: 23811085]
Vero C1008	IC₅₀	512 3 Compound: Ribavirin	Antiviral activity against HSV1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against HSV1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
MDCK	EC₅₀	18.43 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/duck/Minnesota/1525/1981(H5N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay Antiviral activity against Influenza A virus (A/duck/Minnesota/1525/1981(H5N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay	[PMID: 23811085]
Vero C1008	IC₅₀	1024 3 Compound: Ribavirin	Antiviral activity against HSV-1 L2/Rp-ACV/2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against HSV-1 L2/Rp-ACV/2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
MDCK	EC₅₀	19.4 3 Compound: 3	Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus California/07/2009 /H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
Vero C1008	IC₅₀	125 6 Compound: Ribavirin	Antiviral activity against Human herpesvirus 1 L2 infected in African green monkey Vero E6 cells assessed as protection against virus-induced cytopathic effect Antiviral activity against Human herpesvirus 1 L2 infected in African green monkey Vero E6 cells assessed as protection against virus-induced cytopathic effect	[PMID: 29173944]
MDCK	EC₅₀	19.5 3 Compound: 3	Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza B virus Malaysia/2506/2004 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	19.67 3 Compound: Ribavirin	Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/Georgia/20/2006(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microsc Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/Georgia/20/2006(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microsc	[PMID: 20350949]
WIL2-NS	IC₅₀	>100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of WIL-2-NS cell line. Compound was tested for its effect on the proliferation of WIL-2-NS cell line.	10.1016/0960-894X(96)00216-8
MDCK	EC₅₀	2 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 12 hrs by toluidine blue staining assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 12 hrs by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	2.1 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 murakami/4/64 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 murakami/4/64 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	2.2 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 Adachi/2/57 in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H2N2 Adachi/2/57 in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	2.3 3 Compound: Ribavirin	Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
MDCK	EC₅₀	2.5 3 Compound: ribavirin	Antiviral activity against influenza A virus H1N1 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay Antiviral activity against influenza A virus H1N1 subtype infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay	[PMID: 23811093]
MDCK	EC₅₀	2.8 3 Compound: ribavirin	Antiviral activity against influenza B virus infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay Antiviral activity against influenza B virus infected in dog MDCK cells assessed as reduction of virus-induced cytopathogenicity by MTS assay	[PMID: 23811093]
MDCK	EC₅₀	20.2 3 Compound: 3	Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Wisconsin/67/2005/H3N2 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	20.92 3 Compound: Ribavirin	Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Florida/01/2009(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Florida/01/2009(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis	[PMID: 20350949]
MDCK	EC₅₀	21 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
MDCK	EC₅₀	23.3 3 Compound: 3	Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
MDCK	EC₅₀	23.6 3 Compound: 3	Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
MDCK	EC₅₀	23.75 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay	[PMID: 23811085]
MDCK	EC₅₀	24 6 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/California/07/2009(H1N1) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by visual assay Antiviral activity against Influenza A virus (A/California/07/2009(H1N1) infected in MDCK cell line assessed as reduction of virus induced cytopathic effect by visual assay	[PMID: 26291036]
MDCK	EC₅₀	25 3 Compound: Ribavirin	Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza B virus B/Memphis/20/1996 harboring neuraminidase R152K mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic ana Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza B virus B/Memphis/20/1996 harboring neuraminidase R152K mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic ana	[PMID: 20350949]
MDCK	EC₅₀	25.1 3 Compound: 3	Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Solomon Islands/03/2006/H1N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	27.4 3 Compound: 3	Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Gull/PA/4175/83/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	3.4 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 25752526]
MDCK	EC₅₀	3.56 3 Compound: RBV	Antiviral activity against amantadine-resistant influenza A virus HN/1222 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against amantadine-resistant influenza A virus HN/1222 (H3N2) infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
MDCK	EC₅₀	3.7 3 Compound: Ribavirin	Antiviral activity against influenza A H2N2(A2 japan/305/57) in MDCK cells Antiviral activity against influenza A H2N2(A2 japan/305/57) in MDCK cells	[PMID: 12729645]
MDCK	EC₅₀	3.7 6 Compound: Ribavirin	Antiviral activity against influenza A virus NWS33 in MDCK cells assessed as inhibition of viral cytopathic effect by neutral red assay Antiviral activity against influenza A virus NWS33 in MDCK cells assessed as inhibition of viral cytopathic effect by neutral red assay	[PMID: 9214738]
MDCK	EC₅₀	32.5 3 Compound: 3	Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	34.2 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 Bangkok/10/83 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 Bangkok/10/83 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	35.4 3 Compound: 3	Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Duck/MN/1525/81/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
MDCK	EC₅₀	35.6 3 Compound: Ribavirin	Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Washington/01/2007(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analy Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Washington/01/2007(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analy	[PMID: 20350949]
MDCK	EC₅₀	35.7 3 Compound: ribavirin	Inhibition of viral replication of influenza A virus (A/Vietnam/1203/2004 (H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay Inhibition of viral replication of influenza A virus (A/Vietnam/1203/2004 (H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay	[PMID: 17194832]
MDCK	EC₅₀	38.1 3 Compound: ribavirin	Inhibition of Influenza A virus (A/gull/Pennsylvania/4175/83 (H5N1)) replication in MDCK cells by neutral red uptake assay Inhibition of Influenza A virus (A/gull/Pennsylvania/4175/83 (H5N1)) replication in MDCK cells by neutral red uptake assay	[PMID: 17194832]
MDCK	EC₅₀	4 3 Compound: ribavirin	Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method	[PMID: 19281225]
MDCK	EC₅₀	4.28 3 Compound: RBV	Antiviral activity against influenza B virus B/SZ/155 infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay Antiviral activity against influenza B virus B/SZ/155 infected in dog MDCK cells assessed as inhibition of virus induced cytopathic effect after 40 hrs by Cell-Titer-Glo assay	[PMID: 26686929]
MDCK	EC₅₀	4.3 3 Compound: 3	Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
MDCK	EC₅₀	4.3 6 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
MDCK	EC₅₀	4.5 3 Compound: Ribavirin	Antiviral activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
MDCK	EC₅₀	4.6 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23099097]
MDCK	EC₅₀	4.6 3 Compound: Ribavirin	Antiviral activity against IInfluenza A virus H3N2 A/HK/7/87 infected in MDCK cells after 4 days by MTS assay Antiviral activity against IInfluenza A virus H3N2 A/HK/7/87 infected in MDCK cells after 4 days by MTS assay	[PMID: 31753804]
MDCK	EC₅₀	4.8 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay	[PMID: 22459876]
MDCK	EC₅₀	4.8 3 Compound: ribavirin	Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method Antiviral activity against influenza B virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method	[PMID: 19281225]
MDCK	EC₅₀	4.92 3 Compound: Ribavirin	Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Georgia/17/2006(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Georgia/17/2006(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain	[PMID: 20350949]
MDCK	EC₅₀	43 3 Compound: ribavirin	Inhibition of influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) replication in MDCK cells by neutral red uptake assay Inhibition of influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) replication in MDCK cells by neutral red uptake assay	[PMID: 17194832]
MDCK	EC₅₀	46.7 3 Compound: Ribavirin	Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Texas/12/2007 (clone)(H3N2)) harboring neuraminidase E119I mutant and harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Texas/12/2007 (clone)(H3N2)) harboring neuraminidase E119I mutant and harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral	[PMID: 20350949]
MDCK	EC₅₀	5.1 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
MDCK	EC₅₀	5.5 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza B norway/1/80 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza B norway/1/80 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	5.6 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay	[PMID: 22459876]
MDCK	EC₅₀	5.73 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Florida/4/2006) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay Antiviral activity against Influenza B virus (B/Florida/4/2006) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect by cell-based neutral red uptake assay	[PMID: 23811085]
MDCK	EC₅₀	6 3 Compound: RBV	Antiviral activity against Influenza B virus (B/Lee/1940) clinical isolate infected in MDCK cells assessed as inhibition of viral replication after 2 days by toluidine blue staining assay Antiviral activity against Influenza B virus (B/Lee/1940) clinical isolate infected in MDCK cells assessed as inhibition of viral replication after 2 days by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	6 3 Compound: RBV	Antiviral activity against influenza A virus A/Padova/72/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against influenza A virus A/Padova/72/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	6 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23099097]
MDCK	EC₅₀	6.1 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23099097]
MDCK	EC₅₀	6.1 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 Philippine/2/82 in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 Philippine/2/82 in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	6.7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by colorimetric formazan-based MTS assay	[PMID: 22459876]
MDCK	EC₅₀	6.8 3 Compound: Ribavirin	Antiviral activity against Influenza A/PR/8/34 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay Antiviral activity against Influenza A/PR/8/34 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay	[PMID: 23149298]
MDCK	EC₅₀	6.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy	[PMID: 24974341]
MDCK	EC₅₀	6.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy	[PMID: 24974341]
MDCK	EC₅₀	6.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza A virus H3N2 infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	EC₅₀	6.8 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in MDCK cells assessed as 1-log10 reduction in viral RNA copy number after 24 hrs by quantitative RT-PCR analysis Antiviral activity against Influenza A virus (A/PR/8/1934(H1N1)) infected in MDCK cells assessed as 1-log10 reduction in viral RNA copy number after 24 hrs by quantitative RT-PCR analysis	[PMID: 26288686]
MDCK	EC₅₀	6 6 Compound: Ribavirin	Antiviral activity against influenza B virus infected in MDCK cells assessed as cell viability after 2 days by MTS assay Antiviral activity against influenza B virus infected in MDCK cells assessed as cell viability after 2 days by MTS assay	[PMID: 20724039]
MDCK	EC₅₀	7 3 Compound: RBV	Antiviral activity against influenza A virus A/Padova/30/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against influenza A virus A/Padova/30/2011(H1N1) clinical isolate infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction visual scoring of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
MDCK	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis Antiviral activity against Influenza B virus (B/Hong Kong/05/1972) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis	[PMID: 25752526]
MDCK	EC₅₀	7 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay	[PMID: 24900429]
MDCK	EC₅₀	7.2 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N3 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Influenza A virus H3N3 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
MDCK	EC₅₀	7.3 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as protection against virus-induced cytopathicity Antiviral activity against Influenza B virus infected in MDCK cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	7.3 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/HK/7/1987(H3N2)) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
MDCK	EC₅₀	7.5 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus-induced cytopathic effect measured after 4 days by formazan-based MTS assay Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus-induced cytopathic effect measured after 4 days by formazan-based MTS assay	[PMID: 27112451]
MDCK	EC₅₀	7.6 3 Compound: ribavirin	Antiviral activity against amantadine-sensitive Influenza A virus (A/Ned/378/05 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantadine-sensitive Influenza A virus (A/Ned/378/05 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
MDCK	EC₅₀	7.7 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against Influenza A virus (A/HK/7/87 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
MDCK	EC₅₀	7.8 6 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as cell viability after 2 days by MTS assay Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as cell viability after 2 days by MTS assay	[PMID: 20724039]
MDCK	EC₅₀	7.9 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 ishikawa/7/82 in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H3N2 ishikawa/7/82 in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	7 6 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
MDCK	EC₅₀	8 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of plaque formation after 2 days by toluidine blue staining assay	[PMID: 24313730]
MDCK	EC₅₀	8 3 Compound: RBV, Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34) (H1N1) infected in MDCK cells assessed as reduction in plaque formation after 48 hrs by plaque reduction assay Antiviral activity against Influenza A virus (A/PR/8/34) (H1N1) infected in MDCK cells assessed as reduction in plaque formation after 48 hrs by plaque reduction assay	[PMID: 25856229]
MDCK	EC₅₀	8 3 Compound: ribavirin	Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
MDCK	EC₅₀	8.1 3 Compound: ribavirin	Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method	[PMID: 19281225]
MDCK	EC₅₀	8.1 3 Compound: ribavirin	Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay Antiviral activity against amantidine and rimantadine-resistant Influenza B virus (B/HK/5/72) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay	[PMID: 24900429]
MDCK	EC₅₀	8.2 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as reduction in host cell viability after 72 hrs by MTS assay	[PMID: 24974341]
MDCK	EC₅₀	8.2 3 Compound: ribavirin	Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect by MTS assay	[PMID: 24900429]
MDCK	EC₅₀	8.3 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
MDCK	EC₅₀	8.3 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 PR8/34 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza A subtype H1N1 PR8/34 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	8.4 3 Compound: 3	Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days Antiviral activity against Influenza A virus Vietnam/1203/ 2004H/H5N1 infected MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days	[PMID: 20231094]
MDCK	EC₅₀	8.4 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 23117173]
MDCK	EC₅₀	8.4 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 A/HK/7/87 infected in MDCK cells assessed as reduction in virus induced cytopathic effect after 4 days by microscopy based method Antiviral activity against Influenza A virus H3N2 A/HK/7/87 infected in MDCK cells assessed as reduction in virus induced cytopathic effect after 4 days by microscopy based method	[PMID: 31753804]
MDCK	EC₅₀	8.4 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
MDCK	EC₅₀	8.4 6 Compound: Ribavirin	Antiviral activity against Influenza A H3N2 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Influenza A H3N2 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
MDCK	EC₅₀	8.5 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by MTS assay	[PMID: 23117173]
MDCK	EC₅₀	8.5 6 Compound: Ribavirin	The compound was evaluated for inhibitory effect on the replication of influenza B Singapore/222/79 strain in MDCK cells The compound was evaluated for inhibitory effect on the replication of influenza B Singapore/222/79 strain in MDCK cells	10.1016/S0960-894X(97)10154-8
MDCK	EC₅₀	8.68 3 Compound: ribavirin	Antiviral activity against influenza A/Hong Kong/7/87 (H3N2) in MDCK cells assessed as inhibition of virus-induced cytopathic effect by MTS assay Antiviral activity against influenza A/Hong Kong/7/87 (H3N2) in MDCK cells assessed as inhibition of virus-induced cytopathic effect by MTS assay	[PMID: 17588747]
MDCK	EC₅₀	8.7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity by MTS assay Antiviral activity against Influenza A virus (A/Hong Kong/7/1987(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity by MTS assay	[PMID: 20805012]
MDCK	EC₅₀	8.7 3 Compound: Ribavirin	Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus induced cytopathic effect measured by visual scoring of cytopathic effect Antiviral activity against Influenza A virus A/PR/8/34 infected in MDCK cells assessed as reduction of virus induced cytopathic effect measured by visual scoring of cytopathic effect	[PMID: 27112451]
MDCK	EC₅₀	8.7 3 Compound: ribavirin	Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against amantadine-resistant Influenza A virus (A/PR/8/34 (H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
MDCK	EC₅₀	8.8 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/Ishikawa/7/82 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against Influenza A virus (A/Ishikawa/7/82 (H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
MDCK	EC₅₀	8.8 3 Compound: ribavirin	Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect measured 3 days post infection by microscopic analysis	[PMID: 24900429]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis Antiviral activity against Influenza A virus (A/PR/8/34(H1N1)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis	[PMID: 23117173]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis Antiviral activity against Influenza A virus (A/X-31(H3N2)) infected in MDCK cells assessed as virus-induced cytopathic effect after 3 days by microscopic analysis	[PMID: 23117173]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza A/HK/7/87 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay Antiviral activity against Influenza A/HK/7/87 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay	[PMID: 23149298]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza B/HK/5/72 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay Antiviral activity against Influenza B/HK/5/72 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured on day 3 post infection by MTS assay	[PMID: 23149298]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy Antiviral activity against Influenza B virus (B/HK/05/1972) infected in MDCK cells assessed as virus-induced cytopathic effect after 72 hrs by microscopy	[PMID: 24974341]
MDCK	EC₅₀	8.9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as cell viability after 72 hrs by MTS assay	[PMID: 25752526]
MDCK	EC₅₀	8400 3 Compound: ribavirin	Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by MTS method	[PMID: 19281225]
MDCK	EC₅₀	9 3 Compound: 1	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
MDCK	EC₅₀	9 3 Compound: 1	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against Influenza B virus infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
MDCK	EC₅₀	9 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by microscopic analysis	[PMID: 25752526]
MDCK	EC₅₀	9 3 Compound: ribavirin	Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method Antiviral activity against influenza H3N2 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method	[PMID: 19281225]
MDCK	EC₅₀	9.4 3 Compound: 3	Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay Antiviral activity against Influenza A virus Hong Kong/213/2003/H5N1 infected MDCK cells after 42 to 46 hrs by neutral red dye uptake assay	[PMID: 20231094]
MDCK	EC₅₀	9.6 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
MDCK	EC₅₀	9.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection against virus-induced cytopathicity Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
MDCK	EC₅₀	900 3 Compound: ribavirin	Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method Antiviral activity against influenza H1N1 virus in MDCK cells assessed as reduction of virus-induced cytopathicity by visual cytopathic effect scoring method	[PMID: 19281225]
MDCK	EC₅₀	9 6 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
MDCK	EC₅₀	9 6 Compound: Ribavirin	Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
MDCK	EC₅₀	9 6 Compound: Ribavirin	Antiviral activity against influenza B virus infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against influenza B virus infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
MDCK	EC₅₀	9 6 Compound: Ribavirin	Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Influenza A H1N1 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
MDCK	EC₅₀	9 6 Compound: Ribavirin	Antiviral activity against Influenza A H3N2 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE Antiviral activity against Influenza A H3N2 virus subtype infected in MDCK cells assessed as inhibition of virus induced cytopathicity by visual scoring of CPE	[PMID: 20971531]
MDCK	ED₅₀	24.6 3 Compound: Ribavirin	Antiviral activity against Influenza virus A/California/07/09 (H1N1) pdm09 infected in MDCK cells after 48 hrs followed by incubated in chicken erythrocytes for 1 hr by hemagglutinination based end-point dilution method Antiviral activity against Influenza virus A/California/07/09 (H1N1) pdm09 infected in MDCK cells after 48 hrs followed by incubated in chicken erythrocytes for 1 hr by hemagglutinination based end-point dilution method	[PMID: 23099095]
MDCK	IC₅₀	0.41 3 Compound: RIBA	Antiviral activity against Influenza A virus A/Hong Kong/8/68(H3N2) infected in dog MDCK cells after 3 days by CPE assay Antiviral activity against Influenza A virus A/Hong Kong/8/68(H3N2) infected in dog MDCK cells after 3 days by CPE assay	[PMID: 23806112]
MDCK	IC₅₀	1.9 3 Compound: RBV	Antiinfluenza activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs Antiinfluenza activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs	[PMID: 22341943]
MDCK	IC₅₀	1.92 6 Compound: RBV	Antiviral activity against Influenza A virus (A/FM/1/1947(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against Influenza A virus (A/FM/1/1947(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	100.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as compound concentration required for inhibiting influenza virus yield at 48 h post-infection by crystal violet staining based CPE inhibition assay Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as compound concentration required for inhibiting influenza virus yield at 48 h post-infection by crystal violet staining based CPE inhibition assay	[PMID: 21879714]
MDCK	IC₅₀	101 3 Compound: Ribavirin	Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay	[PMID: 24967847]
MDCK	IC₅₀	113.1 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) PR/8 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 48 hrs by crystal-violet staining-based assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) PR/8 infected in MDCK cells assessed as protection against virus-induced cytopathogenicity after 48 hrs by crystal-violet staining-based assay	[PMID: 23886345]
MDCK	IC₅₀	114.8 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 48 hrs Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus induced cytopathicity after 48 hrs	[PMID: 22487178]
MDCK	IC₅₀	115 3 Compound: Ribavirin	Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells incubated for 48 hrs assessed as inhibition of virus-induced cytopathic effect by crystal violet staining assay Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells incubated for 48 hrs assessed as inhibition of virus-induced cytopathic effect by crystal violet staining assay	[PMID: 26046820]
MDCK	IC₅₀	131 3 Compound: ribavirin	Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining assay	[PMID: 24499327]
MDCK	IC₅₀	14 3 Compound: Ribavirin	Antiviral activity against Influenza A/PR8/H1N1 virus infected in MDCK cells assessed as inhibition of virus yield after 24 hrs Antiviral activity against Influenza A/PR8/H1N1 virus infected in MDCK cells assessed as inhibition of virus yield after 24 hrs	[PMID: 24216089]
MDCK	IC₅₀	14.7 3 Compound: RBV	Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs	[PMID: 22341943]
MDCK	IC₅₀	15.2 3 Compound: ribavirin	Antiviral activity against influenza B/Jingfang/76/98 in MDCK cells by CPE assay Antiviral activity against influenza B/Jingfang/76/98 in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	16.3 3 Compound: Ribavirin	Inhibitory concentration against influenza virus B in MDCK cells Inhibitory concentration against influenza virus B in MDCK cells	[PMID: 7658442]
MDCK	IC₅₀	164 3 Compound: ribavirin	Antiviral activity against influenza B/Sichuan/83/2000 virus in MDCK cells by CPE assay Antiviral activity against influenza B/Sichuan/83/2000 virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	176 3 Compound: ribavirin	Antiviral activity against influenza A/Jingfang/262/95(H1N1) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Jingfang/262/95(H1N1) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	185.9 3 Compound: ribavirin	Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay	[PMID: 26114936]
MDCK	IC₅₀	2.06 11 Compound: Ribavirin	Antiviral activity against influenza A virus H3N2 (A3 China/15/90) expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against influenza A virus H3N2 (A3 China/15/90) expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect	[PMID: 18160286]
MDCK	IC₅₀	2.6 6 Compound: ribavirin	Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
MDCK	IC₅₀	2.6 6 Compound: ribavirin	Antiviral activity against RSV Long in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against RSV Long in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
MDCK	IC₅₀	20.2 3 Compound: RIBA	Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in dog MDCK cells after 3 days by CPE assay Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in dog MDCK cells after 3 days by CPE assay	[PMID: 23806112]
MDCK	IC₅₀	24.6 6 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as protection against virus-induced cytopathic effect after 48 hrs by crystal violet staining method Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as protection against virus-induced cytopathic effect after 48 hrs by crystal violet staining method	[PMID: 23411074]
MDCK	IC₅₀	3.27 6 Compound: RBV	Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of plaque formation after 3 to 4 days by crystal violet staining-based assay Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of plaque formation after 3 to 4 days by crystal violet staining-based assay	[PMID: 24583605]
MDCK	IC₅₀	3.73 6 Compound: ribavirin	Antiviral activity against influenza A H3N2 virus in MDCK cells Antiviral activity against influenza A H3N2 virus in MDCK cells	[PMID: 16183283]
MDCK	IC₅₀	3.9 3 Compound: RBV	Antiinfluenza activity against influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs Antiinfluenza activity against influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs	[PMID: 22341943]
MDCK	IC₅₀	35.3 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Tianjin-Jinnan/15/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Tianjin-Jinnan/15/2009(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 22824205]
MDCK	IC₅₀	4.27 11 Compound: Ribavirin	Antiviral activity against influenza B virus expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against influenza B virus expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect	[PMID: 18160286]
MDCK	IC₅₀	4.9 3 Compound: Ribavirin	Inhibitory concentration against influenza virus A in MDCK cells Inhibitory concentration against influenza virus A in MDCK cells	[PMID: 7658442]
MDCK	IC₅₀	42.6 3 Compound: ribavirin	Antiviral activity against Influenza A virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay Antiviral activity against Influenza A virus infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay	[PMID: 19267453]
MDCK	IC₅₀	45.5 3 Compound: RBV	Antiviral activity against Influenza B virus (strain B/Jifang/13/97) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza B virus (strain B/Jifang/13/97) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 22824205]
MDCK	IC₅₀	4 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Influenza A in MDCK cell line Tested for inhibitory effect on RNA virus Influenza A in MDCK cell line	[PMID: 8246242]
MDCK	IC₅₀	4 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Influenza B in MDCK cell line Tested for inhibitory effect on RNA virus Influenza B in MDCK cell line	[PMID: 8246242]
MDCK	IC₅₀	5.04 3 Compound: ribavirin	Antiviral activity against influenza A/Jifang/15/90 (H3N2) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Jifang/15/90 (H3N2) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	5.59 6 Compound: RBV	Antiviral activity against Influenza A virus A/hanfang/359/95(H3N2) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against Influenza A virus A/hanfang/359/95(H3N2) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	5.85 3 Compound: ribavirin	Antiviral activity against influenza A/Yuefang/243/72 (H3N2) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Yuefang/243/72 (H3N2) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	5.86 3 Compound: RBV	Antiviral activity against influenza A virus (A/Hanfang/359/95(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption Antiviral activity against influenza A virus (A/Hanfang/359/95(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption	[PMID: 26132528]
MDCK	IC₅₀	6.5 6 Compound: RBV	Antiviral activity against oseltamivir-resistant Influenza A virus (A/Tianjinjinnan/15/2009/H1N1) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against oseltamivir-resistant Influenza A virus (A/Tianjinjinnan/15/2009/H1N1) infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	62.5 6 Compound: ribavirin	Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against influenza virus type A H1N1 in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 15104496]
MDCK	IC₅₀	62.5 6 Compound: ribavirin	Cytotoxicity against MDCK cells Cytotoxicity against MDCK cells	[PMID: 15104496]
MDCK	IC₅₀	7.01 3 Compound: ribavirin	Antiviral activity against influenza A/Hanfang/359/95 (H3N2) virus in MDCK cells by CPE assay Antiviral activity against influenza A/Hanfang/359/95 (H3N2) virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	7.84 6 Compound: RBV	Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs	[PMID: 24583605]
MDCK	IC₅₀	8.8 3 Compound: RBV	Antiviral activity against Influenza A virus (A/Guangdong-Luohu/219/2006(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Influenza A virus (A/Guangdong-Luohu/219/2006(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 22824205]
MDCK	IC₅₀	84 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining technique Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs by crystal violet staining technique	[PMID: 24495078]
MDCK	IC₅₀	87 3 Compound: Ribavirin	Antiviral activity against Influenza A virus H1N1 infected in dog MDCK cells after 48 hrs by CPE inhibition assay Antiviral activity against Influenza A virus H1N1 infected in dog MDCK cells after 48 hrs by CPE inhibition assay	[PMID: 23758051]
MDCK	IC₅₀	87.7 6 Compound: Ribavirin	Antiviral activity against Influenza A virus H3N2 A3/JINGKE/30/95 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs Antiviral activity against Influenza A virus H3N2 A3/JINGKE/30/95 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs	[PMID: 26791013]
MDCK	IC₅₀	9 3 Compound: ribavirin	Antiviral activity against Influenza B virus infected in MDCK cells after 3 days by neutral red dye-based plaque reduction assay Antiviral activity against Influenza B virus infected in MDCK cells after 3 days by neutral red dye-based plaque reduction assay	[PMID: 26260336]
MDCK	IC₅₀	96.2 3 Compound: ribavirin	Antiviral activity against influenza B/Jifang/13/97 virus in MDCK cells by CPE assay Antiviral activity against influenza B/Jifang/13/97 virus in MDCK cells by CPE assay	[PMID: 17611105]
MDCK	IC₅₀	98.3 3 Compound: Ribavirin	Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect incubated for 48 hrs by crystal violet staining based assay	[PMID: 32520560]
MDCK	IC₅₀	> 1310 3 Compound: 3	Cytotoxicity against MDCK cells after 3 days by neutral red dye uptake assay Cytotoxicity against MDCK cells after 3 days by neutral red dye uptake assay	[PMID: 20231094]
MDCK	IC₅₀	> 200 6 Compound: Ribavirin	Cytotoxicity against MDCK cells by neutral red assay Cytotoxicity against MDCK cells by neutral red assay	[PMID: 9214738]
MDCK	IC₅₀	> 200 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in MDCK cell line Tested for inhibitory effect on RNA virus cell morphology in MDCK cell line	[PMID: 8246242]
MOLT-4	IC₅₀	5.7 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of MOLT-4 human lymphoblastic T-leukemia cell line. Compound was tested for its effect on the proliferation of MOLT-4 human lymphoblastic T-leukemia cell line.	10.1016/0960-894X(96)00216-8
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against human MT4 cells after 96 hrs by MTT assay Cytotoxicity against human MT4 cells after 96 hrs by MTT assay	[PMID: 19482481]
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against human MT4 cells after 96 hrs by MTT assay Cytotoxicity against human MT4 cells after 96 hrs by MTT assay	[PMID: 20359898]
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against mock-infected human MT4 cells after 96 hrs by MTT assay Cytotoxicity against mock-infected human MT4 cells after 96 hrs by MTT assay	[PMID: 25082514]
MT4	CC₅₀	31 3 Compound: Ribavirin	Cytotoxicity against human MT4 cells assessed as cell viability after 96 hrs by MTT assay Cytotoxicity against human MT4 cells assessed as cell viability after 96 hrs by MTT assay	[PMID: 26443549]
MT4	IC₅₀	23 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of MT-4 cells expressing the TAT gene of HTLV-1. Compound was tested for its effect on the proliferation of MT-4 cells expressing the TAT gene of HTLV-1.	10.1016/0960-894X(96)00216-8
MT4	IC₅₀	6.5 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell growth in MT-4 cell line Tested for inhibitory effect on RNA virus cell growth in MT-4 cell line	[PMID: 8246242]
MT4	IC₅₀	> 5 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus HIV-1 in MT-4 cell line Tested for inhibitory effect on RNA virus HIV-1 in MT-4 cell line	[PMID: 8246242]
MT4	IC₅₀	> 5 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus HIV-2 in MT-4 cell line Tested for inhibitory effect on RNA virus HIV-2 in MT-4 cell line	[PMID: 8246242]
RD	CC₅₀	1485 3 Compound: Ribavirin	Cytotoxicity against human RD cells assessed as reduction in cell viability after 12 hrs by CCK8 assay Cytotoxicity against human RD cells assessed as reduction in cell viability after 12 hrs by CCK8 assay	[PMID: 31063370]
RD	CC₅₀	485.9 6 Compound: Ribavirin	Cytotoxicity against human RD cells assessed as reduction in cell viability after 3 days by MTT assay Cytotoxicity against human RD cells assessed as reduction in cell viability after 3 days by MTT assay	[PMID: 28858766]
RD	IC₅₀	60 6 Compound: Ribavirin	Antiviral activity against C4 type Human enterovirus 71 FY0805 infected in human RD cells assessed as inhibition of viral replication by plaque reduction assay Antiviral activity against C4 type Human enterovirus 71 FY0805 infected in human RD cells assessed as inhibition of viral replication by plaque reduction assay	[PMID: 22342145]
Raji	IC₅₀	56 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of RAJI burkitt lymphoma cell line. Compound was tested for its effect on the proliferation of RAJI burkitt lymphoma cell line.	10.1016/0960-894X(96)00216-8
Rhabdomyosarcoma cell	CC₅₀	> 500 6 Compound: Ribavirin	Cytotoxicity against human rhabdomyosarcoma cells after 72 hrs by MTT assay Cytotoxicity against human rhabdomyosarcoma cells after 72 hrs by MTT assay	[PMID: 23920438]
SK-OV-3	IC₅₀	10 6 Compound: RBV	Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 4 days by trypan blue exclusion assay	[PMID: 31883488]
SK-OV-3	IC₅₀	10 6 Compound: RBV	Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 7 days by trypan blue exclusion assay Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 7 days by trypan blue exclusion assay	[PMID: 31883488]
SK-OV-3	IC₅₀	9 6 Compound: RBV	Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 3 days by trypan blue exclusion assay	[PMID: 31883488]
SNB-19	CC₅₀	485.2 3 Compound: Ribavirin	Cytotoxicity against human SNB-19 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against human SNB-19 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
SNB-75	IC₅₀	18.53 3 Compound: RBV	Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay	[PMID: 31883488]
Vero	CC₅₀	0.3 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells Cytotoxicity against African green monkey Vero E6 cells	[PMID: 27262598]
Vero	CC₅₀	1245 3 Compound: RBV	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTS assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTS assay	[PMID: 35661850]
Vero	CC₅₀	156 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells after 7 to 8 days by neutral-red dye uptake assay Cytotoxicity against african green monkey Vero cells after 7 to 8 days by neutral-red dye uptake assay	[PMID: 17606691]
Vero	CC₅₀	1622 3 Compound: 95	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 4 days by MTT assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 4 days by MTT assay	[PMID: 28689975]
Vero	CC₅₀	297 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTT assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability by MTT assay	[PMID: 31843348]
Vero	CC₅₀	300 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells by MTT assay Cytotoxicity against African green monkey Vero cells by MTT assay	[PMID: 33822611]
Vero	CC₅₀	3931 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells infected with Tacaribe virus TRVL11573 by neutral red dye based analysis Cytotoxicity against African green monkey Vero cells infected with Tacaribe virus TRVL11573 by neutral red dye based analysis	[PMID: 36898483]
Vero	CC₅₀	409 3 Compound: ribavirin	Cytotoxicity against african green monkey Vero B cells Cytotoxicity against african green monkey Vero B cells	[PMID: 26039671]
Vero	CC₅₀	470.5 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells assessed as cell growth inhibition measured after 24 hrs by MTT assay Cytotoxicity against African green monkey Vero cells assessed as cell growth inhibition measured after 24 hrs by MTT assay	[PMID: 35306290]
Vero	CC₅₀	8189.67 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells after 96 hrs by MTT assay Cytotoxicity against african green monkey Vero cells after 96 hrs by MTT assay	[PMID: 23999140]
Vero	CC₅₀	> 100 3 Compound: 9	Cytotoxicity against African green monkey Vero cells Cytotoxicity against African green monkey Vero cells	[PMID: 31549836]
Vero	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero 76 cells by crystal violet staining Cytotoxicity against african green monkey Vero 76 cells by crystal violet staining	[PMID: 19482481]
Vero	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells Cytotoxicity against african green monkey Vero cells	[PMID: 20359898]
Vero	CC₅₀	> 1000 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells after 4 days by MTT assay Cytotoxicity against African green monkey Vero cells after 4 days by MTT assay	[PMID: 24679044]
Vero	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Human coxsackievirus B4 infected african green monkey Vero cells by trypan blue exclusion method Cytotoxicity against Human coxsackievirus B4 infected african green monkey Vero cells by trypan blue exclusion method	[PMID: 20034711]
Vero	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against PIV 3 infected african green monkey Vero cells by trypan blue exclusion method Cytotoxicity against PIV 3 infected african green monkey Vero cells by trypan blue exclusion method	[PMID: 20034711]
Vero	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Punta Toro virus infected african green monkey Vero cells by trypan blue exclusion method Cytotoxicity against Punta Toro virus infected african green monkey Vero cells by trypan blue exclusion method	[PMID: 20034711]
Vero	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Reovirus 1 infected african green monkey Vero cells by trypan blue exclusion method Cytotoxicity against Reovirus 1 infected african green monkey Vero cells by trypan blue exclusion method	[PMID: 20034711]
Vero	CC₅₀	> 250 3 Compound: Ribavirin	Cytotoxicity against Sindbis virus infected african green monkey Vero cells by trypan blue exclusion method Cytotoxicity against Sindbis virus infected african green monkey Vero cells by trypan blue exclusion method	[PMID: 20034711]
Vero	CC₅₀	> 3562 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by neutral red dye based analysis Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by neutral red dye based analysis	[PMID: 36898483]
Vero	CC₅₀	> 400 3 Compound: 73	Cytotoxicity against African green monkey Vero cells by CCK8 assay method Cytotoxicity against African green monkey Vero cells by CCK8 assay method	[PMID: 33070079]
Vero	CC₅₀	> 400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 48 hrs by MTT assay Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 48 hrs by MTT assay	[PMID: 30612844]
Vero	CC₅₀	> 400 6 Compound: ribavirin	Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of Vero cells Cytotoxic concentration required to cause microscopically detectable alteration of normal cell morphology of Vero cells	[PMID: 8709116]
Vero	CC₅₀	> 4094 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by visual analysis Cytotoxicity against African green monkey Vero cells infected in Pichinde virus AN 4763 by visual analysis	[PMID: 36898483]
Vero	CC₅₀	> 4094 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells infected with Tacaribe virus TRVL11573 by visual analysis Cytotoxicity against African green monkey Vero cells infected with Tacaribe virus TRVL11573 by visual analysis	[PMID: 36898483]
Vero	CC₅₀	> 410 3 Compound: Ribavirin	Cytotoxicity against DENV serotype 2 strain New Guinea C infected african green monkey Vero B cells by virus yield-reduction assay Cytotoxicity against DENV serotype 2 strain New Guinea C infected african green monkey Vero B cells by virus yield-reduction assay	[PMID: 25791449]
Vero	CC₅₀	> 4100 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero cells by luciferase-based cell viability assay Cytotoxicity against African green monkey Vero cells by luciferase-based cell viability assay	[PMID: 18955536]
Vero	CC₅₀	> 500 3 Compound: Ribavirin	Cytotoxicity against Vero cells Cytotoxicity against Vero cells	[PMID: 17181162]
Vero	CC₅₀	> 850 3 Compound: ribavirin	Cytotoxicity against Vero E6 cells Cytotoxicity against Vero E6 cells	[PMID: 17336519]
Vero	EC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Tacaribe virus TRVL11573 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days Antiviral activity against Tacaribe virus TRVL11573 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days	[PMID: 17606691]
Vero	EC₅₀	100 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus in Vero cells Antiviral activity against Punta Toro virus in Vero cells	[PMID: 17181162]
Vero	EC₅₀	100 3 Compound: Ribavirin	Antiviral activity against reovirus 1 in Vero cells Antiviral activity against reovirus 1 in Vero cells	[PMID: 17181162]
Vero	EC₅₀	11 3 Compound: Ribavirin	Antiviral activity against Junin virus Candid-1 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days Antiviral activity against Junin virus Candid-1 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days	[PMID: 17606691]
Vero	EC₅₀	111 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay	[PMID: 20034711]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 26001344]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Para-influenza-3 virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Para-influenza-3 virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Yellow fever virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Yellow fever virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against para influenza 3 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against para influenza 3 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	112 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Vero	EC₅₀	112 6 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero	EC₅₀	112 6 Compound: Ribavirin	Antiviral activity against Reovirus 1 virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Reovirus 1 virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero	EC₅₀	119 3 Compound: Ribavirin	Inhibition of West Nile viral Rluc-Neo-Rep in Vero cells Inhibition of West Nile viral Rluc-Neo-Rep in Vero cells	[PMID: 16539402]
Vero	EC₅₀	120 6 Compound: ribavirin	Antiviral activity against Parainfluenza 3 in Vero cells reduction of virus-induced cytopathogenicity after 4 days Antiviral activity against Parainfluenza 3 in Vero cells reduction of virus-induced cytopathogenicity after 4 days	[PMID: 17948980]
Vero	EC₅₀	120 6 Compound: ribavirin	Antiviral activity against Sindbis virus in Vero cells reduction of virus-induced cytopathogenicity after 4 days Antiviral activity against Sindbis virus in Vero cells reduction of virus-induced cytopathogenicity after 4 days	[PMID: 17948980]
Vero	EC₅₀	121 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Parainfluenza virus 3 infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Vero	EC₅₀	125 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Punta Toro virus infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Vero	EC₅₀	126 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	126 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
Vero	EC₅₀	126 3 Compound: ribavirin	Antiviral activity against Punts virus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Punts virus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
Vero	EC₅₀	12 6 Compound: Ribavirin	Antiviral activity against Pichinde virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect Antiviral activity against Pichinde virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect	[PMID: 31431358]
Vero	EC₅₀	13 3 Compound: Ribavirin	Antiviral activity against Pichinde virus An 4763 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days Antiviral activity against Pichinde virus An 4763 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days	[PMID: 17606691]
Vero	EC₅₀	13.5 3 Compound: RIBA	Antiviral activity against DENV-2 New guinea infected in African green monkey Vero cells assessed as reduction in plaque formation administered post viral infection after 8 days by crystal violet staining technique Antiviral activity against DENV-2 New guinea infected in African green monkey Vero cells assessed as reduction in plaque formation administered post viral infection after 8 days by crystal violet staining technique	[PMID: 26638041]
Vero	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Punta Toro virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Vero	EC₅₀	146 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
Vero	EC₅₀	146 3 Compound: ribavirin	Antiviral activity against Reovirus 1 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Reovirus 1 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Vero	EC₅₀	146 3 Compound: ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
Vero	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Vero	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Para influenza-3 virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Para influenza-3 virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Vero	EC₅₀	146 6 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Vero	EC₅₀	146 6 Compound: ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Vero	EC₅₀	150 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Punta Toro virus expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Vero	EC₅₀	150 3 Compound: ribavirin	Antiviral activity against Punta Toro virus in Vero cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against Punta Toro virus in Vero cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
Vero	EC₅₀	150 3 Compound: ribavirin	Antiviral activity against parainfluenza 3 virus in Vero cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against parainfluenza 3 virus in Vero cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
Vero	EC₅₀	18.5 3 Compound: Ribavirin	Antiviral activity against Junin virus IV4454 infected in african green monkey Vero cells assessed as reduction in virus yield after 48 hrs by plaque assay Antiviral activity against Junin virus IV4454 infected in african green monkey Vero cells assessed as reduction in virus yield after 48 hrs by plaque assay	[PMID: 21115214]
Vero	EC₅₀	18.5 3 Compound: Ribavirin	Antiviral activity against Junin virus IV4454 infected in African green monkey Vero cells assessed as reduction in vrius yield after 48 hrs by plaque assay Antiviral activity against Junin virus IV4454 infected in African green monkey Vero cells assessed as reduction in vrius yield after 48 hrs by plaque assay	[PMID: 30612844]
Vero	EC₅₀	183 3 Compound: 1	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20207546]
Vero	EC₅₀	196 3 Compound: Ribavirin	Effective concentration required to inhibit parainfluenza-3 virus-induced cytopathicity by 50% in Vero cell lines Effective concentration required to inhibit parainfluenza-3 virus-induced cytopathicity by 50% in Vero cell lines	[PMID: 11495586]
Vero	EC₅₀	2.42 3 Compound: Ribavirin	Antiviral activity against Chikungunya virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection Antiviral activity against Chikungunya virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection	[PMID: 31843348]
Vero	EC₅₀	20.8 3 Compound: 9	Inhibition of RNA-dependent RNA polymerase in Zika virus MR766 infected in African green monkey Vero cells assessed as antiviral activity after 72 hrs by DAPI staining based assay Inhibition of RNA-dependent RNA polymerase in Zika virus MR766 infected in African green monkey Vero cells assessed as antiviral activity after 72 hrs by DAPI staining based assay	[PMID: 31549836]
Vero	EC₅₀	200 6 Compound: ribavirin	Antiviral activity against Reovirus 1 in Vero cells reduction of virus-induced cytopathogenicity after 4 days Antiviral activity against Reovirus 1 in Vero cells reduction of virus-induced cytopathogenicity after 4 days	[PMID: 17948980]
Vero	EC₅₀	240 6 Compound: ribavirin	Antiviral activity against coxsackie B4 virus in Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against coxsackie B4 virus in Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
Vero	EC₅₀	240 6 Compound: ribavirin	Antiviral activity against sindbis virus in Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against sindbis virus in Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
Vero	EC₅₀	250 3 Compound: Ribavirin	Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
Vero	EC₅₀	250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Vero	EC₅₀	250 3 Compound: ribavirin	Antiviral activity against reovirus1 virus in Vero cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against reovirus1 virus in Vero cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
Vero	EC₅₀	250 3 Compound: ribavirin	Antiviral activity against Sindbis virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Sindbis virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Vero	EC₅₀	250 6 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero	EC₅₀	28 3 Compound: Ribavirin	Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as inhibition of virus induced cytopathic effect by microscopic analysis Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as inhibition of virus induced cytopathic effect by microscopic analysis	[PMID: 18955536]
Vero	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
Vero	EC₅₀	29 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	3.95 3 Compound: Ribavirin	Antiviral activity against Zika virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection Antiviral activity against Zika virus infected in African green monkey Vero cells assessed as reduction in viral replication treated with compound at 1 hr post-viral infection	[PMID: 31843348]
Vero	EC₅₀	30 3 Compound: Ribavirin	Inhibition of Rluc-FL-WNV replicon in Vero cells Inhibition of Rluc-FL-WNV replicon in Vero cells	[PMID: 16539402]
Vero	EC₅₀	300 3 Compound: Ribavirin	Antiviral activity against para influenza 3 virus in Vero cells Antiviral activity against para influenza 3 virus in Vero cells	[PMID: 17181162]
Vero	EC₅₀	35 3 Compound: Ribavirin	Antiviral activity against RSV infected in African green monkey Vero 76 cells after 5 days by plaque reduction assay Antiviral activity against RSV infected in African green monkey Vero 76 cells after 5 days by plaque reduction assay	[PMID: 25913116]
Vero	EC₅₀	40 3 Compound: Ribavirin	Effective concentration required to inhibit PuntaToro virus-induced cytopathicity by 50% in Vero cell lines Effective concentration required to inhibit PuntaToro virus-induced cytopathicity by 50% in Vero cell lines	[PMID: 11495586]
Vero	EC₅₀	40 3 Compound: Ribavirin	Effective concentration required to inhibit reovirus-induced cytopathicity by 50% in Vero cell lines Effective concentration required to inhibit reovirus-induced cytopathicity by 50% in Vero cell lines	[PMID: 11495586]
Vero	EC₅₀	40 6 Compound: ribavirin	Antiviral activity against Punta Toro virus in Vero cells reduction of virus-induced cytopathogenicity after 4 days Antiviral activity against Punta Toro virus in Vero cells reduction of virus-induced cytopathogenicity after 4 days	[PMID: 17948980]
Vero	EC₅₀	42 3 Compound: ribavirin	Antiviral activity against DENV serotype 2 strain New Guinea V infected in African green monkey Vero B cells assessed as inhibition of virus replication after 4 days by qRT-PCR analysis Antiviral activity against DENV serotype 2 strain New Guinea V infected in African green monkey Vero B cells assessed as inhibition of virus replication after 4 days by qRT-PCR analysis	[PMID: 26039671]
Vero	EC₅₀	45 3 Compound: Ribavirin	Antiviral activity against Human parainfluenza virus 3 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human parainfluenza virus 3 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Vero	EC₅₀	45 6 Compound: Ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Vero	EC₅₀	45 6 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Parainfluenza virus type 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Vero	EC₅₀	47.9 3 Compound: Ribavirin	Antiviral activity against DENV serotype 2 strain New Guinea C infected in african green monkey Vero cells assessed as reduction in production and release of infectious progeny virions after 2 hrs by virus yield-reduction assay Antiviral activity against DENV serotype 2 strain New Guinea C infected in african green monkey Vero cells assessed as reduction in production and release of infectious progeny virions after 2 hrs by virus yield-reduction assay	[PMID: 25791449]
Vero	EC₅₀	48 6 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
Vero	EC₅₀	48 6 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
Vero	EC₅₀	48 6 Compound: ribavirin	Antiviral activity against parainfluenza3 virus in Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against parainfluenza3 virus in Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
Vero	EC₅₀	48 6 Compound: ribavirin	Antiviral activity against punta toro virus in Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against punta toro virus in Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
Vero	EC₅₀	48 6 Compound: ribavirin	Antiviral activity against reovirus1 in Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against reovirus1 in Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 17298047]
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity by MTT assay Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity by MTT assay	[PMID: 20034711]
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	50 3 Compound: Ribavirin	Antiviral activity against Human parainfluenza virus 3 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Human parainfluenza virus 3 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Vero	EC₅₀	50 3 Compound: ribavirin	Antiviral activity against sindbis virus in Vero cells assessed as reduction of virus plaque formation after 7 days Antiviral activity against sindbis virus in Vero cells assessed as reduction of virus plaque formation after 7 days	[PMID: 17539622]
Vero	EC₅₀	50 3 Compound: ribavirin	Antiviral activity against Punta Toro virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Punta Toro virus in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Vero	EC₅₀	64 3 Compound: d	concentration required to inhibit Punta Toro virus-induced cytopathicity by 50% in Vero cells concentration required to inhibit Punta Toro virus-induced cytopathicity by 50% in Vero cells	[PMID: 9748360]
Vero	EC₅₀	64 3 Compound: d	concentration required to inhibit Sindbis virus -induced cytopathicity by 50% in Vero cells concentration required to inhibit Sindbis virus -induced cytopathicity by 50% in Vero cells	[PMID: 9748360]
Vero	EC₅₀	64 3 Compound: d	concentration required to inhibit parainfluenza-3 virus-induced cytopathicity by 50% in Vero cells concentration required to inhibit parainfluenza-3 virus-induced cytopathicity by 50% in Vero cells	[PMID: 9748360]
Vero	EC₅₀	64 3 Compound: d	concentration required to inhibit reovirus-1-induced cytopathicity by 50% in Vero cells concentration required to inhibit reovirus-1-induced cytopathicity by 50% in Vero cells	[PMID: 9748360]
Vero	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against RSV A2 infected in african green monkey Vero cells after 5 days by plaque reduction assay Antiviral activity against RSV A2 infected in african green monkey Vero cells after 5 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 5 days by plaque reduction assay Antiviral activity against Respiratory syncytial virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 5 days by plaque reduction assay	[PMID: 25082514]
Vero	EC₅₀	73.5 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Parainfluenza virus 3 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Vero	EC₅₀	80 6 Compound: Ribavirin	Antiviral activity against Reovirus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Reovirus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Parainfluenza virus 3 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
Vero	EC₅₀	85 3 Compound: Ribavirin	Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Parainfluenza virus 3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Vero	EC₅₀	9.3 6 Compound: Ribavirin	Antiviral activity against Tacaribe virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect Antiviral activity against Tacaribe virus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect	[PMID: 31431358]
Vero	EC₅₀	95 3 Compound: Ribavirin	Antiviral activity against PIV 3 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay Antiviral activity against PIV 3 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay	[PMID: 20034711]
Vero	EC₅₀	95 3 Compound: Ribavirin	Antiviral activity against West Nile virus infected in African green monkey Vero cells incubated for 4 days by crystal violet staining based plaque reduction assay Antiviral activity against West Nile virus infected in African green monkey Vero cells incubated for 4 days by crystal violet staining based plaque reduction assay	[PMID: 30721061]
Vero	EC₅₀	95 6 Compound: Ribavirin	Antiviral activity against parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against parainfluenza-3 virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against HSV1 KOS infected in african green monkey Vero cells after 3 days by plaque reduction assay Antiviral activity against HSV1 KOS infected in african green monkey Vero cells after 3 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B2 Ohio-1 infected in african green monkey Vero cells after 3 days by plaque reduction assay Antiviral activity against Human coxsackievirus B2 Ohio-1 infected in african green monkey Vero cells after 3 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Polio virus type1 Sabin strain Chat infected in african green monkey Vero cells after 2 days by plaque reduction assay Antiviral activity against Polio virus type1 Sabin strain Chat infected in african green monkey Vero cells after 2 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Vaccinia virus Elstree-Lister infected in african green monkey Vero cells after 3 days by plaque reduction assay Antiviral activity against Vaccinia virus Elstree-Lister infected in african green monkey Vero cells after 3 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay	[PMID: 25082514]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against HSV1 infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay Antiviral activity against HSV1 infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay	[PMID: 25082514]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Poliovirus type 1 Sabin strain infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 2 days by plaque reduction assay Antiviral activity against Poliovirus type 1 Sabin strain infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 2 days by plaque reduction assay	[PMID: 25082514]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Vaccinia Virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay Antiviral activity against Vaccinia Virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay	[PMID: 25082514]
Vero	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Vesicular stomatitis virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 2 days by plaque reduction assay Antiviral activity against Vesicular stomatitis virus infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 2 days by plaque reduction assay	[PMID: 25082514]
Vero	EC₅₀	> 1600 3 Compound: Ribavirin	Effective concentration required to inhibit respiratory synaptial (RSV) virus-induced cytopathicity by 50% in Vero cell lines Effective concentration required to inhibit respiratory synaptial (RSV) virus-induced cytopathicity by 50% in Vero cell lines	[PMID: 11495586]
Vero	EC₅₀	> 1600 3 Compound: d	concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in Vero cells concentration required to inhibit Coxsackie virus B4-induced cytopathicity by 50% in Vero cells	[PMID: 9748360]
Vero	EC₅₀	> 200 6 Compound: ribavirin	Antiviral activity against Coxsackie virus B4 in Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackie virus B4 in Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 17948980]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Mammalian orthoreovirus 1 virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Mammalian orthoreovirus 1 virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay Antiviral activity against Sindbis virus infected Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay	10.1007/s00044-009-9248-y
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay Antiviral activity against Human coxsackievirus B4 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay	[PMID: 20034711]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Sindbis virus infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 days	[PMID: 22459876]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathogenicity	[PMID: 22464686]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity	[PMID: 23911856]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Reovirus 1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Reovirus 1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 24312722]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 26001344]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Reovirus-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis	[PMID: 26114811]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Coxsackievirus B4 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Reovirus 1 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Reovirus 1 expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity Antiviral activity against Sindbis virus expressed in African green monkey Vero cells assessed as reduction in cytopathogenicity	[PMID: 26291038]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Coxsackie virus B4 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Reovirus-1 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect measured after 3 to 5 days by microscopic analysis	[PMID: 27979594]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Coxsackie B4 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Coxsackie B4 virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Reovirus 1 infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Reovirus 1 infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Sindbis virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Yellow fever virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis Antiviral activity against Yellow fever virus infected in African green monkey Vero cells assessed as inhibition of viral-induced cytopathic effect measured after 3 to 6 days post infection by microscopic analysis	[PMID: 28477572]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Human coxsackievirus B4 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Human coxsackievirus B4 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Mammalian orthoreovirus 1 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Mammalian orthoreovirus 1 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Vero	EC₅₀	> 250 3 Compound: Ribavirin	Antiviral activity against Sendai virus infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay Antiviral activity against Sendai virus infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay	[PMID: 32214762]
Vero	EC₅₀	> 250 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
Vero	EC₅₀	> 250 3 Compound: ribavirin	Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
Vero	EC₅₀	> 250 3 Compound: ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathogenicity	[PMID: 23811093]
Vero	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Vero	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Vero	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as reduction in virus-induced cytopathogenicity after 3 days	[PMID: 18851889]
Vero	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Coxsackie virus B4 infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Vero	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Reovirus-1 infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Vero	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as protection against virus-induced cytopathogenicity after 2 days	[PMID: 20724039]
Vero	EC₅₀	> 250 6 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus induced cytopathicity after 2 to 4 days by MTS assay	[PMID: 20971531]
Vero	EC₅₀	> 250 6 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Coxsackievirus B4 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Vero	EC₅₀	> 250 6 Compound: ribavirin	Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days	[PMID: 19419804]
Vero	EC₅₀	> 250 6 Compound: ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days postinfection Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity after 3 days postinfection	[PMID: 19419804]
Vero	EC₅₀	> 400 6 Compound: Ribavirin	Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathicity	[PMID: 20377249]
Vero	EC₅₀	> 50 3 Compound: ribavirin	Antiviral activity against Parainfluenza virus type 3 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Parainfluenza virus type 3 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Vero	EC₅₀	> 500 3 Compound: Ribavirin	Antiviral activity against Sindbis virus in Vero cells Antiviral activity against Sindbis virus in Vero cells	[PMID: 17181162]
Vero	EC₅₀	>= 174 3 Compound: Ribavirin	Antiviral activity against Mammalian orthoreovirus 1 infected in Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Mammalian orthoreovirus 1 infected in Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 21565516]
Vero	EC₅₀	>= 250 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B4 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity Antiviral activity against Coxsackievirus B4 in african green monkey Vero cells assessed as protection against virus-induced cytopathicity	[PMID: 19281225]
Vero	ED₅₀	0.00016 41 Compound: 3	In vitro antiviral activity against parainfluenza type 3 virus in Vero cells. In vitro antiviral activity against parainfluenza type 3 virus in Vero cells.	[PMID: 3950908]
Vero	ED₅₀	0.00016 41 Compound: Ribavirin	In vitro antiviral activity against Parainfluenza type 3 was evaluated. In vitro antiviral activity against Parainfluenza type 3 was evaluated.	[PMID: 4020823]
Vero	ED₅₀	0.00019 41 Compound: 3	In vitro antiviral activity against herpes simplex virus type 2 (HSV-2) in Vero cells. In vitro antiviral activity against herpes simplex virus type 2 (HSV-2) in Vero cells.	[PMID: 3950908]
Vero	ED₅₀	0.00019 41 Compound: Ribavirin	In vitro antiviral activity against herpes simplex virus type 2 virus was evaluated. In vitro antiviral activity against herpes simplex virus type 2 virus was evaluated.	[PMID: 4020823]
Vero	ED₅₀	9.9 x 10^-5 41 Compound: 3	In vitro antiviral activity against measles virus in Vero cells In vitro antiviral activity against measles virus in Vero cells	[PMID: 3950908]
Vero	ED₅₀	9.0 x 10^-5 41 Compound: 3	In vitro antiviral activity against vaccinia virus in Vero cells. In vitro antiviral activity against vaccinia virus in Vero cells.	[PMID: 3950908]
Vero	ED₅₀	3.3 x 10^-5 41 Compound: Ribavirin	In vitro antiviral activity against measles virus was evaluated. In vitro antiviral activity against measles virus was evaluated.	[PMID: 4020823]
Vero	ED₅₀	8.5 x 10^-5 41 Compound: Ribavirin	In vitro antiviral activity against vaccinia virus was evaluated. In vitro antiviral activity against vaccinia virus was evaluated.	[PMID: 4020823]
Vero	IC₅₀	0.04 3 Compound: Ribavirin	Antiviral activity against Hepatitis C virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against Hepatitis C virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect	[PMID: 27262598]
Vero	IC₅₀	0.7 6 Compound: ribavirin	Antiviral activity against Reovirus1 in vero cells Antiviral activity against Reovirus1 in vero cells	[PMID: 17518459]
Vero	IC₅₀	0.9 2 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect after 48 hrs by Reed-Muench analysis Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as protection against virus-induced cytopathic effect after 48 hrs by Reed-Muench analysis	[PMID: 24070022]
Vero	IC₅₀	10 3 Compound: Ribavirin	Antiviral activity against Herpes simplex virus type 1 L2 infected in African green monkey Vero E6 cells assessed as reduction of virus-induced cytopathic effect Antiviral activity against Herpes simplex virus type 1 L2 infected in African green monkey Vero E6 cells assessed as reduction of virus-induced cytopathic effect	[PMID: 27262598]
Vero	IC₅₀	1197.58 3 Compound: RBV	Antiviral activity against coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption Antiviral activity against coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect dosed 1 hr after viral adsorption	[PMID: 26132528]
Vero	IC₅₀	1200 3 Compound: ribavirin	Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 26110443]
Vero	IC₅₀	13.3 3 Compound: Ribavirin	Antiviral activity against human EV71 infected in African green monkey Vero cells assessed as reduction in cytopathic effect by CCK-8 assay Antiviral activity against human EV71 infected in African green monkey Vero cells assessed as reduction in cytopathic effect by CCK-8 assay	[PMID: 32937282]
Vero	IC₅₀	13.3 3 Compound: Ribavirin	Antiviral activity against human EV71 infected in African green monkey Vero cells assessed as reduction in cytopathic effect incubated for 72 to 96 hrs by CCK-8 assay Antiviral activity against human EV71 infected in African green monkey Vero cells assessed as reduction in cytopathic effect incubated for 72 to 96 hrs by CCK-8 assay	[PMID: 32937282]
Vero	IC₅₀	1576.11 3 Compound: Ribavirin	Antiviral activity against Coxsackie B3 virus Nancy in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs Antiviral activity against Coxsackie B3 virus Nancy in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs	[PMID: 23999140]
Vero	IC₅₀	160 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Reo-1 in Vero cell line Tested for inhibitory effect on RNA virus Reo-1 in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	1690 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
Vero	IC₅₀	1708 3 Compound: RBV	Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
Vero	IC₅₀	1951 3 Compound: RBV	Antiviral activity against Coxsackievirus B1 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B1 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
Vero	IC₅₀	2088 3 Compound: RBV	Antiviral activity against Coxsackievirus B6 Schmitt infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B6 Schmitt infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	2088 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B6 (strain Schmitt) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B6 (strain Schmitt) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	20 6 Compound: ribavirin	Antiviral activity against Punta Toro virus in vero cells Antiviral activity against Punta Toro virus in vero cells	[PMID: 17518459]
Vero	IC₅₀	20 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus Coxsackie B4 in Vero cell line Tested for inhibitory effect on RNA virus Coxsackie B4 in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	20 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus PV-3 in Vero cell line Tested for inhibitory effect on RNA virus PV-3 in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	2101 3 Compound: RBV	Antiviral activity against Coxsackievirus B2 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B2 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
Vero	IC₅₀	2119 3 Compound: RBV	Antiviral activity against Enterovirus 71 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis Antiviral activity against Enterovirus 71 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis	[PMID: 21880491]
Vero	IC₅₀	222.2 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 23734721]
Vero	IC₅₀	2340 3 Compound: RBV	Antiviral activity against Human enterovirus 71 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Human enterovirus 71 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
Vero	IC₅₀	2375 3 Compound: RBV	Antiviral activity against Coxsackievirus B1 Conn 5 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B1 Conn 5 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	2375 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B1 Conn-5 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B1 Conn-5 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	253.1 3 Compound: Ribavirin	Antiviral activity against Enterovirus 71 BrCr infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay Antiviral activity against Enterovirus 71 BrCr infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay	[PMID: 24679044]
Vero	IC₅₀	26.7 3 Compound: ribavirin	Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay	[PMID: 26260336]
Vero	IC₅₀	286.8 3 Compound: Ribavirin	Inhibitory concentration against parainfluenza-3 virus in vero cells Inhibitory concentration against parainfluenza-3 virus in vero cells	[PMID: 7658442]
Vero	IC₅₀	292 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27792321]
Vero	IC₅₀	3316 3 Compound: RBV	Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	3316 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B5 Faulkner infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	37.3 3 Compound: ribavirin	Antiviral activity against Rift Valley fever virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay Antiviral activity against Rift Valley fever virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay	[PMID: 26260336]
Vero	IC₅₀	379.1 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 Nancy infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B3 Nancy infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	379.12 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B3 (strain Nancy) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B3 (strain Nancy) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	38.49 6 Compound: RBV	Antiviral activity against Herpes simplex virus 1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect by microscopic analysis Antiviral activity against Herpes simplex virus 1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect by microscopic analysis	[PMID: 30578076]
Vero	IC₅₀	4090 3 Compound: RBV	Antiviral activity against Coxsackievirus A16 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Coxsackievirus A16 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
Vero	IC₅₀	447.8 6 Compound: RVB	Antiviral activity against Coxsackie virus B3 growth by 50% in Vero cells Antiviral activity against Coxsackie virus B3 growth by 50% in Vero cells	[PMID: 15603937]
Vero	IC₅₀	5.2 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus JV in Vero cell line Tested for inhibitory effect on RNA virus JV in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	6.4 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus TV in Vero cell line Tested for inhibitory effect on RNA virus TV in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	694.6 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B3 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
Vero	IC₅₀	82 3 Compound: ribavirin	Antiviral activity against SARS-CoV Frankfurt1 in Vero E6 cells by plaque reduction assay Antiviral activity against SARS-CoV Frankfurt1 in Vero E6 cells by plaque reduction assay	[PMID: 17336519]
Vero	IC₅₀	884.9 3 Compound: Ribavirin	Antiviral activity against CVB3 infected in African green monkey Vero cells by MTT assay Antiviral activity against CVB3 infected in African green monkey Vero cells by MTT assay	[PMID: 31735601]
Vero	IC₅₀	909.96 3 Compound: Ribavirin	Antiviral activity against Coxsackie B6 virus Schmitt in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs Antiviral activity against Coxsackie B6 virus Schmitt in african green monkey Vero cells assessed as inhibition virus-induced cytopathic effect after 48 hrs	[PMID: 23999140]
Vero	IC₅₀	910 3 Compound: RBV	Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method Antiviral activity against Coxsackievirus B6 infected in african green monkey Vero cells assessed as inhibition of viral growth after 24 hrs by Reed-Muench method	[PMID: 21441033]
Vero	IC₅₀	910 3 Compound: RBV	Antiviral activity against Coxsackievirus B3 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis Antiviral activity against Coxsackievirus B3 infected in african green monkey vero cells assessed as inhibition of viral replication by Reed-Muench analysis	[PMID: 21880491]
Vero	IC₅₀	910.8 3 Compound: RBV	Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero cells assessed as reduction in viral-induced cytopathic effect	[PMID: 25699158]
Vero	IC₅₀	9622 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus A16 shzh05-1 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus A16 shzh05-1 infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	> 400 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay	[PMID: 21115214]
Vero	IC₅₀	> 400 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus cell morphology in Vero cell line Tested for inhibitory effect on RNA virus cell morphology in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	> 40948 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B2 (strain Ohio-1) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B2 (strain Ohio-1) infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	> 40948 3 Compound: Ribavirin	Antiviral activity against Coxsackievirus B4 J.V.B infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis Antiviral activity against Coxsackievirus B4 J.V.B infected in African green monkey Vero cells assessed as reduction in viral-induced cytopathic effect by Reed and Muench analysis	[PMID: 28109785]
Vero	IC₅₀	> 500 3 Compound: RBV	Antiviral activity against Coxsackievirus B2 Ohio-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B2 Ohio-1 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	> 500 3 Compound: RBV	Antiviral activity against Coxsackievirus B4 JVB infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect Antiviral activity against Coxsackievirus B4 JVB infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect	[PMID: 27750147]
Vero	IC₅₀	>= 235 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus SFV in Vero cell line Tested for inhibitory effect on RNA virus SFV in Vero cell line	[PMID: 8246242]
Vero	IC₅₀	>= 250 6 Compound: ribavirin	Tested for inhibitory effect on RNA virus SV in Vero cell line Tested for inhibitory effect on RNA virus SV in Vero cell line	[PMID: 8246242]
Vero 76	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against mock-infected african green monkey Vero 76 cells after 48 to 96 hrs by MTT assay Cytotoxicity against mock-infected african green monkey Vero 76 cells after 48 to 96 hrs by MTT assay	[PMID: 25082514]
Vero 76	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by MTT method Cytotoxicity against African green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by MTT method	[PMID: 25913116]
Vero 76	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by crystal violet staining method Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by crystal violet staining method	[PMID: 26443549]
Vero 76	CC₅₀	> 100 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero 76 cells assessed as decrease in cell viability after 48 to 96 hrs by MTT assay Cytotoxicity against African green monkey Vero 76 cells assessed as decrease in cell viability after 48 to 96 hrs by MTT assay	[PMID: 29028528]
Vero 76	CC₅₀	> 1000 3 Compound: ribavirin	Cytotoxicity against African green monkey Vero 76 cells Cytotoxicity against African green monkey Vero 76 cells	[PMID: 26260336]
Vero 76	CC₅₀	> 1000 3 Compound: ribavirin	Cytotoxicity against African green monkey Vero 76 cells relative to control Cytotoxicity against African green monkey Vero 76 cells relative to control	[PMID: 26260336]
Vero 76	CC₅₀	> 4094 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero 76 cells infected with Rift Valley fever virus MP-12 by neutral red dye based analysis Cytotoxicity against African green monkey Vero 76 cells infected with Rift Valley fever virus MP-12 by neutral red dye based analysis	[PMID: 36898483]
Vero 76	CC₅₀	> 4094 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero 76 cells infected with Rift Valley fever virus MP-12 by visual analysis Cytotoxicity against African green monkey Vero 76 cells infected with Rift Valley fever virus MP-12 by visual analysis	[PMID: 36898483]
Vero 76	EC₅₀	1.2 3 Compound: Ribavirin	Antiviral activity against Human respiratory syncytial virus A2 ATCC VR 1540 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 5 days by crystal violet staining-based plaque reduction assay Antiviral activity against Human respiratory syncytial virus A2 ATCC VR 1540 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 5 days by crystal violet staining-based plaque reduction assay	[PMID: 29028528]
Vero 76	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against Respiratory syncytial virus A2 infected in Vero-76 cells after 5 days by plaque reduction assay Antiviral activity against Respiratory syncytial virus A2 infected in Vero-76 cells after 5 days by plaque reduction assay	[PMID: 19482481]
Vero 76	EC₅₀	7 3 Compound: Ribavirin	Antiviral activity against human RSV infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by plaque reduction assay Antiviral activity against human RSV infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by plaque reduction assay	[PMID: 26443549]
Vero 76	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Coxsackie virus type B2 virus infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay Antiviral activity against Coxsackie virus type B2 virus infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay	[PMID: 19482481]
Vero 76	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against HSV1 infected in Vero-76 cells after 3 days by plaque reduction assay Antiviral activity against HSV1 infected in Vero-76 cells after 3 days by plaque reduction assay	[PMID: 19482481]
Vero 76	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against Human poliovirus 1 Sabin infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity by plaque reduction assay Antiviral activity against Human poliovirus 1 Sabin infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity by plaque reduction assay	[PMID: 26443549]
Vero 76	EC₅₀	> 100 3 Compound: Ribavirin	Antiviral activity against human CVB5 infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 3 days by plaque reduction assay Antiviral activity against human CVB5 infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 3 days by plaque reduction assay	[PMID: 26443549]
Vero C1008	CC₅₀	> 100 3 Compound: RBV	Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell viability Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell viability	[PMID: 31902708]
Vero C1008	CC₅₀	> 160 3 Compound: R	Cytotoxicity against African green monkey Vero E6 cells infected with ZIKV COL345Si measured after 6 days by MTT assay Cytotoxicity against African green monkey Vero E6 cells infected with ZIKV COL345Si measured after 6 days by MTT assay	[PMID: 35969814]
Vero C1008	CC₅₀	> 160 3 Compound: R	Cytotoxicity against African green monkey Vero E6 cells infected with Zika 459148 measured after 72 hrs by MTT assay Cytotoxicity against African green monkey Vero E6 cells infected with Zika 459148 measured after 72 hrs by MTT assay	[PMID: 35969814]
Vero C1008	CC₅₀	> 200 3 Compound: Ribavirin	Cytotoxicity in African green monkey Vero E6 cells assessed as reduction in cell viability Cytotoxicity in African green monkey Vero E6 cells assessed as reduction in cell viability	[PMID: 32378892]
Vero C1008	CC₅₀	> 400 3 Compound: 5	Cytotoxicity against African green monkey Vero E6 cells by the CCK8 assay Cytotoxicity against African green monkey Vero E6 cells by the CCK8 assay	[PMID: 32845145]
Vero C1008	CC₅₀	> 400 3 Compound: 53	Cytotoxicity against African green monkey Vero E6 cells by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells by CCK-8 assay	[PMID: 33486200]
Vero C1008	CC₅₀	> 400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells by CCK8 assay Cytotoxicity against African green monkey Vero E6 cells by CCK8 assay	[PMID: 32511912]
Vero C1008	CC₅₀	> 400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells assessed as reduction of cell viability measured after 48 hrs by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells assessed as reduction of cell viability measured after 48 hrs by CCK-8 assay	[PMID: 32563814]
Vero C1008	CC₅₀	> 400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells assessed as cell growth inhibition measured after 48 hrs by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells assessed as cell growth inhibition measured after 48 hrs by CCK-8 assay	[PMID: 32992245]
Vero C1008	CC₅₀	> 400 3 Compound: Ribavirin	Cytotoxicity against African green monkey Vero E6 cells infected with SARS-COV-2 by celltiter-glo luminescent cell viability assay Cytotoxicity against African green monkey Vero E6 cells infected with SARS-COV-2 by celltiter-glo luminescent cell viability assay	[PMID: 34273661]
Vero C1008	EC₅₀	109.5 3 Compound: 53	Antiviral activity against SARS-CoV infected in Vero E6 cells assessed as reduction in viral replication measured after 48 hrs by qRT-PCR assay Antiviral activity against SARS-CoV infected in Vero E6 cells assessed as reduction in viral replication measured after 48 hrs by qRT-PCR assay	[PMID: 33486200]
Vero C1008	EC₅₀	33 3 Compound: RBV	Antiviral activity against Zika virus infected in African green monkey Vero E6 cells assessed as reduction in viral induced cytopathic effect Antiviral activity against Zika virus infected in African green monkey Vero E6 cells assessed as reduction in viral induced cytopathic effect	[PMID: 31902708]
Vero C1008	EC₅₀	33 3 Compound: Ribavirin	Antiviral activity against Zika virus infected in Vero E6 cells assessed as reduction in virus-induced cytopathic effect incubated for 96 hrs by CCK8 assay Antiviral activity against Zika virus infected in Vero E6 cells assessed as reduction in virus-induced cytopathic effect incubated for 96 hrs by CCK8 assay	[PMID: 32378892]
Vero C1008	IC₅₀	1024 3 Compound: Ribavirin	Antiviral activity against HSV-1 L2/Rp-ACV/2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against HSV-1 L2/Rp-ACV/2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
Vero C1008	IC₅₀	1024 3 Compound: Ribavirin	Antiviral activity against acyclovir and cidofovir-resistant HSV-1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against acyclovir and cidofovir-resistant HSV-1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
Vero C1008	IC₅₀	1024 3 Compound: Ribavirin	Antiviral activity against acyclovir and foscarnet-resistant HSV-1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against acyclovir and foscarnet-resistant HSV-1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
Vero C1008	IC₅₀	1024 3 Compound: Ribavirin	Antiviral activity against acyclovir-resistant HSV-1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against acyclovir-resistant HSV-1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
Vero C1008	IC₅₀	1024 3 Compound: Ribavirin	Antiviral activity against foscarnet-resistant HSV-1 F+ infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against foscarnet-resistant HSV-1 F+ infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
Vero C1008	IC₅₀	125 6 Compound: Ribavirin	Antiviral activity against Human herpesvirus 1 L2 infected in African green monkey Vero E6 cells assessed as protection against virus-induced cytopathic effect Antiviral activity against Human herpesvirus 1 L2 infected in African green monkey Vero E6 cells assessed as protection against virus-induced cytopathic effect	[PMID: 29173944]
Vero C1008	IC₅₀	512 3 Compound: Ribavirin	Antiviral activity against HSV1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect Antiviral activity against HSV1 L2 infected in African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect	[PMID: 28408228]
WIL2-NS	IC₅₀	> 100 3 Compound: Ribavirin	Compound was tested for its effect on the proliferation of WIL-2-NS cell line. Compound was tested for its effect on the proliferation of WIL-2-NS cell line.	10.1016/0960-894X(96)00216-8

体外実験

Treatment of LPS-stimulated microglia with 5, 10 and 20 μM Ribavirin (ICN-1229) induces reduction of NO₂ levels for 43% (p<0.05), 53% (p<0.05) and 59% (p<0.05), respectively. Ribavirin (ICN-1229) (10 mM) insignificantly decreases the cell surface area in non-stimulated culture, but significantly reduces cell surface area (by 32%, p<0.05) in LPS-stimulated microglia^[3]. Ribavirin (ICN-1229) is active against DENV, with an EC₅₀ of 3 μM in A549 cells, and combination of CM-10-18 with Ribavirin (ICN-1229) demonstrates a clear enhancement in the reduction of virus replication^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

ALT, AST activities and bilirubin levels are significantly loared by administration of JAT in combination with interferon and Ribavirin (ICN-1229) (p<0.01). JAT, interferon or ribavirin alone with CCl₄, livers appear to exhibit some liver protection against CCl₄ as evident by the presence of normal hepatic cords, absence of necrosis and lesser fatty infiltration. Groups treated with JAT, Peg-interferon and Ribavirin (ICN-1229) separately or in combination shows reduction in the expression of TGF- β and Bax. In the group treated by triple combination of interferon, Ribavirin (ICN-1229), and JAT, the expression level of p53 is markedly reduced^[1].
Ribavirin (ICN-1229) capsules (400 mg of ribavirin)-treated Wistar rats show a significant decrease in activin-A and significant increase in follistatin at the serum and liver levels. Ribavirin (ICN-1229) has strong antiviral activity only when ribavirin is combined with either IFN-α or Peg-IFN-α^[2].
Ribavirin (40 mg/kg, p.o.) significantly improves the antiviral efficacy of CM-10-18 in mice. Ribavirin (ICN-1229) inhibits DENV virus infection in cultured cells, but it is ineffective in reducing viremia in monotherapy^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

臨床実験

分子量

244.20

分子式

C₈H₁₂N₄O₅

CAS 番号

36791-04-5

Appearance

Solid

Color

White to off-white

SMILES

O[C@H]1[C@@H](O)[C@H](N2N=C(C(N)=O)N=C2)O[C@@H]1CO

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

H₂O : 100 mg/mL (409.50 mM; Need ultrasonic)

DMSO : 100 mg/mL (409.50 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	4.0950 mL	20.4750 mL	40.9500 mL
5 mM	0.8190 mL	4.0950 mL	8.1900 mL
10 mM	0.4095 mL	2.0475 mL	4.0950 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）

体積 _（開始）

濃度 _（終了）

体積 _（終了）

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (10.24 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (10.24 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (10.24 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: PBS
Solubility: 110 mg/mL (450.45 mM); Clear solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).

純度とドキュメンテーション

純度: 99.96%

Select Batch:

データシート (284 KB) SDS (418 KB)

COA (254 KB) HNMR (131 KB) RP-HPLC (87 KB) MS (69 KB)

取扱説明書 (2659 KB)

参考文献

[1]. Abdel-Hamid NM, et al. Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in Rats. Asian Pac J Cancer Prev. 2016;17(4):1979-85. [Content Brief]

[2]. Refaat B, et al. The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report. BMC Res Notes. 2015 Jun 26;8:265 [Content Brief]

[3]. Savic D, et al. Ribavirin shows immunomodulatory effects on activated microglia. Immunopharmacol Immunotoxicol. 2014 Dec;36(6):433-41 [Content Brief]

[4]. Chang J, et al. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res. 2011 Jan;89(1):26-34 [Content Brief]

[5]. Robert O Baker, et al. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003 Jan;57(1-2):13-23. [Content Brief]

細胞実験 ^[3]	The effect of Ribavirin (ICN-1229) on microglial cell viability is evaluated by the sulforhodamine B (SRB) chemosensitivity assay. Briefly, LPS-stimulated microglial cells are incubated for 48 h in the presence or absence of Ribavirin (ICN-1229). Afterward, the cells are fixed in 10% (w/v) trichloroacetic acid for 1 h at 4°C, rinsed in tap water and stained with 0.4% (w/v) SRB in 1% acetic acid (100 μL/well) for 30 min at room temperature (RT). The cells are then rinsed three times in 1% acetic acid to remove the unbound stain. The protein bound stain is extracted with 200 μL 10 mM Tris base (pH 10.5) per well. The optical density is read at 540 nm, with correction at 670 nm. The results are presented as percentage of the control (non-stimulated/untreated microglial cells), that is arbitrarily set to 100%. MedChemExpress (MCE) はこれらの方法の精度を確認していません。こちらは参照専用です。
動物実験 ^[4]	The in vivo efficacy experiments are largely performed, using a dengue viremia model in AG129 mouse (defective of both type I and type II interferon receptors). Each experiment contains 6 mice (7 to 8 week-old) per dosing group. The mice are challenged with DENV (serotype 2, TSV01 strain), at 5×10⁶ pfu/mouse via i.p. injection. Imino sugars are dosed twice daily at 12 hr intervals, and ribavirin is dosed once daily, for 3 consecutive days post-infection. Blood samples are drawn 3 days post-infection for determination of plasma virus titer by plaque assay. MedChemExpress (MCE) はこれらの方法の精度を確認していません。こちらは参照専用です。
参考文献	[1]. Abdel-Hamid NM, et al. Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in Rats. Asian Pac J Cancer Prev. 2016;17(4):1979-85. [Content Brief] [2]. Refaat B, et al. The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report. BMC Res Notes. 2015 Jun 26;8:265 [Content Brief] [3]. Savic D, et al. Ribavirin shows immunomodulatory effects on activated microglia. Immunopharmacol Immunotoxicol. 2014 Dec;36(6):433-41 [Content Brief] [4]. Chang J, et al. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res. 2011 Jan;89(1):26-34 [Content Brief] [5]. Robert O Baker, et al. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003 Jan;57(1-2):13-23. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

H₂O / DMSO	1 mM	4.0950 mL	20.4750 mL	40.9500 mL	102.3751 mL
	5 mM	0.8190 mL	4.0950 mL	8.1900 mL	20.4750 mL
	10 mM	0.4095 mL	2.0475 mL	4.0950 mL	10.2375 mL
	15 mM	0.2730 mL	1.3650 mL	2.7300 mL	6.8250 mL
	20 mM	0.2048 mL	1.0238 mL	2.0475 mL	5.1188 mL
	25 mM	0.1638 mL	0.8190 mL	1.6380 mL	4.0950 mL
	30 mM	0.1365 mL	0.6825 mL	1.3650 mL	3.4125 mL
	40 mM	0.1024 mL	0.5119 mL	1.0238 mL	2.5594 mL
	50 mM	0.0819 mL	0.4095 mL	0.8190 mL	2.0475 mL
	60 mM	0.0683 mL	0.3413 mL	0.6825 mL	1.7063 mL
	80 mM	0.0512 mL	0.2559 mL	0.5119 mL	1.2797 mL
	100 mM	0.0410 mL	0.2048 mL	0.4095 mL	1.0238 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Ribavirin Related Classifications

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量		濃度		体積		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）	×	体積 _（開始）	=	濃度 _（終了）	×	体積 _（終了）
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Ribavirin36791-04-5RibasphereHCVRSVOrthopoxvirusAntibioticHepatitis C virusRespiratory syncytial virusInhibitorinhibitorinhibit

日本の代理先をお選びくださいナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
製品名			カスタマ需要量 *
お名前 *			タイトル
メールアドレス *			電話番号 *
デパートメント			組纖名 *
市区町村			都道府県
国或いは地域 *
必ず会社名を記載ください。個人への返信は行いません。
備考

製品名			Lot #
お名前 *			メールアドレス *
電話番号 *			部門 *
組纖名 *			国或いは地域 *
備考

リバビリン (Synonyms: Ribavirin; Ribasphere)

カスタマーレビュー

Other Forms of Ribavirin:

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

Antibiotic アイソフォーム固有の製品をすべて表示:

生物活性

プロトコル

純度とドキュメンテーション

参考文献

カスタマーレビュー

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Ribavirin Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

お名前
メール *

	Sorry, but the email address you supplied was invalid.

リバビリン (Synonyms: Ribavirin; Ribasphere)

カスタマーレビュー

Other Forms of Ribavirin:

リバビリン 関連抗体

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

Antibiotic アイソフォーム固有の製品をすべて表示:

生物活性

プロトコル

純度とドキュメンテーション

参考文献

カスタマーレビュー

リバビリン 関連抗体

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Ribavirin Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

カスタマーレビュー

Request for HNMR Report

Request for HNMR Report

リバビリン関連抗体

リバビリン関連抗体